Skip to main content
  • 156 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Shealy YF, Krauth CA, Montgomery JA (1962) J Org Chem 27:2150–2154

    CAS  Google Scholar 

  2. Playle AC (1976) Drugs of Today 12:20–23

    Google Scholar 

  3. Kazemifard G, Moattar F, Zia H (1979) Arch Pharm 312:573–577

    CAS  Google Scholar 

WM

  1. Loo TL, Householder GE, Gerulath AH et al. (1976) Cancer Treat Rep 60:149–152

    PubMed  CAS  Google Scholar 

  2. Mizuno NS, Decker RW (1976) Biochem Pharmacol 25:2643–2647

    PubMed  CAS  Google Scholar 

  3. Audette RCS, Connors TA, Mandel HG et al. (1973) Biochem Pharmacol 22:1855–1864

    PubMed  CAS  Google Scholar 

  4. Lown JW, Singh R (1982) Biochem Pharmacol 31:1257–1266

    PubMed  CAS  Google Scholar 

  5. Beal DD, Skibba JL, Whitnable KK et al. (1976) Cancer Res 36:2827–2831

    PubMed  CAS  Google Scholar 

  6. Lonn U, Löhn S (1987) Cancer Res 47:26–30

    PubMed  CAS  Google Scholar 

  7. Loo TL, Luce JK, Jardine H et al. (1968) Cancer Res 28:2448–2453

    PubMed  CAS  Google Scholar 

  8. Skibba JL, Ramirez G, Beal DD (1969) Cancer Res 29:1944–1951

    PubMed  CAS  Google Scholar 

  9. Breithaupt H, Dammann A, Aigner K (1982) Cancer Chemother Pharmacol 9:103–109

    PubMed  CAS  Google Scholar 

  10. Benvenuto JA, Hall SW, Farquar D et al. (1979) Chromatogr Sci 10:377–395

    CAS  Google Scholar 

  11. Householder GE, Loo TL (1971) J Pharmacol Exp Ther 179:386–395

    Google Scholar 

  12. Comis RL (1976) Cancer Treat Rep 60:165–176

    PubMed  CAS  Google Scholar 

  13. Bonadonna G, Zucali R, Monfardini S et al. (1975) Cancer 36:252–259

    PubMed  CAS  Google Scholar 

  14. Bonadonna G, Valagussa P, Santoro A (1986) Ann Intern Med 104:739–746

    PubMed  CAS  Google Scholar 

  15. Moore GE, Meiselbaugh D (1976) Cancer Treat Rep 60:219

    PubMed  CAS  Google Scholar 

  16. Feaux de Lacroix W, Runne U, Hauk H et al. (1983) Cancer Treat Rep 67:779–784

    PubMed  CAS  Google Scholar 

  17. Carey RW,Kunz VS (1987) Am J Hematol 25:119–121

    PubMed  CAS  Google Scholar 

OJ

  1. Brockmann H, Lackner H (1964) Die Naturwissenschaften 16:384–385

    Google Scholar 

  2. Okawa K, Nakajima K, Tanaka T (1980) J Heterocycl Chem 17:1815–1816

    CAS  Google Scholar 

WM

  1. Frei E (1974) Cancer Chemother Rep 58:49–54

    PubMed  Google Scholar 

  2. Schmoll H-J, Peters H-D, Fink U (1986) Kompendium internistische Onkologie, Teill. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  3. Heenen M, Preumont AM, Galand P (1973) Cancer Res 33:2.624–2.626

    Google Scholar 

  4. Ross WE, Glaubiger DL, Kohn KW (1979) Biochem Biophys Acta 562:41–50

    PubMed  CAS  Google Scholar 

  5. Gause GF, Dudnik YV (1980) Antibiot Chemother 28:102–108

    PubMed  CAS  Google Scholar 

  6. Neidle S, Abraham Z (1984) CRC Crit Rev Biochem 17:73–121

    PubMed  CAS  Google Scholar 

  7. Sobell HM (1973) Progr Nucleic Acid Res Mol Biol 13:153–159

    CAS  Google Scholar 

  8. Chabner BA, Myers CE (1982) Clinical pharmacology of cancer chemotherapy. In: De Vita jr V, Hellmann S, Rosenberg SA (Hrsg.) Cancer. Principles and Practice of Oncology. Lipincott, Philadelphia Toronto, S. 156–197

    Google Scholar 

  9. Dabrowiak JC (1983) Life Sci 32:2.915–2.931

    Google Scholar 

  10. Giannini L, Bonadonna G (1988) Antitumor antibiotics. In: Bonadonna G, Robustelli delle Cuna G (Hrsg.) Handbook of Medical Oncology, Masson, Milano Parigi Barcelona Mesico, S. 359–360, 1.063

    Google Scholar 

  11. Reich E, Franklin RM, Shatkin AJ (1962) Proc Natl Acad Sci USA 48:1.238–1.245

    Google Scholar 

  12. Biedler JL Chang TD, Meyers MB, Peterson RH, Spengler BA (1983) Cancer Treat Rep 67:859–867

    PubMed  CAS  Google Scholar 

  13. Kessel D (1986) Cancer Surv 5:109–127

    PubMed  CAS  Google Scholar 

  14. Grossberg SE (1972) 2. N Engl J Med 287:79–85

    PubMed  CAS  Google Scholar 

  15. Vermund H (1971) Acta Radiol Suppl Stockh 311:1–78

    PubMed  CAS  Google Scholar 

  16. Goffinet DR, Bagshaw MA (1974) Cancer Treat Rev 1:15–26

    PubMed  CAS  Google Scholar 

  17. Thiel HJ, Fietkau R, Sauer R (1988) Rec Res Cancer Res 108:205–226

    CAS  Google Scholar 

  18. Fromm M, Littman P, Raney RB, Nelson L, Handler S, Diamond G, Stanley C (1986) Cancer 57:2.070–2.076

    Google Scholar 

  19. Galbraith WM, Mellet LB (1975) Cancer Chemother Rep 59:1.061–1.069

    Google Scholar 

  20. Tattersall MHN, Sodergren JE, Sengupta SK, Trites DH, Modest EJ, Frei III E (1975) Clin Pharmacol Ther 17:701–708

    PubMed  CAS  Google Scholar 

  21. Emmanuel IC (1969) B J Radiol 42:948–952

    CAS  Google Scholar 

  22. Jereb B (1971) Acta Radiol Ther Biol 10:417–426

    CAS  Google Scholar 

  23. Haas RJ, Devens K, Helmig M, Janka G, Klose H, Lampert F (1978) Onkologie 1:142–148

    PubMed  CAS  Google Scholar 

  24. Meuret (1978) Dtsch Med Wochenschr 103:308–313

    PubMed  CAS  Google Scholar 

  25. Tebbi CK, Gaeta J (1988) Pediatr Ann 17:283–300

    Google Scholar 

  26. Ebeling K, Bielek K (1978) Zentralbl Gynäkol 100:897–912

    PubMed  CAS  Google Scholar 

  27. Edson M (1979) J Urol 122:763–765

    PubMed  CAS  Google Scholar 

  28. Tscherne H, (1979) Wien Klin Wochenschr Suppl 103:1–21

    PubMed  CAS  Google Scholar 

  29. Obrist R, Hartmann D, Obrecht JP (1978) Onkologie 1:20–22

    PubMed  CAS  Google Scholar 

  30. Baas PC, Hoekstra HJ, Schraffordt-Koops H, Oosterhuis JW, Oldhoff J (1989) Arch Surg 124:373–376

    PubMed  CAS  Google Scholar 

  31. Chakravorty NK (1979) Gerontology 25:151–158

    PubMed  CAS  Google Scholar 

  32. Strian F, Maurach R (1980) Med Klin 75:478–484

    PubMed  CAS  Google Scholar 

  33. Levantine A, Almeyda J (1974) B J Dermatol 90:239–242

    CAS  Google Scholar 

  34. Ferguson MK (1982) Surg Gynecol Obstet 154:421–429

    PubMed  CAS  Google Scholar 

  35. Harris CC (1976) Cancer 37:1.014–1.023

    Google Scholar 

  36. Best JB, Morita M (1982) Teratogenesis Carcinog Mutagen 2:277–291

    PubMed  CAS  Google Scholar 

Mw

  1. Barbieri RL, Lee H, Ryan KJ (1979) Fertil Steril 31:182–186

    PubMed  CAS  Google Scholar 

  2. Shaw RW (1992) Lancet 340:1.267–1.271

    Google Scholar 

  3. Barbieri RL, Canick JA, Makris A, Davies IJ, Ryan KJ (1977) Fertil Steril 28:809–813

    PubMed  CAS  Google Scholar 

  4. Barbieri RL (1990) Drugs 39:501–510

    Google Scholar 

  5. Hooper WD, Eadie MJ, Dickinson RG (1991) Biopharm Drug Dispos 12:577–582

    PubMed  CAS  Google Scholar 

  6. Saltiel E, Garabendian-Ruffalo SM (1991) Clin Pharm 10:518–531

    PubMed  CAS  Google Scholar 

  7. Deeny M, Hawthorn R, McKay-Hart D (1991) Postgrad Med J 67:450–454

    PubMed  CAS  Google Scholar 

  8. Holt JP, Keller D (1984) Fertil Steril 41:70–74

    PubMed  Google Scholar 

  9. Barbieri RL, Evans S, Kistner RW (1982) Fertil Steril 37:737–746

    PubMed  CAS  Google Scholar 

vB

  1. White R, Schwan TJ (1976) J Pharm Sci 65:135

    CAS  Google Scholar 

  2. Clarke’s Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London, S. 508

    Google Scholar 

  3. Kracmar J, Alvarez Sotolongo M, Kracmarova J (1978) Pharmazie 33:659–661 (UV)

    PubMed  CAS  Google Scholar 

  4. Hollifield RD, Conklin JD (1973) J Pharm Sci 62:271

    PubMed  CAS  Google Scholar 

  5. Lalande M, Mills P, Peterson RG (1988) J Chromatogr 430(1):187

    PubMed  CAS  Google Scholar 

  6. Wuis EW, Grutters ACLM, Vree TB, van der Kleyn E (1982) J Chromatogr 231(1):401

    PubMed  CAS  Google Scholar 

DG

  1. Cedarbaum JM, Schleifer LS (1990) Drugs for Parkinson’s disease, spasticity and acute muscle spasms. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.), Goodman and Gillman’s the pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York, S. 463–484

    Google Scholar 

  2. Greef K, Wirth KE (1987) Pharmakologische Beeinflussung der cholinergen Erregungsübertragung. Pharmakotherapeutische Anwendung von Parasympathomimetia, Parasympatholytika und peripheren Muskelrelaxantien. In: Forth W, Hentschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie,5. Aufl., Bibliographisches Institut & F.A. Brockhaus, Mannheim, S. 103–121

    Google Scholar 

  3. Winkle van B (1976) Science 193:1130–1131

    PubMed  Google Scholar 

  4. Putney SW, Bianchi CP (1973) Fed Proc 32 (part 1):772

    Google Scholar 

  5. Butterfield AC, Ellis KO (1973) Fed Proc 32 (part 1):772

    Google Scholar 

  6. Monster AW, Tamai Y, Mc Henry J, (1974) Arch Phys Med Rehabil 55:355–362

    PubMed  CAS  Google Scholar 

  7. Hermann R, Mayer N, Mecomber SA (1972) Am J Physiol Med 51:296–311

    Google Scholar 

  8. Ellis KO, Castellion AW, Honkomp LJ et al. (1973) J Pharm Sci 62:948–951

    PubMed  CAS  Google Scholar 

  9. Ward A, Caffman MO, Sorkin EM (1986) Drugs 32:130–168

    PubMed  CAS  Google Scholar 

  10. Büch HP, Büch U (1987) Narkotika, Narkose. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut & F.A. Brockhaus, Mannheim, S. 1203–1219

    Google Scholar 

  11. Wislon RD, Dent TE, Traber DL, McCoy NR, Allen CR (1967) J Amer Med Ass 202:183

    Google Scholar 

  12. Dykes MHM (1975) J Amer Med Ass 231:862

    CAS  Google Scholar 

  13. Product information: Dantrium, Norwich-Eaton, 1985

    Google Scholar 

  14. Morrison DH (1983) Anesthesiology 59:265

    Google Scholar 

  15. Hollifield RS, Conklin JD (1973) J Pharm Sci 62:271

    PubMed  CAS  Google Scholar 

  16. Meyler WJ, Vermeer GA, Agoston S, Wesseling H (1980) Excretion pattern of dantrolen sodium and metabolites in patients with and without cholecystectomy. Abstract No. 0796. Proceeding of the World Conference on Clinical Pharmacology and Therapeutics, London

    Google Scholar 

  17. Mar 29, S. 1232

    Google Scholar 

NB

  1. Mar 29, S. 1.086

    Google Scholar 

vB

  1. Orzech CE, Nash NG, Daley RD (1976) in Ana 5:87

    CAS  Google Scholar 

  2. Beilstein 13:536, EII 300, EIII, S. 1246

    Google Scholar 

  3. Gordon GR, Ghoul DC, Peters JH (1975) J Pharm Sci 64.1.205–1.210

    Google Scholar 

  4. Tomicek O (1948) Collect Czech Chem Commun 13:116–130

    Google Scholar 

  5. Wojahn H (1948) Süddtsch Apoth Ztg 88:395–96

    CAS  Google Scholar 

  6. Murray JF, Gordon GR, Gulledge CC, Peters JH (1975) J Chromatogr 107:67–72

    PubMed  CAS  Google Scholar 

Ot

  1. Hastings RC, Franzblau SG (1988) Ann Rev Pharmacol Toxicol 28:231–245

    CAS  Google Scholar 

  2. Mandell GL, Sande MA (1990) Antimicrobial Agents. Drugs Used in the Chemotherapy of Tuberculosis and Leprosy. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) The Pharmacological Basis of Therapeutics, 8. Aufl., Pergamon Press, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, S.1.146–1.164

    Google Scholar 

  3. Venkatesan K (1989) Clin Pharmcokin 16:365–368

    CAS  Google Scholar 

  4. N.N.. (1988) Lancet II:487–488

    Google Scholar 

  5. Treatment of Leprosy, Mar 29, S. 551–552

    Google Scholar 

  6. Monographie Acedapsone, Mar 29, S.553

    Google Scholar 

  7. Monographie Dapsone, Mar 29, S. 558–560

    Google Scholar 

  8. Twose TM (1989) Dapsone and Sulphapyridine. In: Greaves MW, Shuster S (Hrsg.) Pharmacology of the Skin II. Handb Exp Pharmacol 87,II:543–552

    Google Scholar 

  9. Meyer H, Baumann HR, Leuenberger P, Sonntag R (1988) Drugs Used in Tuberculosis and Leprosy. In: Dukes MNG (Hrsg.) Meylers Side Effects of Drugs, 11. Aufl., Elsevier, Amsterdam New York Oxford, S. 633–650

    Google Scholar 

  10. Goldsmith P, Burton JL, Staughton RCD (1989) Immunosuppressive (Cytotoxic) and Immunostimulant Drugs. In: Greaves MW, Shuster S (Hrsg.) Pharmacology of the Skin II. Handb Exp Pharmac 87, II:307–327

    Google Scholar 

  11. Fernex M (1984) Internist 25:208–215

    PubMed  CAS  Google Scholar 

  12. N.N. (1989) Arzneimittelbrief 23:1–4

    Google Scholar 

  13. Kastrup EK (1988) Drugs, Facts and Comparison. Lippincott, St. Louis, S. 1.589–1.591

    Google Scholar 

  14. Fränz J, Windorfer A (1990) Arzneimittel in Schwangerschaft und Stillzeit, 3. Aufl., Wissenschaftliche Verlagsgesellschaft, Stuttgart, S.59

    Google Scholar 

  15. N.N. (1989) Arznei-telegramm 10/89:91–92

    Google Scholar 

Ry

  1. Di Marco A, Acarmone F (1975) Adriamycin and its mechanism of action. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 11–24

    Google Scholar 

  2. Pigram WJ, Fuller W, Hamilton LD (1972) Nature (New Biol) 235:17–19

    CAS  Google Scholar 

  3. Chaires JB (1990) Biophys Chem 35:191–202

    PubMed  CAS  Google Scholar 

  4. Schwartz HS (1975) Res Commun Chem Pathol Pharmacol 10:51–64

    PubMed  CAS  Google Scholar 

  5. Casazza AM, Isetta AM, Giuliani M, Di Marco A (1975) Immunodepressive activity of daunomycin and adriamycin. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action, Adriamycin Review, European Press Medikon, Ghent, Belgium, S. 121–131

    Google Scholar 

  6. Maral RJ, Jouanne M (1981) Cancer Treat Rep 65(Suppl4):9–18

    PubMed  CAS  Google Scholar 

  7. Peterson C, Paul C (1983) Pharmacokinetics of doxorubicin and daunorubicin. In: Hansen HH (Hrsg.) Anthracyclines and cancer therapy. Excerpta Medica, Elsevier Science Publishers BV, Amsterdam, S.7–12

    Google Scholar 

  8. Bachur NR, Riggs jr CE, Green MR, Langone JJ, Van Vunakis H, Levine L (1977) Clin Pharmacol Ther 21:70–77

    PubMed  CAS  Google Scholar 

  9. Paul C, Liliemark J, Tidefelt U, Gahrton G, Peterson C (1989) Therapeutic Drug Monitoring 11:140–148

    PubMed  CAS  Google Scholar 

  10. Lenaz L, Di Fronzo G, Molinari R (1975) Distribution of daunomycin and adriamycin in man. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 89–99

    Google Scholar 

  11. Speth PA, Linssen PCM, Termond EFS, Boeseman JBM, Wessels HMC, Haanen C (1989) Drug Metab Dispos 17:98–105

    PubMed  CAS  Google Scholar 

  12. Noel G, Trouet A, Zenebergh A, Tulkens P (1975) Comparative cell pharmacokinetics of daunorubicin and adriamycin. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 99–105

    Google Scholar 

  13. Nooter K, Sonneveld P, Martens A, Hagenbeek A, Schultz F (1986) Eur J Clin Oncol 2:801–806

    Google Scholar 

  14. Benjamin RS, Riggs CE, Bachur NR (1977) Cancer Res 37:1.416–1.420

    Google Scholar 

  15. Huffman DH, Bachur NR (1972) Cancer Res 32:600

    PubMed  CAS  Google Scholar 

  16. Le Bot MA, Bégué JM, Kernaleguen D, Robert J, Ratanasavanh D, Airiau J, Riche C, Guillouzo A (1988) Biochem Pharmacol 37:3.877–3.887

    Google Scholar 

  17. Goldin A, Johnson RK (1975) Antitumor effect of adriamycin in comparison with related drugs, and in combination chemotherapy. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 7–54

    Google Scholar 

  18. Walters TR (1976) Med Clin North Am 60:987–1.000

    PubMed  CAS  Google Scholar 

  19. Gale RP (1984) Ann Intern Med 101:702–705

    PubMed  CAS  Google Scholar 

  20. Steuber CP (1981) Am J Pediatr Hematol Oncol 3:379–388

    PubMed  CAS  Google Scholar 

  21. Von Hoff DD, Rozencweig M, Layard M, Slavik M, MuggiaFM(1977) Am J Med 62:200–208

    Google Scholar 

  22. Von Hoff DD, Layard M (1981) Cancer Treat Rep 65(Suppl4):19–23

    Google Scholar 

  23. Uzuka Y, Saito Y, Takahashi H, Komatu M, Ito T (1989) Rinshoe Ketsueki 30:980–987

    CAS  Google Scholar 

  24. Reszka K, Hartley JA, Lown JW (1990) Biophys Chem 35:313–323

    PubMed  CAS  Google Scholar 

  25. Arena E, D’Alessandro N, Dusonchet L, Gebbia N, Gerbasi F, Rausa L (1973) J Antibiotics 26:338

    Google Scholar 

  26. Marzin D, Jasmin C, Maral R, Mathe G (1983) Eur J Cancer Clin Oncol 19:641–647

    PubMed  CAS  Google Scholar 

Mw

  1. Robinson C (1980) Drugs of Today 16:371–373

    Google Scholar 

WM

  1. Haubrich DR, Gerber NH, Pflueger AB (1981) J Neurochem 37:476–482

    PubMed  CAS  Google Scholar 

  2. Lohr J, Acara M (1990) J Pharmacol Exp Ther 252:154–158

    PubMed  CAS  Google Scholar 

  3. Pepeu G, Freedman DX, Giarman NJ (1960) J Pharmacol Exp Ther 129:291–295

    PubMed  CAS  Google Scholar 

  4. Rimland B (1988) J Child Neurol 3(Suppl):68–72

    Google Scholar 

hr

  1. Wenner W (1965) J Med Chem 8:125–126

    PubMed  CAS  Google Scholar 

LJ

  1. Moe RA, Bates HM, Palkoski ZM, Banziger R (1964) Curr Ther 193:194–208

    Google Scholar 

  2. Luria HM, Freis ED (1965) Curr Ther Res 7:289–296

    PubMed  CAS  Google Scholar 

  3. Adi FC, Eze CJ, Anwunah A (1975) Brit Med J 1:482–485

    PubMed  CAS  Google Scholar 

  4. Silas JH, Lennard MS, Tucker GT, Smith AJ, Malcolm SL, Marten TR (1977) Br Med J I:422–425

    Google Scholar 

  5. McMahon FG (1984) Peripheral adrenergic blocking agents. In: McMahon FG (Hrsg.) Management of essential hypertension: The new low-dose era, Futura Publishing Company, Inc, Mount Kisco New York, S. 457–497

    Google Scholar 

  6. Medina MA, Giachetti A, Shore PA (1969) Biochem Pharmacol 18:891–901

    PubMed  CAS  Google Scholar 

  7. Allen JG, East PB, Francis JR, Haigh JL (1975) Drug Metab Dispos 3:332–337

    PubMed  CAS  Google Scholar 

  8. Mahgoub A, Dring LG, Idle JR, Lancaster R, Smith RL (1977) Lancet II:584–586

    Google Scholar 

GW

  1. Kle 82

    Google Scholar 

  2. Wenner W (1965) J Med Chem 8:125–126

    PubMed  CAS  Google Scholar 

  3. Malcolm SL, Marten TR (1976) Analyt Chem 48:807–809

    CAS  Google Scholar 

LJ

  1. Blomquist AT, Hallam BF, Josey AD (1959) J Am Chem Soc 81:678–680

    CAS  Google Scholar 

  2. Clarke’s Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London, S.510

    Google Scholar 

DG

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Bickel H et al (1960) Helv Clim Acta 43: 2118

    CAS  Google Scholar 

HU

  1. Keberle H (1964) Ann N Y Acad Sci 119:758–768

    PubMed  CAS  Google Scholar 

  2. Day JP (1986) Chemical aspects of aluminium chelation by desferrioxamine. In: Taylor A (Hrsg.) Aluminium and other trace elements in renal disease, Baillière Tindall, London, S. 184–192

    Google Scholar 

  3. Pippard MJ, Callender ST, Finch CA (1982) Blood 60:288–294

    PubMed  CAS  Google Scholar 

  4. Allain P, Chaleil D, Mauras Y, Beaudeau G, Varin MC, Poignet JL, Ciancioni C, Ang KS, Cam G, Simon P (1987) Clin Chim Acta 170:331–338

    PubMed  CAS  Google Scholar 

  5. Allain P, Mauras Y, Chaleil D, Simon P, Ang KS, Cam G, Le Mignon L, Simon M (1987) Br J Clin Pharmac 24:207–212

    CAS  Google Scholar 

  6. Stremmel W, Niederau C, Strohmeyer G (1988) Dtsch Med Wochenschr 113:1648–1650

    PubMed  CAS  Google Scholar 

  7. Zoller WG, Hehlmann R (1986) Klin Wschr 64:417–422

    PubMed  CAS  Google Scholar 

  8. Hümpfner A (1989) Aluminiumintoxikation bei Niereninsuffizienz, Zuckschwerdt, München, S. 63–68

    Google Scholar 

  9. Milliner DS, Nebeker HG, Ott SM (1984) Ann Intern Med 101:775–780

    PubMed  CAS  Google Scholar 

  10. Gallant T, Boyden MH, Gallant LA, Carley H, Freedman MH (1987) Am J Med 83:1085–1090

    PubMed  CAS  Google Scholar 

  11. Cases A, Kelly J, Sabater J, Campistol JM, Torras A, Montoliu J, Lopez I, Revert L (1988) Clin Nephrol 29:176–178

    PubMed  CAS  Google Scholar 

  12. Gabutti V, Sandri A, Capalbo P, D’Oria A, Sacchetti L, Tricta F, Piga A (1989) Toxicity of desferrioxamine treatment. In: Kattamis C (Hrsg.) Iron overload and chelation in thalassaemia, Hans Huber Publishers, Toronto, S. 26–33

    Google Scholar 

  13. Walker JA, Sherman RA, Eisinger RP (1985) Am J Kidney Dis 6:254–256

    PubMed  CAS  Google Scholar 

Fk

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Mar 29, S. 1.359

    Google Scholar 

vB

  1. Beil Erg. Werk 4, Bd. 10, Teil 5, S.3478

    Google Scholar 

Rj

  1. Okolicsanyi L, Lirussi F, Strazzabosco M, Jemmolo R, Orlando R, Nassuato G, Muraca M, Crepaldi G (1986) Drugs 31:430–448

    PubMed  CAS  Google Scholar 

  2. Bobowiec R, Studzinski T, Sikorska M (1990) Acta Physiol Polon 41:146–154

    PubMed  CAS  Google Scholar 

  3. Boyer J, Klatskin G (1970) Gastroenterology 59:853–859

    PubMed  CAS  Google Scholar 

  4. Bloomer J, Boyer J, Klatskin G (1973) Gastroenterology 65:929–935

    PubMed  CAS  Google Scholar 

  5. Eulenburg F, Bode J (1976) Zeitschr Gastroenterologie 14:354–364

    CAS  Google Scholar 

  6. Maurer C (1971) Arzneim Forsch 21:1.375–1.379

    Google Scholar 

  7. Soloway R, Hofmann A, Thomas P, Schoenfield L, Klein P (1973) J Clin Invest 52:715–724

    PubMed  CAS  Google Scholar 

  8. Hardison W (1971) J Lab Clin Med 77:811–820

    PubMed  CAS  Google Scholar 

  9. Yousef I, Mignault D, Weber A, Tuchweber B (1990) Digestion 45:40–51

    PubMed  CAS  Google Scholar 

  10. Roma M, Marinelli R, Rodriguez Garay E (1991) Biochem Pharmacol 42:1.775–1.781

    Google Scholar 

  11. Binder H (1981) Colonic secretion. In: Johnson L (Hrsg.) Physiology of the gastrointestinal tract, Raven Press, New York, S. 1.003–1.019

    Google Scholar 

  12. Hofmann A (1989) The enterohepatic circulation of bile acids in health and disease. In: Sleisenger M, Fordtran J (Hrsg.) Gastrointestinal disease, 4. Aufl., Vol.1, Saunders, Philadelphia, S. 144–161

    Google Scholar 

  13. Cowen A, Korman M, Hofmann A, Thomas P (1975) Gastroenterology 68:1.567–1.573

    Google Scholar 

  14. Yoneda M, Makino I, Tamasawa N, Takebe K, Sakuraba K, Goto J, Nambara T (1989) Amer J Gastroenterol 84:290–295

    CAS  Google Scholar 

  15. Adinolfi L, Utili R, Gaeta G, Abernathy C, Zimmerman H (1982) Hepatology 2: Abstract No. 121, S.703

    Google Scholar 

  16. Peters G, Witten D (1971) Minnesota Med 54:787–788

    PubMed  CAS  Google Scholar 

  17. Lindholm A, Henricsson S, Dahlquist R (1990) Br J Clin Pharmacol 29:541–548

    PubMed  CAS  Google Scholar 

  18. Vonk R, Scholtens E, Keulemans G, Meijer D (1978) Naunyn-Schmiedeberg’s Arch Pharmacol 302:1–9

    CAS  Google Scholar 

  19. Silverman S, Andrews A (1977) J Natl Cancer Inst 59:1.557–1.559

    Google Scholar 

  20. Cohen B, Raicht R, Deschner E, Takahashi M, Sarwal A, Fazzini E (1980) J Natl Cancer Inst 64:573–578

    PubMed  CAS  Google Scholar 

BJ

  1. Blanc F, Nosny Y, Armgengaud M, Sankale M, Martin M, Charmot G, Nosny P (1961) Bull Soc Pathd Exotique (Paris) 54:29–38

    CAS  Google Scholar 

  2. Manson-Bahr PEC, Apted FIC (1982) Manson’s tropical diseases, 18. Aufl., Ballière Tindall, London, S. 132–140

    Google Scholar 

  3. Steck EA (1971) Walter Reed Army Institute of Research, Washington 1:3.132–3.137

    Google Scholar 

  4. Rees PH (1982) Drugs. In: Manson-Bahr PEC, Apted FIC (Hrsg.) Manson’s tropical diseases, 18. Aufl., Ballière Tindall, London, S. 610–636

    Google Scholar 

  5. Powell SJ, Wilmot AJ, MacLeod IN (1967) Ann Trop Med Parasitol 61:26–28

    PubMed  CAS  Google Scholar 

  6. Merchant HC, Shikaripurkar NK (1964) Ind J Med Sci 18:200–209

    CAS  Google Scholar 

  7. Werner GT, Stickl H (1976) Med Klin 71:2.254–2.259

    Google Scholar 

  8. Al-Khateeb GH, Molan AL (1981) Chemotherapy 27:117–125

    PubMed  CAS  Google Scholar 

  9. Fourage M, Dewulf M, Couvreur P, Roland M, Vranchx H (1989) J Microencapsul 6:29–34

    Google Scholar 

  10. Bienzle U, Ebert F, Dietrich M (1978) Tropenmed Parasitol 29:188–197

    PubMed  CAS  Google Scholar 

  11. Aguirre Errasti C, Merino Angulo J, Flores Torres M, Rios A de los (1981) Med Clin (Barc.) 76:125–128

    Google Scholar 

  12. Farid Z, Trabolsi B, Boctor F, Hafez A (1986) J Inf Dis 154:920–921

    CAS  Google Scholar 

  13. Auer H, Aspoeck H, Picher O, Ploier R, Tulzer W (1981) Wien Klin Wochenschr 93:360–366

    PubMed  CAS  Google Scholar 

  14. Muangmanee L, Aswapokee N, Jaroonvesama N, Viranuvatti V (1974) Southeast Asian J Trop Med Pub Hlth 5:581–585

    CAS  Google Scholar 

  15. Hernandez-Perez E (1980) Cutis 25:424–426

    PubMed  CAS  Google Scholar 

  16. Salako LA (1972) J Pharm Pharmac 24:32–39

    CAS  Google Scholar 

  17. Webster LT jr (1985) Drugs used in the chemotherapy of protozoal infections amebiasis, giardiasis and trichomoniasis. In: Goodman and Gillman’s the pharmacological basis of therapeutics, 7. Aufl., McMillan, New York Toronto London, S. 1.049–1.057

    Google Scholar 

  18. Rollo IM (1980) Drugs used in the chemotherapy of amebiasis. In: Goodman and Gilman’s The pharmacological basis of therapeutics, 6. Aufl., McMillan, New York, S. 1.066–1.067

    Google Scholar 

  19. Salako LA (1974) W Afr J Pharmac Drug Res 1:13–17

    CAS  Google Scholar 

  20. Sharma S (1976) Indian J Med Sci 30:239–240

    PubMed  CAS  Google Scholar 

HA

  1. Miyake A, Itoh K, Oka Y (1986) Chem Pharm Bull 34:2852–2858

    PubMed  CAS  Google Scholar 

MA

  1. Salvetti A (1990) Drugs 40:800–828

    PubMed  CAS  Google Scholar 

MJ

  1. Miyake A, Itoh K, Oka Y (1986) Chem Pharm Bull 34:2.852

    PubMed  CAS  Google Scholar 

  2. Hiroyukil, Mikio Y, Yoshiru U (1985) Fukuoka Igaku Zasshi 76(9):441–450; CA (1986) 104:104902c

    Google Scholar 

MA

  1. Mar 29, S. 1396

    Google Scholar 

vB

  1. Mar 29, S. 728

    Google Scholar 

vB

  1. Keck J, Pueschmann S, Krueger G, Noll K (Thomae, Dr. Karl G.m.b.H.) (1972/74) Dt Pat Ger offen 2251891, zit. nach CA (1974) 81:25327

    Google Scholar 

KU

  1. Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S. 245–262

    Google Scholar 

  2. Toon S, Rowland M (1979) J Pharm Pharmacol 31:43P

    Google Scholar 

  3. Münch R (1981) Schweiz Apoth Ztg 119:222–226

    Google Scholar 

fm

  1. McCormick JRD et al. (1957), J Am Chem Soc 79:4561–4563

    CAS  Google Scholar 

  2. Casy AF, Yasin A (1983), J Pharm Biomed Anal 1:281–292

    PubMed  CAS  Google Scholar 

  3. Asleson GL, Frank CW (1975), J Am Chem Soc 97: 6246–6248

    CAS  Google Scholar 

  4. Am Cyanamid Co, USP 2878289 (1959), zit. nach CA (1959) 53:9584c

    Google Scholar 

Gd

  1. Clarke EGC (1974) Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 21

    Google Scholar 

  2. Fox RH (1969) Paper Chromatography. In: Clarke EGC (Hrsg.) Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 34

    Google Scholar 

  3. Curry AS (1969) Thin-layer Chromatography In: Clarke ECG (Hrsg.) Isolation and Identification of Drugs, The Pharmaceutical Press, London, S. 46

    Google Scholar 

WM

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. McCormick JRD et al. (1957) Jam Chem Soc 79:4561–4562

    CAS  Google Scholar 

Gd

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Hafely W, Kyburz E, Gerecke M, Möhler H (1985) Adv Drug Res 14:165–322

    Google Scholar 

  2. Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice, Raven Press, New York

    Google Scholar 

Wm

  1. Nardi D, Tajana A, Leonardo A, Pennini R, Portioli F,Magistretti MJ, Subissi A (1981) J Med Chem 24:727

    PubMed  CAS  Google Scholar 

  2. Tajana A, Sibili C, Cappeletti R, Cova A, Nardi D (1986) Boll Chim Farm 125:7–20

    PubMed  CAS  Google Scholar 

PA

  1. Mar 29, S.400

    Google Scholar 

vB

  1. Tajana A, Sibili C, Cappeletti R, Cova A, Nardi D (1986) Boll Chim Farm 125:7–20

    PubMed  CAS  Google Scholar 

PA

  1. Van der Stelt C, Harms AF, Nauta WT (1961) J Med Pharm Chem 4:335–349

    PubMed  CAS  Google Scholar 

  2. Beilsteins Handbuch der Organischen Chemie EV21/1,S.224

    Google Scholar 

  3. Moffat AC, Jackson AV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London

    Google Scholar 

  4. Van der Stelt C, Funcke ABH, Tersteege HM, Nau taWT (1966) Arzneim Forsch 16:1342–1345

    Google Scholar 

MP

  1. Mar 29, S.451

    Google Scholar 

EH

  1. Austin WC, Potter MD, Taylor EP (1958) J Chem Soc:1.489–1.898

    Google Scholar 

  2. Aka T, Soda K, Adachi T, Kitano K, Ono S (1965) Jap Pat 5835 (’65), zit. nach CA 62:16213 f

    Google Scholar 

  3. Attwood D, Natarajan R (1979) J Pharm Pharmacol 32:460–462

    Google Scholar 

  4. Eigene Untersuchungen

    Google Scholar 

  5. Surmann JP, Glienke M (1988) Fresenius’ Z Anal Chem 331:630–633

    CAS  Google Scholar 

  6. Pinzauti S, La Porta E (1977) Analyst 102:938–942

    CAS  Google Scholar 

hh

  1. Kramer A, Wallhäußer KH (im Druck) Wirkungsspektrum und Anwendungseigenschaften häufig aus prophylaktischer Indikation angewendeter Antiseptika. In: Kramer A, Weuffen W, Gröschel D, Heeg P, Hingst V, Lippert H, Rotter M (Hrsg.) Klinische Anwendung von Antiseptika, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo Hing Kong Barcelona

    Google Scholar 

  2. Tatra G (1972) Muench Med Wochenschr 114:773–776

    CAS  Google Scholar 

  3. Mühlbauer W (1972) Therapiewoche 22:1.416–1.417

    Google Scholar 

  4. Gjermo P, Baastad KL, Rölla G (1970) J Periodont Res 5:102–109

    PubMed  CAS  Google Scholar 

  5. Raitano A (1981) Disinfettanti, Medico Farmaceutica, Milano

    Google Scholar 

  6. Kramer A, Rozsahegyi I, Weuffen W (1985) Chronische Vergiftungen durch Antiseptika. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Handbuch der Antiseptik, Bd. I/5, Toxische und allergische Nebenwirkungen von Antiseptika, Volk Und Gesundheit, Berlin, S.218

    Google Scholar 

  7. Ludewig R, Lohs KH (1988) Akute Vergiftungen, Fischer Verlag, Jena, S. 49–50

    Google Scholar 

ak

  1. Bláha L, Weichet J, Žváćek J, Šmolík S, Kakáć B (1960) Coll Czech Chem Commun 25:237–243

    Google Scholar 

  2. Klohs MW, Keller F, Williams RE, Kusserow GW (1955) J Am Chem Soc 77:4.084–4.087

    Google Scholar 

  3. Stoll A, Hoffmann A (1955) J Am Chem Soc 77:820–821

    CAS  Google Scholar 

  4. Neuss N, Boaz HE, Forbes JW (1955) J Am Chem Soc 77:4.087–4.090

    Google Scholar 

  5. Kle 82, S.272

    Google Scholar 

LJ

  1. Cicco C F (BOC Inc) Eur Pat Appl Ep 388,144 ( Cl. C07C41/22) 1990, US Appl 323,579 1985, zit. nach CA (1991) 114:121477s

    Google Scholar 

  2. Robin M L, Halpern D F, (BOC Inc) Eur Pat Appl Ep 341,004, zit. nach CA (1990) 112:178052n

    Google Scholar 

QO

  1. Mar 29, S.476

    Google Scholar 

EH

  1. Eger EI (1992) Anesth Anaig 75: Suppl 4, S3–S7

    CAS  Google Scholar 

  2. Rampil IJ, Lockhart SH, Zwass MS, Peterson N, Yasuda N, Eger EI, Weiskopf RB, Damask MC (1991) Anesthesiol 74:429–433

    CAS  Google Scholar 

  3. Ghouri AF, Bodner M, White PF (1991) Anesthesiol 74:419–424

    CAS  Google Scholar 

  4. Litt L, Lockhart S, Cohen Y, Yasuda N, Kim F, Freire B, Laster M, Peterson N, Taheri S, Chang LH (1991) Ann N Y Acad Sci 625:707–724

    PubMed  CAS  Google Scholar 

  5. Smiley RM (1992) Anesth Anaig 75:Suppl 4, S38–S44

    CAS  Google Scholar 

  6. White PF (1992) Anesth Anaig 75: Suppl 4, S47–S53

    CAS  Google Scholar 

  7. Yasuda N, Lockhart SH, Eger EI; Weiskopf RB, Johnson BH, Freire BA, Fassoulaki A (1991) Anesthesiol 74:489–498

    CAS  Google Scholar 

  8. Koblin DD (1992) Anaesth Anaig 75:Suppl 4, S10–S16

    CAS  Google Scholar 

  9. Fassoulaki A, Lockhart SH, Freire BA, Yasuda N, Eger EI, Weiskopf RB, Johnson BH (1991) Anesthesiol 74:479–483

    CAS  Google Scholar 

  10. Zwass MS, Fisher DM, Welborn LG, Cote CJ, Davis PJ, Dinner M, Hannallah RS, Liu LM, Sarner J, McGill WA (1992) Anesthesiol 76:373–378

    CAS  Google Scholar 

  11. Wedel DJ, Iaizzo PA, Milde JH (1991) Anesthesiol 74:508–512

    CAS  Google Scholar 

  12. Sebel PS, Glass PS, Fletcher JE, Murphy MR, Gallagher C, Quill T (1992) Anesthesiol 76:52–59

    CAS  Google Scholar 

vB

  1. Kielholz P, Labhardt F, Battegay R, Rümmele W, Feer H (1963) Dt Med Wochenschr 88:1.617–1.624

    Google Scholar 

  2. Bickel MH (1968) Untersuchungen zur Biochemie und Pharmakologie der Thymoleptika. In: Jucker E (Hrsg.) Fortschritte der Arzneimittelforschung, Bd. 11, Birkhäuser Verlag, Basel Stuttgart, S. 121–225

    Google Scholar 

  3. Baldessarini RJ (1982) McLean Hosp J 7:1–27

    Google Scholar 

  4. Baldessarini RJ (1989) J Clin Psychiat 50:117–126

    CAS  Google Scholar 

  5. Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The pharmacological basis of therapeutics, 8th edition, Macmillan, New York, S. 383–435

    Google Scholar 

  6. Shopsin B, Cassano GB, Conti L (1981) An overview of new “second generation” antidepressant compounds: research and treatment implications. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S.219–251

    Google Scholar 

  7. Richelson E, Pfenning M (1984) Eur J Pharmacol 104:277–286

    PubMed  CAS  Google Scholar 

  8. Shein K, Smith SE (1978) Br J Pharmacol 62:567–571

    PubMed  CAS  Google Scholar 

  9. Richelson E, Nelson A (1984) J Pharmacol Exp Ther 230:94–102

    PubMed  CAS  Google Scholar 

  10. Sulser F (1983) Psychopharmacol Bull 19:300–304

    PubMed  CAS  Google Scholar 

  11. Nielsen M, Braestrup C (1977) Naunyn-Schmiedeberg’s Arch Pharmacol 300:87–92

    CAS  Google Scholar 

  12. Mobley PL, Sulser F (1981) Down-regulation of the central noradrenergic receptor system by antidepressant therapies: biochemical and clinical aspects. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 31–51

    Google Scholar 

  13. MacMillan BA, Warnack W, German DC, Shore PA (1980) Eur J Pharmacol 61:239–246

    Google Scholar 

  14. Pi EH, Simpson GH, Cooper TB (1986) Am J Psychiat 143:1.174–1.176

    Google Scholar 

  15. Pollock BG, Perel JM (1989) Can J Psychiat 34:609–617

    CAS  Google Scholar 

  16. Ciraulo D, Barnhill JA, Jaffe JH (1988) Clin Pharmacol Ther 43:509–518

    PubMed  CAS  Google Scholar 

  17. Ciraulo DA, Barnhill J, Boxenbaum H (1985) Am J Psychiat 142:1.373–1.374

    Google Scholar 

  18. Abernethy DR, Greenblatt DJ, Shader RI (1985) J Pharmacol Exp Ther 232:183–188

    PubMed  CAS  Google Scholar 

  19. Steiner E, Spina E (1987) Clin Pharmacol Ther 42:278–282

    PubMed  CAS  Google Scholar 

  20. Spina E, Steiner E, Ericsson Ö, Sjöquist F (1987) Clin Pharmacol Ther 41:314–319

    PubMed  CAS  Google Scholar 

  21. Brøsen K, Otton SV, Gram LF (1986) Clin Pharmacol Ther 40:543–549

    Google Scholar 

  22. Brøsen K, Gram LF, Klysner R, Bech P (1986) Eur J Clin Pharmacol 30:43–49

    PubMed  Google Scholar 

  23. Liebermann JA, Cooper TB, Suckow RF, Steinberg H, Borenstein M, Brenner R, Kane JM (1985) Clin Pharmacol Ther 37:103–107

    Google Scholar 

  24. Sieberns S (1985) Therapiewoche 35:5.804–5.815

    Google Scholar 

  25. Spina E, Pacifici GM, van Bahr C, Rane A (1986) Acta Pharmacol Toxicol 5:277–281

    Google Scholar 

RM

  1. Kirkeby CJ, Risoe C (1984) Acta Chir Scand 150:91–92

    PubMed  CAS  Google Scholar 

  2. De-Luca B, Cerciello A, Monda M (1982) Neuropharmacology 21:1.211–1.214

    Google Scholar 

  3. Helke CJ, Keller KJ, Gillis RA (1978) Eur J Pharmacol 52:47–55

    PubMed  CAS  Google Scholar 

  4. Helke CJ, Keller KJ, Gillis RA (1979) Arch Int Pharmacodyn Ther 242:44–49

    PubMed  CAS  Google Scholar 

  5. Marzo A, Ghirardi P, Brusoni B, Marchetti G (1978) Arch Int Pharmacodyn Ther 233:156–165

    PubMed  CAS  Google Scholar 

  6. Ambrosioni E, Costa FV, Bracchetti D (1979) Int J Clin Pharmacol Biopharm 17:416–420

    PubMed  CAS  Google Scholar 

  7. Bekke DM, Lehmann V, Lien E (1981) J Cardiovasc Pharmacol 3:1.015–1.025

    Google Scholar 

  1. Andersson KE (1988) Drugs of Today 24:509–528

    CAS  Google Scholar 

  2. Dinnendahl V, Fricke U (1987) Arzneistoff-Profile: Desmopressin, Govi-Verlag, Frankfurt/Main

    Google Scholar 

js

  1. Zeelen FJ (1990) Medicinal chemistry of steroids, Elsevier, Amsterdam Oxford New York Tokyo, S. 107–110

    Google Scholar 

  2. de Visser J, de Jager E, de Jongh HP, van de Vies J, Zeelen FJ (1975) Actaendocr Copenh 10 (Suppl 199):405–420

    Google Scholar 

  3. Widholm O, Alapapiessa U (1977) Contraception 15:1–13

    PubMed  CAS  Google Scholar 

  4. Cyran W, Feldmann HM (1981) Gyne Heft 8, H.U.F.-Verlag, Essen

    Google Scholar 

  5. Oviol22, Oviol 28, Informationsschrift der Fa. Nourypharma, 1990

    Google Scholar 

  6. Dik M, Hönes S, Schindler AE, Donath EM (1986) Gynäkol Prax 10:265–275

    Google Scholar 

  7. Levrier M (1988) Therapiewoche 3:1.225–1.231

    Google Scholar 

  8. Wynants P (1986) Contraception 33:149–157

    PubMed  CAS  Google Scholar 

  9. Käär K (1984) Scand J Clin Lab Invest 44:623–627

    PubMed  Google Scholar 

  10. März W, Jung-Hoffmann C, Heidt F, Gross W, Kuhl H (1990) Contraception 41:245–250

    PubMed  Google Scholar 

  11. Chez RA (1989) Am J Obstet Gynecol 160:1.296–1.300

    Google Scholar 

  12. Kuhnz W, Pfeffer M, Al-Yacoub G (1990) J Steroid Biochem 35:313–318

    PubMed  CAS  Google Scholar 

OM

  1. Miller JA, Munro DD (1980) Drugs 19:119–134

    PubMed  CAS  Google Scholar 

  2. Goa KL (1988) Drugs 36 S5:51–61

    PubMed  Google Scholar 

  3. Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533

    CAS  Google Scholar 

  4. Tronnier H (1987) Aerztl Kosmetol 17:458–482

    CAS  Google Scholar 

  5. Leiferman KM, Schroeter A, Kirschner MK, Spelsberg TC(1983) J Inv Dermatol 81:355–360

    CAS  Google Scholar 

  6. Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10

    PubMed  CAS  Google Scholar 

  7. Miesfeld RL (1990) Am Rev Respir Dis 141 S2:S11–17

    PubMed  CAS  Google Scholar 

  8. Bowen DL, Fauci AS (1988) Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–897

    Google Scholar 

  9. Barry BW, Woodford R (1974) Br J Dermatol 91:323–338

    PubMed  CAS  Google Scholar 

  10. Meyer E, Smith EW, Haigh JM, Kanfer I (1988) Arzneim Forsch 38:1840–1843

    CAS  Google Scholar 

  11. Laasko L (1981) Curr Ther Res 30:19

    Google Scholar 

  12. Niedner R (1989) Dtsch Aerztebl 86:1798–1803

    Google Scholar 

  13. Takeda K, Arase S, Takahashi S (1988) Drugs 36:15–23

    PubMed  Google Scholar 

  14. Karl HJ (1980) Muench Med Wochenschr 122:1191–1194

    CAS  Google Scholar 

GM

  1. Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10

    PubMed  CAS  Google Scholar 

  2. Schleimer RP (1985) Ann Rev Pharmacol Toxicol 25:381–412

    CAS  Google Scholar 

  3. Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56

    Google Scholar 

  4. Heel RC, Brogden RN, Speight TM, Avery GS (1978) Drugs 16:302–321

    PubMed  CAS  Google Scholar 

  5. Alpermann HG, Sandow J, Vogel HG (1986) Z Hautkrkh61:S7–17

    Google Scholar 

  6. Hein R, Krieg T (1989) Z Hautkrkh 64 S1:13–17

    Google Scholar 

  7. Hornke I, Cavagna F, Christ O, Fehlhaber HW, Kellner HM, Sandow J (1980) Arzneim Forsch 30:47–51

    CAS  Google Scholar 

  8. Kim KH, Henderson NL (1989) Z Hautkrkh 64 Sl:19–22

    Google Scholar 

  9. Niedner R (1989) Dtsch Aerztebl 86:1.798–1.803

    Google Scholar 

  10. Miller JA, Munro DD (1990) Drugs 19:119–134

    Google Scholar 

  11. Takeda K, Arase S, Takahashi S (1988) Drugs 36 S5:15–23

    PubMed  Google Scholar 

  12. Karl HK (1980) Muench Med Wochenschr 122:1.191–1.194

    Google Scholar 

GM

  1. Fieser LF, Rajagopalan S (1949) Am Soc 71:3935–3937

    CAS  Google Scholar 

  2. Fieser LF, Fieser M (1959) Steroids, Reinhold, New York

    Google Scholar 

  3. Beil Erg. Werk 3, Bd. 10, Teil 2, S. 1641

    Google Scholar 

  4. Gattermann-Wieland (1961) Praxis des organischen Chemikers, 40. Aufl., de Gruyter, Berlin, S. 361

    Google Scholar 

  5. Wieland H, Siebert W (1939) Z Physiol Chem 262:1

    CAS  Google Scholar 

  6. Garcia Valdes J, Cabrara Vazquez N (1987) Rev Cubana Farm 21:217–230, zit. nach CA 108 (14):118794p

    Google Scholar 

  7. Hag 4, S. 492

    Google Scholar 

  8. MI 11

    Google Scholar 

  9. Dictionary of Organic Compounds 5th ed 1982 and Supplements

    Google Scholar 

  10. Hag 2, S. 799

    Google Scholar 

  11. Hag 4, S. 492

    Google Scholar 

  12. Grinbaum R, Marchlewski L (1937) Bl Acad Polon 1937A:171–186

    CAS  Google Scholar 

  13. Stoffliste

    Google Scholar 

  14. Silberman H, Silberman-Martybcewa S (1946) J Biol Chem 165:359–362

    PubMed  CAS  Google Scholar 

  15. Kaziro K, Shimada T (1938) Z Physiol Chem 254:57,58

    Google Scholar 

  16. Vold RD, McBain JW (1941) Am Soc 63:1296

    CAS  Google Scholar 

  17. Shimada T (1939) J Biochem Tokyo 29:41

    Google Scholar 

  18. Zhang Q, Qian L (1991) Tianran Chanwu Yanjiu Yu Kaifa 3:56–60, zit. nach CA 115 (18):189551n u M, Cheng Z, Hong M (1990) Zhongguo Yaoxue Zazhi 25:524–528, zit. nach CA 114 (16):149998m

    CAS  Google Scholar 

  19. Shen F, Fu D, Wen H (1990) Zhongguo Yaoxue Zazhi 25:457–459, zit. nach CA 114 (8):68913c

    CAS  Google Scholar 

  20. Yokota Y, Ishida M, Arisawa M, Murakuwi M, Ejiri Ch, Saito H (1988) Toyama-Ken Yakuji Kenkyusho Nenpo 16:103–113; zit. nach CA 114 (2):12281c Zhang Q, Li S, Cheng J, Yan K, Tian S (1990) Zhongguo Zhonggao Zazhi 15:360–362, zit nach CA 113 (26):237916t Li H, Zhou J, Wu G (1989) Yaowu Fenxi Zazhi 9:284–287, zit. nach CA 112 (2):11978g Ni K, Zhong G, Hong H (1989) Zhongguo Yaoke Daxue Xuebao 20:22–24, zit. nach CA 110 (22):199296u Li W, Wang J, Chen L, Hu Z (1981) Proc. Sino-West Ger. Symp. Chromatogr. 447–462, zit. nach CA 102 (10):89376x ark JD, Yoo SJ (1984) Saengyak Hakhoechi 15:139–146, zit. nach CA 102 (8):67461u

    Google Scholar 

  21. Wang Y, Wang Q, Guo Y, Cheng H (1989) Zhongguo Yaoxue Zazhi 24:732–734, zit. nach CA 113 (18): 158761k Ni K, Chang L, Chen F (1989) Zhongguo Yaoke Daxue Xuebao 20:100–102, zit. nach CA 112 (14):125307t Li J (1988) Yaoxue Tongbao 23:355–358, zit. nach CA 109 (22): 197298b Liu L, Xu D, Xie D (1987) 18:361–362, zit. nach CA 107 (20):183699e Han X, Han L (1986) Yaoxue Xuebao 21:864–867, zit.nach CA 106 (10):72990c

    CAS  Google Scholar 

  22. Wang Y, Yang Z (1989) Shenyang Yaoxueyuan Xuebao 6:157–163, zit. nach CA 111 (26):239621a

    CAS  Google Scholar 

  23. Tankano I, Yasuda I, Seto T, Hamano T, Akiyama K (1986) 37:73–78, zit. nach CA 106 (22):182736g

    Google Scholar 

  24. Maeda M, Tsuji A (1985) Analyst (London) 110:665–668, zit. nach CA 103 (20):171205v

    CAS  Google Scholar 

  25. Bottari E, Festa MR, Jasionowksa R (1988) Ann. Chim. (Rome), 78:261–271, zit. nach CA 109 (20): 177572h

    CAS  Google Scholar 

  26. Preti C, Tassi L, Tosi G (1985) Ann. Chim. (Rome) 75:201–206, zit. nach CA 103 (14):115391r

    CAS  Google Scholar 

  27. Johns MR, Chong R, Maddox IS (1982) Can. J. Microbiol. 28:1019–1021, zit. nach CA 97 (21):180067m (by Curvularia coicis) Ascher RH, Maddox IS, Chong R (1981) Eur. J. Appl. Microbiol. Biotechnol. 12:46–52, zit. nach CA 95 (5):40825r (by Clostridium bifermentans)

    CAS  Google Scholar 

  28. Neubert R, Fuerst W, Amlacher R, Haertl A (18. Juli 1991) DD 291927 A5, zit. nach CA 115 (20):214888n

    Google Scholar 

  29. Simon B, Menaste L (10. Okt. 1990) EP 391369 A2, zit. nach CA 114 (26):254013j

    Google Scholar 

  30. Luecke L, Fries G, Voigt G, Neubert R, Fuerst W, Slapke J, Schewe T (3. Okt. 1990) EP 389773 A2, zit. nach CA 114(24):235054g Ueda Y, Shimojo F, Myatake T, Ozoki M (22. Mai 1989) JP 01128926 A2, zit. nach CA 112 (2):11933p Behl ChR, Unowsky J (6. Okt. 1987) EP 87–114589, zit. nach CA 110 (14):121391b Ueda Y, Shimojo F, Miyatake T, Ozaki M (18. Nov. 1987) JP 62265226, zit. nach CA 108 (26):226860r Andonova V, Radeva K (1987) Farmatsiya (Sofia) 37:32–36, zit. nach CA 108 (14):118859n Wu Q, Wu Q (1986) Yaoxue tongbao 21:457–459, zit. nach CA 106 (12):90092r Lee SJ, Yang BR (1984) Han’guk Saenghwa Hakhoechi 17:456–461, zit. nach CA 102 (8):67335f

    Google Scholar 

  31. Fujita S (10. Juli 1989) Heisei JP 01174355 A2, zit. nach CA 112 (20):185809t Niazy EM, Molokhia AM, ElGorashi AS (1989) Int. J. Pharm. 56:181–185, zit. nach CA 112 (8):62492b

    Google Scholar 

  32. Hermens WAJJ, Hooymans PM, Verhoef JC, Merkus FWHH (1990) Pharm. Res. 7:144–146, zit. nach CA 112 (14):125099b Sekline K, Araki D, Suzuki Y (7. Jan. 1988) Showa JP 63002932 A2, zit. nach CA HO (2):13573d Hersey SJ, Kackson RT (1987) J. Pharm. Sci. 76:876–879, zit. nach CA 108 (8):62354a Duchateau GSMJE (1987) Pharm. Veekbl. 122:281–286, zit. nach CA 107 (4):28286z

    PubMed  CAS  Google Scholar 

  33. Yokota T, Fukukura I, Yamaguchi M (13.Dez. 1988) Showa JP 6330530 A2, zit. nach CA 110 (18):160198p

    Google Scholar 

  34. Ritschel WA, Ritschel GB, Ritschel BEC, Luecker PW (1988) Methods Find. Exp. Clin. Pharmacol. 10:645–656, zit. nach CA 109 (26):236908x

    PubMed  CAS  Google Scholar 

  35. Roemisch J, Heimburger N (11. Okt. 1990) DE 3911629 Al, zit. nach CA 114 (22):214406h Daddona PE, Davis HM, Fogler WE, Klug TL, Le-Donne NC, McKinney S (5. Mai 1989) WO 8903885 Al, zit. nach CA 112 (12):104896u

    Google Scholar 

Rj

  1. Funder JW, Feldman D, Edelman IS (1973) Endocrinol 92:994–1.004

    CAS  Google Scholar 

  2. Morris DJ, Souness GW (1990) Am J Physiol 258:F756–759

    PubMed  CAS  Google Scholar 

  3. Marra CA, de Alaniz MJ (1990) Biochem Int 22:483–493

    PubMed  CAS  Google Scholar 

  4. Janiak PC, Lewis SJ, Brody MJ (1990) Am J Physiol 259:R1.025–1.034

    Google Scholar 

  5. Gomez-Sanchez EP (1991) Am J Hypertens 4:374–381

    PubMed  CAS  Google Scholar 

  6. Majima M, Katori M, Hanazuka M, Mizogami S, Nakano T, Nakao Y, Mikami R, Uryu H, Okamura R, Mohsin St, Ohnishi S (1991) Hypertension 17:806–813

    PubMed  CAS  Google Scholar 

  7. Zappia A, Hwang BH, Wu JY (1990) Anat Rec 227:518–522

    PubMed  CAS  Google Scholar 

  8. Milosovich SM, Hussain AA, Hussain M, Dittert L (1989) Prog Clin Biol Res 292:273–277

    PubMed  CAS  Google Scholar 

vB

  1. Kadac B, Vejdelek ZJ, Photometric (1977), Bd.2, S.1096

    Google Scholar 

Rh

  1. Beil Erg. Werk 4, Bd. 9, Teil 3, S. 1760 Rh

    Google Scholar 

Vb

  1. Bergeron RJ, McManis JS (1987) J Org Chem 52:1.700–1.703

    Google Scholar 

  2. Yamashita K, Watanabe K, Koga R, Mizuguchi S, Hashimoto Y, Nakamura T, Umezawa H (1988) J Chromatogr 424:39–48

    PubMed  CAS  Google Scholar 

us

  1. Hibasami H, Midorikawa Y, Gasaluck P, Yoshimura H, Masuji A, Takaji S, Nakashima K, Imai M (1991) Chemother 37:202–205

    CAS  Google Scholar 

  2. Dickneite G, Walter P, Schorlemmer HU, Sedlacek HH (1985) In: Ishigami J (Hrsg.), Rec Adv Chemotherp, Tokyo, Univ of Tokyo

    Google Scholar 

  3. Hibasami H, Tsukada T, Suzuki R, Takano K, Takaji S, Takeuchi T, Shirakawa S, Murata T, Nakashima K (1991) Anticancer Res 11:325–330

    PubMed  CAS  Google Scholar 

  4. Dickneite G, Schorlemmer HU, Sedlacek HH, Falk W, Ulrichs K, Müller-Ruchholtz W (1987) Transplant Proc 19:1.301–1.304

    Google Scholar 

  5. Dickneite G, Schorlemmer HU, Racenberg J, Sedlacek HH (1989) Transplantat Proc 21:1.097–1.098

    Google Scholar 

  6. Kerr PG, Atkins RC (1989) Transplant 48:1.048–1.052

    Google Scholar 

  7. Takasu S, Sagakami K, Orita K (1989) Transplant Proc 21:1.081–1.084

    Google Scholar 

  8. Müller WE, Weissmann N, Maidhof A, Bachmann M, Schröder HC (1987) J Antibiot 40:1.028–1.035

    Google Scholar 

  9. Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama I, Dohi K, Fukuda Y, Fukao K (1990) Transplant 49:337–343

    CAS  Google Scholar 

  10. Okubo M, Inoue K, Umetani N, Sato N, Kamata K, Masaki Y, Uchiyama T, Yan XJ, Aoyagi T, Shirai T (1988) Kidney Int 34:467–473

    PubMed  CAS  Google Scholar 

  11. Ishigaki Y, Sato T, Tonglin S, Hayashi K (1988) Ann N Y Acad Sci 540:551–553

    PubMed  CAS  Google Scholar 

  12. Nemoto K, Abe F, Takita T, Nakamura T, Takeuchi T, Umezawa H (1987) J Antibiot 40:1.193–1.194

    Google Scholar 

  13. Muindi JF, Lee S-J, Baltzer L, Jakubowski A, Scher HI, Sprancmanis LA, Riley CM, Vander Velde D, Young CW(1991) Cancer Res 51:3.096–3.101

    Google Scholar 

vB

  1. East Germany Pat. 82731 (1971), zit. nach CA (1971) 77:19864

    Google Scholar 

ms

  1. Vaughan-Williams EM (1975) Pharmac Ther 31:115–138

    Google Scholar 

  2. Wruck C, Hofmann H, Sziegoleit W, Forster W (1982) Z Ges Inn Med 37:519–525

    PubMed  CAS  Google Scholar 

  3. MollekenK,RugerK(1980) Z Ges Inn Med 35:296–299

    Google Scholar 

EH

  1. Cohen E in Ana 2, S. 174

    Google Scholar 

  2. Kadac B, Vejdelek ZJ (1977) Photometrie 1977, Verlag Chemie, Weinheim. Bd.2, S. 1.095

    Google Scholar 

  3. Kom

    Google Scholar 

Rh

  1. Kaiser H (1987) Thieme, Stuttgart New York

    Google Scholar 

  2. Hochhaus F, Möllmann H, Barth J (1990) Akt Rheumatol 15:66–69

    Google Scholar 

  3. Rohdewald P, Möllmann HW, Hochhaus G (1984) Atemw Lungenkrkh 10:484–489

    CAS  Google Scholar 

  4. Miesfeld RL (1990) Am Rev Respir Dis 141 S2:11–17

    Google Scholar 

  5. Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:2–10

    Google Scholar 

  6. Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56

    Google Scholar 

  7. Schleimer RP (1990) Am Rev Respir Dis 141 S2:59–69

    Google Scholar 

  8. Bowen DL, Fauci AS (1988) Adrenal Corticosteroids. In: Gallin JI, Goldstein M, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–896

    Google Scholar 

  9. Nichols T, Nugent CA, Tyler FH (1967) J Clin Endocrinol 27:549

    Google Scholar 

  10. Loew D, Schuster O, Graul EH (1985) Therapiewoche 35:1106–1113

    Google Scholar 

  11. Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527

    CAS  Google Scholar 

  12. Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15

    Google Scholar 

  13. Hwang DG, Stern WH, Hwang PH, MacGowan-Smith LA (1989) Arch Ophthalmol 107:1375–1380

    PubMed  CAS  Google Scholar 

  14. Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM (1988) Arch Ophthalmol 106:686–687

    PubMed  CAS  Google Scholar 

  15. Kaiser H (1988) Akt Rheumatol 13:27–30

    Google Scholar 

  16. Tsuei SE, Moore RG, Ashley JJ, McBride WG (1979) J Pharm Biopharm 7:249–264

    CAS  Google Scholar 

  17. Laasko L (1981) Curr Ther Res 30:19

    Google Scholar 

  18. Miyabo S, Nakamura T, Kuwazima S, Kishida S (1981) Eur J Clin Pharmacol 20:277–282

    PubMed  CAS  Google Scholar 

  19. Hornke I, Cavagna F, Christ O, Fehlhaber HW, Kellner HM, Sandow J (1980) Arzneim Forsch 30:47–51

    CAS  Google Scholar 

  20. Straub W (1987) Augenkrankheiten. In: Kaiser H (Hrsg.) Cortisonderivate in Klinik und Praxis, Thieme, Stuttgart New York, S. 216–225

    Google Scholar 

  21. Ortega E, Rodriguez C, Strand LJ, Segre E (1976) J Int Med Res 4:326–337

    PubMed  CAS  Google Scholar 

  22. Fiegel G (1981) Med Welt 32:130–134

    PubMed  CAS  Google Scholar 

  23. Karl HJ (1980) Muench Med Wochenschr 122:1191–1194

    CAS  Google Scholar 

  24. Jubiz W, Meikle AW (1979) Drugs 18:113–121

    PubMed  CAS  Google Scholar 

GM

  1. Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527

    CAS  Google Scholar 

  2. Kaiser H (1988) Akt Rheumatol 13:27–30

    Google Scholar 

  3. Clark JE, Lee HJ (1982) Curr Ther Res 32:761–781

    Google Scholar 

  4. Müller W (1981) Therapiewoche 31:6258–6265

    Google Scholar 

GM/vB

  1. Fresenius’ Z Anal Chem (1988) 389:778–780

    Google Scholar 

Rh

  1. Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15

    Google Scholar 

  2. Jack D (1975) Atemw Lungenkrkh 1:S. 13–20

    Google Scholar 

GM/vB

  1. Möllmann HW, Barth J, Schott D, Ulmer WT, Derendorf H, Hochhaus G (1989) Intensivmed 26:2–15

    Google Scholar 

  2. Tsuei SE, Moore RG, Ashley JJ, McBride WG (1979) J Pharm Biopharm 7:249–264

    CAS  Google Scholar 

  3. Melby JC (1977) Ann Rev Pharmacol Toxicol 17:511–527

    CAS  Google Scholar 

GM/vB

  1. Harfst G, Katzung K, Sahihi A (1991) Rauschgift-Szene-Jargon von A-Z, Holger Harfst Verlag, Würzburg

    Google Scholar 

  2. Karrer P, Portmann P, Suter M (1948) Helv Chim Acta 31:1617–1623

    Google Scholar 

  3. Karrer P, Ehrhardt K (1951) Helv Chim Acta 34:2202–2210

    CAS  Google Scholar 

  4. Johns I B, Burch J M (1938) J Am Chem Soc 60:919–920

    CAS  Google Scholar 

  5. v Braun J, Friehmelt E (1933) Chem Ber 66:684–685

    Google Scholar 

  6. Wallis E S, Nagel S C (1931) J Am Chem Soc 53:2787–2791

    CAS  Google Scholar 

  7. Leithe W (1932) Chem Ber 65:660–666

    Google Scholar 

  8. Temmler (1939) Brit 508757

    Google Scholar 

  9. Magidson, Garkusha (1941) J Gen Chem (USSR) 11:339

    CAS  Google Scholar 

  10. Firmenschrift Knoll AG (1977): Pharma Chemikalien

    Google Scholar 

NE

  1. Dring LG, Smith RL, Williams RT (1970) Biochem J 116:425–435

    PubMed  CAS  Google Scholar 

  2. Campbell DB (1969) Pharm Pharmac 21:129–130

    CAS  Google Scholar 

  3. Axelrod J (1970) Amphetamine: metabolism, physiological disposition and its effects on catecholamine storage. In: Costa E, Garattini S (Hrsg.) Amphetamines and related compounds, Raven Press, New York, S. 207–216 (enthält noch andere Artikel zu diesem Thema)

    Google Scholar 

  4. Lange KW (1990) Dtsch Med Wochenschr 115:1.244–1.250

    Google Scholar 

  5. Warneke L (1990) Can J Psychiat 35:3–10

    CAS  Google Scholar 

hr

  1. Harfst G, Katzung K, Sahihi A (1991) Rauschgift-Szene-Jargon von A-Z, Holger Harfst Verlag, Würzburg

    Google Scholar 

  2. Temmler (1939) Brit 508757

    Google Scholar 

  3. Magidson, Garkusha (1941) J Gen Chem (USSR) 11: 339

    CAS  Google Scholar 

  4. Firmenschrift Knoll AG (1977) Pharma Chemikalien

    Google Scholar 

  5. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

  6. Kovar KA, Noy M, Pieper R (1982) Dtsch Apoth Ztg 122:3–22

    CAS  Google Scholar 

NE

  1. Walter LA, US Pat 3030371, zit. nach CA (1962) 57:9822i; Walter LA, US Pat 3061517, zit. nach CA (1963) 58:6744c

    Google Scholar 

  2. Beil Erg. Werk 5, Bd. 22, Teil 10, S.490

    Google Scholar 

MP

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London

    Google Scholar 

MP

  1. Walter LA, US Pat 3030371, zit. nach CA (1962) 57:9822i Walter LA, US Pat 3061517, zit. nach CA (1963) 58:6744c

    Google Scholar 

  2. Beil Erg. Werk 3/4, Bd. 22, Teil 6, S.4921.Brittain RT, D’Arcy PF, Hunt JH (1959) Nature 183:734–735

    Google Scholar 

  3. Fricke FL (1972) J Assoc Off Anal Chem 55:1162–1167

    PubMed  CAS  Google Scholar 

MP

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London

    Google Scholar 

MP

  1. Mar 29, S.530

    Google Scholar 

vB

  1. Beregi Fr Pat M1658 (1963 an Science-Union, Anm. 04.04.1961), zit. nach CA (1963) 59:3831g

    Google Scholar 

  2. Wieduwilt H, Haendel KH, Jassmann E (1974) Ger (East) 108971 (12.10.74, Appl 172919 16.08.73), zit. nach CA (1975) 83(13):113915]

    Google Scholar 

  3. Beregi L, Hugon P, Le Douarec JC, Schmitt H (1965) USP 3198 834 (03.08.65, Appl 27.07.64 an Science Union), zit. nach CA (1965) 63:11425

    Google Scholar 

NE

  1. Mar 29, S.1.441

    Google Scholar 

vB

  1. Brit. Pat. 582156, zit. nach CA 41:2432i

    Google Scholar 

  2. DDR Pat. 45705, zit. nach CA 65:3757f

    Google Scholar 

  3. Beil Erg. Werk 4, Bd.4, Teil 1, S. 1652

    Google Scholar 

  4. Prosser AR, Sheppard AJ (1971) J Pharm Sci 60:909

    PubMed  CAS  Google Scholar 

  5. Umagat H, Tscherne R (1980) Anal Chem 52:1368–1370

    PubMed  CAS  Google Scholar 

hh

  1. Bäßler KH, Grühn E, Loew D, Pietrzik K (1992) Vitamin-Lexikon, Gustav Fischer Verlag, Stuttgart, New York

    Google Scholar 

  2. Buddecke E (1984) Grundriß der Biochemie, 7. Aufl., Gruyter Verlag, Berlin New York

    Google Scholar 

  3. Stryer L (1985) Biochemie, 3. Aufl., Friedrich Viehweg & Sohn, Braunschweig Wiesbaden

    Google Scholar 

  4. Friedrich W (1987) Pantothensäure. In: Friedrich W (Hrsg.) Handbuch der Vitamine, Urban und Schwarzenberg, München Wien Baltimore

    Google Scholar 

  5. Lang K (1976) Biochemie der Ernährung, Steinkopf Verlag, Darmstadt

    Google Scholar 

  6. Pietrzik K, Hornig D (1980) Int J Vit Nutr Res 50:283–293

    CAS  Google Scholar 

  7. Bamji MS (1981) Laboratory tests for the assessment of vitamin nutritional status. In: Briggs M (Hrsg.) Vitamin in Human Biology, CRC Press, Boca Raton

    Google Scholar 

  8. Fox HM (1984) Pantothenic Acid. In: Machlin LJ (Hrsg.) Handbook of Vitamins, Marcel Dekker, Inc., New York

    Google Scholar 

  9. Sauberlich HE, Skala JH, Dowdy RP (1974) The assessment of nutritional status, CRS Press, Inc., Cleveland, Ohio

    Google Scholar 

  10. Hanck A (1986) Pantothensäure. In: Spektrum Vitamine, Arzneimitteltherapie heute, Bd. 42, Aesopus Verlag, Zug, S. 97–102

    Google Scholar 

  11. Höhne E (1985) Pantothensäure/Panthenol. In: Vitamine, 2. Aufl., Otto Hoffmans Verlag GmbH, München

    Google Scholar 

  12. Spector R (1986) Fed Proc 45:37–39

    Google Scholar 

  13. Wagner M, Schubert V, Hötzel D (1972) Med Ernährung 13:25–29

    CAS  Google Scholar 

  14. Monographie Dexpanthenol, BAz (in Vorbereitung)

    Google Scholar 

KP

  1. Gloor M (1982) Pharmakologie dermatologischer Externa, Springer, Berlin Heidelberg New York, S. 27–28

    Google Scholar 

  2. Lochbühler H, Kaufmann W, Storz WL (1978) Therapiewoche 28:2665

    Google Scholar 

  3. Petzoldt D, Henkel W (1979) Ext Derm 3 (Suppl 1):29–34

    Google Scholar 

  4. Jacobsson S, Rothman U, Arturson G (1976) Scand J Plast Reconstr Surg 10:65–72

    PubMed  CAS  Google Scholar 

  5. Paavolainen P, Sundell B (1976) Ann Chir Gynaec Fenn 65:313–317

    CAS  Google Scholar 

  6. Lassus A, Karvonen J, Juvakoski T (1977) Acta Derm Venerol 57:361–363

    PubMed  CAS  Google Scholar 

  7. Matthews RW (1982) Brit Dent J 152:157–159

    PubMed  CAS  Google Scholar 

Gs

  1. Handbook of Pharmaceutical Excipients (1986), American Pharmaceutical Association, Washington, USA, S. 93–94

    Google Scholar 

BK

  1. Fr. M 3683 (1965), zit. nach CA (1967) 66:55204n

    Google Scholar 

  2. Brit. 1,076,174, zit. nach CA (1966) 65:21691v

    Google Scholar 

  3. Schmitt J, Comoy P, Boitard J, Meingan JP, Le Meur J, Briot M (1966) Chim Therap 71–77, zit. nach CA (1966) 65:15255

    Google Scholar 

  4. Neth Appl 6:407,309, zit. nach CA(1965) 63:535

    Google Scholar 

GU

  1. Mar 29, S. 1.609

    Google Scholar 

vB

  1. Fr M3683 (1965), CA 66 (1967) 55204n

    Google Scholar 

  2. Brit 1,076,174, CA 68 (1968) 21691v

    Google Scholar 

  3. Schmitt J, Comoy P, Boitard J, Meingan JP, LeMeur J, Briot M (1966) Chim Ther 71–77; CA 65 (1966) 15255

    Google Scholar 

  4. Neth Appl 6,407,309, CA63 (1965) 535

    Google Scholar 

  5. Schnider O, Hellerbach J (1950) Helv Chim Acta 33:1437–1448

    CAS  Google Scholar 

  6. Schnider O, Grüssner A (1951) Helv Chim Acta 34:2211–2213

    CAS  Google Scholar 

  7. Weiss U, Rüll Th (1965) Bull Soc Chim France 12:3707–3714

    Google Scholar 

  8. Terui Y, Tori K, Maeda S, Sawa YK (1975) Tettrahedron Lett 33:2853–2856

    Google Scholar 

  9. Wainer IW, Tischler MA, Sheinin EB (1980) J Pharm Sci 69:459–461

    PubMed  CAS  Google Scholar 

  10. Achari RG, Theimer EE (1977) J Chromatogr Sci 15:320–321

    PubMed  CAS  Google Scholar 

  11. Park YH, Kuliberg MP, Hinsvark ON (1980) J Pharm Sci 73:24–29

    Google Scholar 

  12. Furlanut M, Cima L, Benetello P, Giusti P (1977) J Chromatogr 140:270–274

    PubMed  CAS  Google Scholar 

  13. Barnhart JW, Massad EN (1979) J Chromatogr 163:390–395

    PubMed  CAS  Google Scholar 

  14. Noirfalise A (1974) J Chromatogr 90:392–393

    PubMed  CAS  Google Scholar 

  15. Häfliger O, Brossi A, Chopard-dit-Jean LH, Walter M, Schnider O (1956) Helv Chim Acta 39:2053–2061

    Google Scholar 

KU

  1. Marks W (1987) Pharmazeut Ztg 132:426–428

    Google Scholar 

  2. Benson WM, Stefko PL, Randell LO (1953) J Pharmacol Exp Ther 109:189–200

    PubMed  CAS  Google Scholar 

  3. Eddy NB, Friebel H, Hahn KJ, Halbach H (1970) Bull WHO 40:169–178

    Google Scholar 

  4. Mortimer Ö, Lindström B, Laurell H, Bergmann U, Rane A (1989)-demethylated and didemethylated metabolites in man, Br J clin Pharmac 27:223–227

    CAS  Google Scholar 

  5. Silvasti M, Karttunen P, Tukiainen H, Kokkonen P, Hänninen U, Nykänen S (1987) Int J Clin Pharmacol Ther Tox 25:493–497

    CAS  Google Scholar 

  6. Hildebrand M, Seifert W, Reichenberger A (1989) Eur J Clin Pharmacol 36:315–318

    PubMed  CAS  Google Scholar 

  7. Matthys H, Bleicher B, Bleicher U (1983) J Int Med Res 11:92–100

    PubMed  CAS  Google Scholar 

  8. Matthys H, Erhard J, Rühle KH (1985) Schweiz Med Wschr 115:307–311

    PubMed  CAS  Google Scholar 

  9. Flemming PhA (1986) Br J Med 293:597

    Google Scholar 

  10. Dodds A, Revai E (1967) Med J Aust 2:231

    Google Scholar 

  11. Schnider O, Grüssner A (1954) US Pat. 2676177; CA (1955) 49:6325a

    Google Scholar 

  12. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaantical Press, London

    Google Scholar 

  13. Farbegas JL, Margalet A (1975) J Pharm Sci 64:1005–1006

    Google Scholar 

  14. Barnhart JW, Massad EN (1979) J Chromatogr 163:390–395

    PubMed  CAS  Google Scholar 

  15. Noirfalise A (1974) J Chromatogr 90:392–393

    PubMed  CAS  Google Scholar 

  16. Park JH, Kuliberg MP, Hinsvark ON (1984) J Pharm Sci 73:24–29

    PubMed  CAS  Google Scholar 

KU

  1. Janssen P A J (1956) J Am Chem Soc 78:3862

    Google Scholar 

  2. Kovar K A, Noy M, Pieper R (1982) Dtsch Apoth Ztg 122:3

    CAS  Google Scholar 

  3. Caddy B, Idowu R (1979) Analyst (London) 104:328

    CAS  Google Scholar 

Rh

  1. Arzneistoff-Profile: Basisinformation über arzneiliche Wirkstoffe (1990) Govi-Verlag, Frankfurt a. M.

    Google Scholar 

  2. Ghodse AH, Sheehan M, Taylor C, Edwards G (1985) Br Med J 290:425–428

    CAS  Google Scholar 

  3. Jurand A, Martin LV (1990) Teratology 42:45–54

    PubMed  CAS  Google Scholar 

  4. Kintz P, Mangin P, Lugnier AA, Chaumont AJ (1990) J Anal Toxicol 14 (4):252–253

    PubMed  CAS  Google Scholar 

  5. Kintz P, Tracqui A, Mangin P, Lugnier AA, Chaumont AJ (1989) J Anal Toxicol 13 (4):238–239

    PubMed  CAS  Google Scholar 

  6. Lançon JP, Pechinot A, Athis PD, Pechinot M, Pointaire P, Obadia JF, Caillard B (1989) Ann Fr Anesth Réanim 8:488–492

    PubMed  Google Scholar 

  7. Meignier M, Zaouter M, Ricard P, Charles-Guillard S, Heloury Y, Rogez JM, Pannier M (1990) Chir Pédiatr 31:341–344

    PubMed  CAS  Google Scholar 

  8. Pagani I, Barzaghi N, Crema F, Perucca E, Ego D, Rovei V (1989) Fundam Clin Pharmacol 3 (l):27–35

    PubMed  CAS  Google Scholar 

KG

  1. Anon (1972) Med Lett Drug Ther 14 (ll):37–40

    Google Scholar 

  2. Baratta RR (1976) Curr Ther Res 20:233–240

    PubMed  CAS  Google Scholar 

  3. Bassendine MF, Woodhouse KW, Bennett M, James OF (1986) Gut 27 (4):444–449

    PubMed  CAS  Google Scholar 

  4. Beaver WT (1984) Hum Toxicol 3 Suppl.:191S–220S

    PubMed  Google Scholar 

  5. Bellville JW,Seed JC (1968) Clin Pharmacol Ther 9:428–434

    PubMed  CAS  Google Scholar 

  6. Briggs GG, Freeman RK, Yaffe SJ (1986) Drugs in Pregnancy and Lactation, 2. Aufl., Williams, Wilkins, Baltimore, 537S.

    Google Scholar 

  7. Brosen K, Gram LF, Schou J, Larsen NE, Thayssen P (1985) Eur J Clin Pharmacol 29 (l):79–84

    PubMed  CAS  Google Scholar 

  8. Claghorn JL, Schoolar JC (1966) JAMA 196:1.089–1.091

    Google Scholar 

  9. Daftery AV (1974) N Engl J Med 291:979–980

    PubMed  CAS  Google Scholar 

  10. Flanagan RJ, Johnston A, White AST, Crome P (1989) Br J Clin Pharmacol 28:463–469

    PubMed  CAS  Google Scholar 

  11. Ford JF, Kellett RJ (1977) Br Med J 2:674

    PubMed  CAS  Google Scholar 

  12. Giacomini KM, Giacomini JC, Gibson TP, Levy G (1980) Clin Pharmacol Ther 28(3):417–424

    PubMed  CAS  Google Scholar 

  13. Hansten PD, Horn JR (1990) Drug Interactions & Updates, 6. Aufl., Lea & Febiger, Philadelphia, London, 620S.

    Google Scholar 

  14. Jaffe JH, Martin WR (1990) Opioid Analgesics and Antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) The Pharmacological Basis of Therapeutics, Pergamon Press, New York, S. 485–521

    Google Scholar 

  15. Kunka RL, Venkataramanan R, Stern RM, Ladik CF (1984) Clin Pharm Ther 35:675–680

    CAS  Google Scholar 

  16. Kurz-Müller K, Zenz M (1991) Schmerz 5:233–242

    PubMed  Google Scholar 

  17. Lee TH, Rees PJ (1977) Br Med J 2:296

    PubMed  CAS  Google Scholar 

  18. Lupin AJ, Harley CH (1976) Can Med Assoc J 114:596

    PubMed  CAS  Google Scholar 

  19. Musa MN, Lyons LL (1976) Curr Ther Res 19 (6):669–674

    PubMed  CAS  Google Scholar 

  20. Owen M, Hillis LJ (1980) Med J Aust 1:617–618

    PubMed  CAS  Google Scholar 

  21. Sewester CS (1990) Drug: Fact and comparison, Lippincott, Philadelphia

    Google Scholar 

  22. Tennant FS (1973) Arch Intern Med 132:191–194

    PubMed  Google Scholar 

  23. Tyson HK (1974) J Pediatr 85 (5):684–685

    PubMed  CAS  Google Scholar 

  24. Verebely K, Inturrisi CE (1974) Clin Pharmacol Ther 15:302–309

    PubMed  CAS  Google Scholar 

  25. Wagner JG, Welling PG, Sedmann AJ (1972) Int J Clin Pharmacol 5:381–388

    CAS  Google Scholar 

  26. Waife SO, Gruber CM, Rodda BE, Nash JF (1976) Int J Clin Pharmacol Biopharm 13:177–181

    PubMed  CAS  Google Scholar 

  27. Welling PG, Lyons LL, Tse FLS, Craig WA (1976) Clin Pharmacol Ther 19:559–565

    PubMed  CAS  Google Scholar 

  28. Wiederholt IC, Genco M, Foley JM (1967) Neurology 17:703

    PubMed  CAS  Google Scholar 

  29. McMahon RE, Shader RI (1973) Life Sci (II) 12:463–473

    CAS  Google Scholar 

  30. Abernethy DR, Greenblatt DJ, Steel K, Sullivan HR, Due SL, Marshall FJ (1982) Ann Intern Med 97:223–224

    PubMed  CAS  Google Scholar 

KG

  1. Schnider O, Grüssner A (1951) Helv Chim Acta 34:2211–2217

    CAS  Google Scholar 

  2. Meyers AI, Bailey TR (1985) J Org Chem 51:872–875

    Google Scholar 

  3. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

  4. Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr323(2):191–225

    PubMed  CAS  Google Scholar 

  5. Furlanut M, Cima L, Benetello G, Giusti P (1977) J Chromatogr 140 (3):270–274

    PubMed  CAS  Google Scholar 

KU

  1. Nahm H, Siedel W (1963) Chem Ber 96:1–9

    CAS  Google Scholar 

  2. In: Pouchert CJ (Hrsg.) (1989) The Aldrich Library of FT-IR-Spectra, Bd. 1, Aldrich Chemical Co., Milwaukee, S. 254

    Google Scholar 

  3. In: Hansch C, Sammes PG, Taylor JB (Hrsg.) (1990) Comprehensive Medicinal Chemistry, Bd. 6, Pergamon Press Oxford, S. 438

    Google Scholar 

Ba

  1. Schwindler H (1968) Wien Med Wochenschr 118:98–100

    Google Scholar 

  2. Myant NB (1964) The thyroid and lipid metabolism. In: Paoletti R (Hrsg.) Lipid Pharmacology, Academic Press Inc, New York, S. 299–323

    Google Scholar 

  3. Kuschinsky G, Lüllmann H (1981) Kurzes Lehrbuch der Pharmakologie und Toxikologie, Georg Thieme Verlag, Stuttgart New York, S. 155

    Google Scholar 

  4. The Coronary Drug Project (1972) J Am Med Assoc 220:996–1.008

    Google Scholar 

  5. The Coronay Drug Project Research Group (1975) J Am Med Assoc 231:360–381

    Google Scholar 

  6. Tapley DF, Davidoff FF, Hatfield WB, Ross JE (1959) Am J Physiol 197:1.021–1.025

    Google Scholar 

  7. Klotz U (1984) Klinische Pharmakokinetik, Gustav Fischer Verlag, Stuttgart New York, S. 120

    Google Scholar 

  8. Weser JK, Sellers E (1971) N Engl J Med 285:547–558

    PubMed  CAS  Google Scholar 

Bj

  1. Neudecker H, Scheiffele E (1971) Arzneim Forsch 21:432

    CAS  Google Scholar 

  2. HeintzB, Hamacher H (1983) Dtsch Apoth 123:417–420

    Google Scholar 

  3. Gübitz G, Juffmann F (1987) J Chromatogr 404:391–393

    PubMed  Google Scholar 

  4. Richheimer SL, Schacher MS (1983) J Pharm Sci 72: 822–823

    PubMed  CAS  Google Scholar 

  5. Wachholz E, Pfeifer S (1972) Pharmazie 27:43–46

    PubMed  CAS  Google Scholar 

  6. Wachholz E, Pfeifer S (1972) Pharmazie 27:97–106

    PubMed  CAS  Google Scholar 

  7. Hay ID, Annesley TM, Jiang NS, Gorman CA (1981) J Chromatogr 226:383–390

    PubMed  CAS  Google Scholar 

  8. DAB 10, Monographie Levothyroxin-Natrium

    Google Scholar 

Ba

  1. Cohen MS (1987) Special aspects of perinatal and pediatric pharmacology. In: Katzung BG (Hrsg.) Basic and clinical pharmacology, Norwalk, Appleton Lange, S. 749–755

    Google Scholar 

  2. Inturrisi CE, Max MB, Foley KM, Schultz M, Shin SU, Houde RW (1984) N Engl J Med 310:1.213–1.217

    Google Scholar 

  3. Jamous MA, Hand CW, Moore RA, Teddy PJ, McQuay HJ (1986) Anesth Analg 65:1.290–1.294

    Google Scholar 

  4. Kaiko RF, Wallenstein SL, Rogers AG, Grabinski PY, Houde RW (1981) N Eng J Med 304:1.501–1.505

    Google Scholar 

  5. Kotob HI, Hand CW, Moore RA, Evans PJ, Wells J, Rubin AP, McQuay HJ (1986) Anesth Analg 65:718–722

    PubMed  CAS  Google Scholar 

  6. Lee A, McKeown D, Brockway M, Bannister J, Wildsmith JA (1991) Anaesthesia 46 (6):447–450

    PubMed  CAS  Google Scholar 

  7. Levine MN, Sackett DL, Bush H (1986) Arch Intern Med 146:353–356

    PubMed  CAS  Google Scholar 

  8. McGrady EM, Brownhill DK, Davis AG (1989) Anaesthesia 44:400–403

    PubMed  CAS  Google Scholar 

  9. Moore A, Bullingham R, McQuay H, Allen M, Baldwin D, Cole A (1984) Clin Pharmacol Ther 35:40–45

    PubMed  CAS  Google Scholar 

  10. Product Information-Diamorphine hydrochloride BP for injection® (1989)

    Google Scholar 

  11. Robinson SL, Rowbotham DJ, Smith G (1991) Anaesthesia 46 (7):538–540

    PubMed  CAS  Google Scholar 

  12. Sawynok J (1986) Can J Physiol Pharmacol 64:1–6

    PubMed  CAS  Google Scholar 

  13. Smith ID, Klubien KE, Wood ML, Macrae DJ, Carli F (1991) Anaesthesia 46 (11):970–973

    PubMed  CAS  Google Scholar 

  14. Stevens JD, Braithwaite P, Corke CF, Madej TH, Wheatley RG (1991) Anaesthesia 46 (4):256–259

    PubMed  CAS  Google Scholar 

  15. Wallenstein SL, Houde RW, Portenoy R, Lapin J, Rogers A, Foley KM (1990) Pain 41 (1):5–13

    PubMed  CAS  Google Scholar 

  16. Way WL, Way EL (1987) Opioid Analgesics and Antagonists. In: Katzung BG (Hrsg.) Basic and clinical pharmacology, Norwalk, Appleton Lange, S. 749–755

    Google Scholar 

KG

  1. Poochikian GK, Cradock JC, Davignon JP (1983) Int J Pharm 13:219

    CAS  Google Scholar 

  2. Beaumont I, Deeks T (1982) J Chromatogr 238:520

    PubMed  CAS  Google Scholar 

  3. Wyatt DK, Grady LT (1982) in Florey K Anal Profiles of Drug Substances 10:357

    Google Scholar 

  4. Bernhauer D, Fuchs E, Neumann H (1983) Fresenius Z Anal Chem 316:357

    Google Scholar 

  5. Rogers GC, Davies MB, Allwood MC (1991) International Pharmacy Journal 5(2):70

    Google Scholar 

Am

  1. Sternbach LH (1978) Progr. Drug Res 22:229–266

    CAS  Google Scholar 

  2. Schütz H (1982) Benzodiazepines, Springer, Berlin Heidelberg New York

    Google Scholar 

  1. Haefely W, Pieri L, Polc P, Schaffner R (1981) General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister F, Stille G (Hrsg.) Handbook of experimental pharmacology, Bd. 55/II, Springer-Verlag, Berlin, S. 13–262

    Google Scholar 

  2. Haefely W, Kyburz E, Gerecke M, Möhler H (1985) Adv in Drug Res 14:165–322

    CAS  Google Scholar 

  3. Müller WE (1987) The benzodiazepine receptor: drug only or a physiologically relevant part of our central nervous system? Cambridge University Press, Cambridge

    Google Scholar 

  4. Klotz U, Kanto J (1988) Clin Pharmacokin 14:1–12

    CAS  Google Scholar 

  5. O’Sullivan GF, Wade DN (1987) Clin Pharmacol Ther 42:254–259

    PubMed  Google Scholar 

  6. Mandelli M, Tognoni G, Garattini S (1978) Clin Pharmacokin 3:72–91

    CAS  Google Scholar 

  7. Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Clin Pharmacol Ther 27:301–312

    PubMed  CAS  Google Scholar 

  8. Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR (1975) J Clin Invest 55:347–359

    PubMed  CAS  Google Scholar 

  9. Greenblatt DJ, Shader RI (1974) Benzodiazepines in clinical practice, Raven-Press, New York

    Google Scholar 

  10. Müller WE (1990) Therapiewoche 40:3.170–3.175, 3.635–3.641

    Google Scholar 

  11. Stoeckel H, Lauven PM, Schwilden H, Murday H (1986) Benzodiazepine als Supplement in der Allgemeinanästhesie. In: Hippius H, Engel RR, Laakmann G (Hrsg.) Benzodiazepine, Rückblick und Ausblick, Springer-Verlag, Berlin Heidelberg New York, S.214–223

    Google Scholar 

  12. Kugler J, Leutner V (Hrsg.) (1987) Benzodiazepine in der Neurologie, Editiones Roche, Grenzach

    Google Scholar 

  13. Nathan PW (1970) J Neurol Sci 10:33–50

    PubMed  CAS  Google Scholar 

  14. Woods JH, Katz JL, Winger G (1987) Pharmacol Rev 39:251–419

    PubMed  CAS  Google Scholar 

  15. Winokur A, Rickels K, Greenblatt DJ, Snyder PJ, Schatz NJ (1980) Arch Gen Psychiatry 37:101–105

    PubMed  CAS  Google Scholar 

  16. Tyrer P, Owen R, Dawling S (1983) Lancet 25:1.402–1.406

    Google Scholar 

  17. Klotz U (1984) Progr Clin Biochem Med 1:117–167

    CAS  Google Scholar 

Wm

  1. Kom

    Google Scholar 

  2. Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia 2. Aufl., Noyes Publications, Park Ridge, New Jersey USA, S. 467

    Google Scholar 

  3. ToplissJG, Sperber N, Rubin AA (1967) US Pat 3.345.365; zit. nach CA (1968) 68:78.318h

    Google Scholar 

  4. Ebel S (1977) Handbuch der Arzneimittelanalytik,Verlag Chemie Weinheim-New York, S.226

    Google Scholar 

  5. JakobsenP, Treppendahl S (1979) Tetrahedron 35:2151

    CAS  Google Scholar 

  6. Mannhold R, Rodenkirchen R, Bayer R, Haas W (1984) Arzneim Forsch 34:407

    CAS  Google Scholar 

  7. DaldrupT, Susanto F, Michalke P (1981) Fresenius Z Anal Chem 308:413

    CAS  Google Scholar 

RE

  1. Rubin AA, Roth FE, Taylor RM, Rosenkilde H (1962) J Pharmacol Exp Ther 136:344–352

    PubMed  CAS  Google Scholar 

  2. Topliss JG, Konzelman LM, Shapiro EP, Sperber N, Roth FE (1964) J Med Chem 7:269–273

    PubMed  CAS  Google Scholar 

  3. Topliss JG, Sherlock MH, Reimann H, Konzelman LM, Shapiro EP, Petterson BW, Schneider H, Sperber N (1963) J Med Chem 6:122–127

    PubMed  CAS  Google Scholar 

  4. Koch-Weser K (1976) N Engl J Med 294:1.271–1.274

    Google Scholar 

  5. Scriabine A (1980) Diazoxide. In: Scriabine A (Hrsg.) Pharmacology of antihypertensive drugs, Raven Press, New York, S. 397–406

    Google Scholar 

  6. McMahon FG (1984) Diazoxide (Hyperstat). In: McMahon FG (Hrsg.) Management of essential Hypertension: The new low dose era. Futura Publishing Company, Inc, Mount Kisco New York, S. 506–522

    Google Scholar 

  7. Küchel O, Fishman ML, Liddle GW, Michelakis A (1967) An Intern Med 67:791–799

    Google Scholar 

  8. Finnerty FA (1974) Am Heart J 88:265–268

    PubMed  Google Scholar 

  9. Dollery CT, Pentecost BL, Samaan NA (1962) Lancet II:735–737

    Google Scholar 

  10. Fang P, Macdonald I, Laver M, Hua A, Kincaid-Smitth P (1974) Med J Aust 2:621–624

    PubMed  CAS  Google Scholar 

  11. Wohl AJ, Hausier LM, Roth FE (1968) Life Sci 7:381–387

    PubMed  CAS  Google Scholar 

  12. Maxwell GM (1971) Nature 233:250

    CAS  Google Scholar 

  13. Quast U, Cook NS (1989) J Pharmacol Exp Ther 250:261–271

    PubMed  CAS  Google Scholar 

  14. Taylor J, Green RG (1970) Europ J Pharmacol 12:385–387

    CAS  Google Scholar 

  15. Thirlwell MP, Green RD (1972) Am Heart J 83:512–517

    CAS  Google Scholar 

  16. Lang RE (1985) Vasodilatantien. In: Ganten D, Ritz E (Hrsg.) Lehrbuch der Hypertonie, Schattauer-Verlag, Stuttgart New York, S. 677–685

    Google Scholar 

  17. Sellers EM, Koch-Weser J (1973) Ann NY Acad Sci 226:319–332

    PubMed  CAS  Google Scholar 

  18. Dayton PG, Pruitt AW, Faraj BA, Israili ZH (1975) Drug Metab Dispos 3:226–229

    PubMed  CAS  Google Scholar 

  19. Pearson RM (1977) Clin Pharmacokin 2:198–204

    CAS  Google Scholar 

  20. Pruitt AW, Faraj BA, Dayton PG (1974) J Pharmacol Exp Ther 188:248–256

    PubMed  CAS  Google Scholar 

  21. Finnerty FA, Kakaviatos N, Tuckman J (1963) Circulation 28:203–208

    PubMed  Google Scholar 

  22. Black J (1968) Ann NY Acad Sci 150:194–203

    PubMed  CAS  Google Scholar 

  23. Morris JA, Arce JJ et al (1977) Obstet Gynecol 49:675–680

    PubMed  CAS  Google Scholar 

  24. Kumar GK, Dastoor FC, Robayo JR, Razzaque MA (1976) J Amer Med Ass 235:275–276

    CAS  Google Scholar 

  25. Combs JT, Grunt JA, Brande IK (1967) Pediatrics 40:90–92

    PubMed  CAS  Google Scholar 

  26. Wales JK, Wolff F (1967) Lancet I:53–54

    Google Scholar 

  27. Lockwood CH, Nicholls DM, Troop VL, Lewis JA (1963) Am J Med Sci 246:312–318

    PubMed  CAS  Google Scholar 

  28. Okun R, Russel RP, Wilson WR (1963) Arch Intern Med 112:120–126

    Google Scholar 

  29. Milner RDG, Chouksey SK (1972) Arch Dis Child 47:537–543

    PubMed  CAS  Google Scholar 

  30. Huysmans FTM, Thien TA, Koene RAP (1982) Am Heart J 103:395–400

    PubMed  CAS  Google Scholar 

  31. Aynsley-Green A, Illig R (1975) Lancet II:658–659

    Google Scholar 

  32. Sellers EM, Koch-Weser J (1970) Clin Pharmacol Ther 11:524–529

    PubMed  CAS  Google Scholar 

GW

  1. Angaben der Fa. Pfizer

    Google Scholar 

Gg

  1. l.Noone P (1984) Drugs 27:548–578

    PubMed  CAS  Google Scholar 

  2. Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S.306

    Google Scholar 

  3. Rimoldi R, Curcio L, Sanfilippo A (1978) Pharmacokinetic study of dibekacin in humans. Current chemotherapy. Proc 10th Congr Chemother, Zürich 1977, Vol.2, S. 928

    Google Scholar 

  4. Bégué P, Safran C, Quiniou F, Michel P, Laget P (1984) Dev Pharmacol Ther 7 (Suppl. 1):116–120

    PubMed  Google Scholar 

  5. Autret E, Borderon JC, Saliba E, Koki P, Ployet MJ, Gold F, Breteau M, Laugier J (1984) Dev Pharmacol Ther 7 (Suppl. 1):121–124

    PubMed  CAS  Google Scholar 

  6. Furlanut M, D’Elia R, Granati B, Bruno R, Mainardi G, Tamassia V (1981) Pharmacokinetic study of dibekacin in full-term newborn infants. Current chemotherapy and immunotherapy. Proc 12th Congr Chemother, Florence 1981, Vol. 12, S. 813–814

    Google Scholar 

  7. Arancibia A, Chávez J, Ibarra R, Ruiz I, Icarte A, Thambo S, Chávez H (1987) Int J Clin Pharmacol Ther Toxicol 25:38–43

    PubMed  CAS  Google Scholar 

  8. Campillo JA, Lanoa JM, Dominguez-Gil A, Rubio F, Martin A (1980) Eur J Clin Pharmacol 18:347–350

    PubMed  CAS  Google Scholar 

fm

  1. Mar 29, S. 1.352

    Google Scholar 

vB

  1. Spezifikation der Fa. Luitpold-Pharma, München

    Google Scholar 

FB

  1. Wallhäußer KH (1988) Praxis der Sterilisation Desinfektion-Konservierung, 4. Aufl., Thieme Verlag, Stuttgart New York, S. 514

    Google Scholar 

  2. Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3 Antibakterielle, antifungielle und antivirale Antiseptik-ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S.292–293

    Google Scholar 

  3. Kramer A, Zbinden G, Stephan U, Koch St, Koch D, Junghans A (1985) Akute Toxizität von Antiseptika. In: Kramer A, Berencsi G, Weuffen W (Hrsg.) Handbuch der Antiseptik, Bd. I/5, Toxische und allergische Nebenwirkungen von Antiseptika, Volk und Gesundheit, Berlin, S. 113–210

    Google Scholar 

  4. Beilfuß W, Bücklers L, Eigener U, Harke HP, Sturm U (1987) Phenole. In: Kramer A, Weuffen W, Krasilnikow AP, Gröschel D, Bulka E, Rehn D (Hrsg.) Handbuch der Antiseptik, Bd.II/3, Antibakterielle, antifungielle und antivirale Antiseptik-ausgewählte Wirkstoffe, Volk und Gesundheit, Berlin, S. 320

    Google Scholar 

ak

  1. Todd A, Sorkin EM (1988) Drugs 35:244–285

    PubMed  CAS  Google Scholar 

  2. Skoutakis VA, Carter CA, Mickle TR, Smith VH, Arkin CR, Alissandratos J, Petty DE (1988) Drug Intell Clin Pharm 22:850–859

    PubMed  CAS  Google Scholar 

  3. Ku EC, Lee W, Kothari HV, Kimble EF, Liauw L, Tjan J (1985) Semin Arthritis Rheum 15 (Suppl 1):36–41

    PubMed  CAS  Google Scholar 

  4. Ku EC, Lee W, Kothari HV, Scholer DW (1986) Am J Med 80 (Suppl4B):18–23

    PubMed  CAS  Google Scholar 

  5. Vane JR (1987) Drugs 33 (Suppl1): 18–27

    PubMed  CAS  Google Scholar 

  6. Brogden RN, Heel RC, Pakes GE, Speight TM, Avery GS(1980) Drugs 20:24–48

    PubMed  CAS  Google Scholar 

  7. Burkhardt D, Ghosh P (1987) Semin Arthritis Rheum 17(Suppll):3–34

    PubMed  CAS  Google Scholar 

  8. Martel-Pelletier J, Pelletier JP, Cloutier JM, Howell DS, Ghandur-Mnaymneh L, Woessner JF (1984) Arthritis Rheum 27:304–312

    Google Scholar 

  9. Woessner JF, Seize MG (1984) J Biol Chem 259:3.633–3.638

    Google Scholar 

  10. Walton EA, Upfold LI, Stephens RW, Ghosh P, Taylor TKF (1981) Semin Arthritis Rheum 11:73–74

    CAS  Google Scholar 

  11. Kruze D, Fehr K, Menninger H, Böni A (1976) Z Rheumatol 35:337–346

    PubMed  CAS  Google Scholar 

  12. Minta JO, Williams MD (1985) J Rheumatol 12:751–757

    PubMed  CAS  Google Scholar 

  13. Kalbhen DA (1984) Biochemically induced osteoarthritis in the chicken and rat. In: Munthe E, Bjelle A (Hrsg.) Effects of drugs on osteoarthritis, Huber-Verlag, Bern Stuttgart Vienna, S. 48–68

    Google Scholar 

  14. Hoedt-Schmidt S, Scheid A, Kalbhen DA (1989) Arzneim Forsch 39:1.212–1.219

    Google Scholar 

  15. McKenzie LS, Horsburgh BA, Ghosh P, Taylor TKF (1977) Ann Rheum Dis 36:369–373

    PubMed  CAS  Google Scholar 

  16. John VA (1979) Rheumatol Rehabil (Suppl2):22–35

    Google Scholar 

  17. Kendall MJ, Thornhill DP, Willis JV (1979) Rheumatol Rehabil (Suppl2):38–45

    Google Scholar 

  18. Riess W, Stierlin H, Degen P, Faigle JW, Gérardin A, Moppert J, Sallmann A, Schmid K, Schweizer A, Theobald W, Wagner J (1978) Scand J Rheumatol 22 (Suppl):17–29

    CAS  Google Scholar 

  19. Morimoto K, Iwamoto Y, Katashima T, Takeeda T, Nakamoto Y, Morisaka K (1985) Pharm Res 4:166–170

    Google Scholar 

  20. Willis JV, Kendall MJ, Jack DB (1981) Eur J Clin Pharmacol 19:33–37

    PubMed  CAS  Google Scholar 

  21. APr

    Google Scholar 

  22. Riess W, Schmid K, Botta L, Kobayashi K, Moppert J, Schneider W, Sioufi A, Strusberg A, Tomasi M (1986) Arzneim Forsch 36:1.092–1.096

    Google Scholar 

  23. Willis JV, Kendall MJ, Flinn RM, Thornhill DP, Welling PG (1979) Eur J Clin Pharmacol 16:405–410

    PubMed  CAS  Google Scholar 

  24. Willis JV, Kendall MJ, Jack DB (1980) Eur J Clin Pharmacol 18:415–418

    PubMed  CAS  Google Scholar 

  25. Chamouard JM, Barce J, Urien S, Houin G, Tillement JP (1985) Biochem Pharmacol 34:1.675–1.700

    Google Scholar 

  26. Brune K, Dietzel K, Nürnberg B, Schneider HT (1987) Scand J Rheumatol 65 (Suppl): 135–140

    CAS  Google Scholar 

  27. Benson MD, Aldo-Benson M, Brandt KD (1985) Semin Arthritis Rheum 15 (Suppl 1):65–67

    PubMed  CAS  Google Scholar 

  28. Stierlin H, Faigle JW, Colombi A (1978) Scand J Rheumatol 22 (Suppl) :30–35

    Google Scholar 

  29. Zimmerer J, Tittor W, Degen P (1982) Fortschr Med 100:683–688

    Google Scholar 

  30. Willis JV, Kendall MJ (1978) Scand J Rheumatol 22 (Suppl):36–41

    CAS  Google Scholar 

  31. Borghi C, Corno C, Palummeri E, Giorgi D (1986) Acta Pharmacol Toxicol 59 (Suppl5):101

    Google Scholar 

  32. Rainsford KD (1984) Trends Pharmacol Sci 5:156–159

    CAS  Google Scholar 

  33. O’Brien WM, Bagdy GF (1985) J Rheumatol 12:13–20, 347–353, 562–567, 785–790

    PubMed  Google Scholar 

  34. Rainsford KD, Velo GP (Hrsg.) (1987) Side effects of anti-inflammatory drugs, Bd. I und II, MTP Press, Lancaster

    Google Scholar 

  35. Rainsford KD (1988) J Rheumatol 15 (Suppl 17):63–70

    Google Scholar 

  36. Small RE (1989) Clin Pharm 8:545–548

    PubMed  CAS  Google Scholar 

  37. Fowler PD (1979) Rheumatol Rehabil 2:60–68

    PubMed  Google Scholar 

  38. Koopmans PP, Thien T, Gribnau FWJ (1987) Eur J Clin Pharmacol 31:553–557

    PubMed  CAS  Google Scholar 

  39. Kuhlmann J (1982) Akt Rheumatol 7:38–43

    Google Scholar 

  40. Reimann IW, Frölich JC (1981) Clin Pharmacol Ther 30:348–352

    PubMed  CAS  Google Scholar 

  41. Danion JM, Schmidt M, Welsch M, Imbs JL, Singer L (1987) Encephale 13:255–260

    PubMed  CAS  Google Scholar 

  42. Gabrielli A, Leoni P, Danieli G (1987) Br Med J 294:776

    Google Scholar 

  43. Daly HM, Boyle J, Roberts CJC, Scott GL (1986) Lancet 1:557

    PubMed  CAS  Google Scholar 

  44. Harima Y, Maekawa T, Miyauchi Y, Tsutsui T, Sakabe T, Koshiro A (1987) Intensive Care Med 13:361–362

    PubMed  CAS  Google Scholar 

  45. Netter P, Lambert H, Larcan A, Godbillon J, Gosset J (1984) Eur J Clin Pharmacol 26:535–536

    PubMed  CAS  Google Scholar 

Hs/KA

  1. Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 532–533

    Google Scholar 

  2. Schmitt C, Vandenheuvel WJA, Walker RW, Plazonnet B (1979) J Pharm Sci 68:381–383

    PubMed  CAS  Google Scholar 

WE

  1. Novello FC, Bell SC, Abrams ELA, Ziegler J, Sprague JM (1960) J Org Chem 25:965–970

    CAS  Google Scholar 

  2. Boissier JR, Dumont C, Lesbros J (1966) Therapie 21:331–340

    PubMed  CAS  Google Scholar 

  3. Mar 29, S.985

    Google Scholar 

  1. Gloxhuber C, Offe HA, Rauenbusch E, Scholtan W, Schmid J (1965) Arzneim Forsch 15:322–330

    CAS  Google Scholar 

  2. Knott T, Lange A, Volkening R (1965) Arzneim Forsch 15:331–340

    CAS  Google Scholar 

  3. Sutherland R, Croydon EAP, Rolinson GN (1970/4) Br Med J:455–460

    Google Scholar 

  4. Gravenkemper CF, Bennett JV, Brodie JL, Kirby WMM (1965) Arch Intern Med 116:340–345

    PubMed  CAS  Google Scholar 

  5. Thijssen HHW, Mattie H (1976) Antimicrob Agents Chemother 10:441–446

    PubMed  CAS  Google Scholar 

  6. Thijssen HHW (1980) J Chromatog 183:339–345

    CAS  Google Scholar 

  7. Thijssen HHW (1979) J Antibiotics 32:1.033–1.037

    Google Scholar 

  8. Cole M, Kenig MD, Hewitt VA (1973) Antimicrob Agents Chemother 3:463–468

    PubMed  CAS  Google Scholar 

  9. Onorato JM, Axelrod JL (1978) Arch Intern Med 89:497–500

    CAS  Google Scholar 

  10. Deboever G (1987) Amer J Gastroenterol 82:483

    CAS  Google Scholar 

  11. Tauris P, Jorgensen NF, Petersen CM, Albertsen K (1985) Acta Med Scand 217:567–569

    PubMed  CAS  Google Scholar 

  12. Nauta EH, Mattie H (1976) Clin Pharmacol Ther 19:98–108

    Google Scholar 

  13. Daten der Firma Bayer (s. Fachinfo zu Dichlor-Stapenor®)

    Google Scholar 

  14. Barza M, Weinstein L (1976) Clin Pharamcokinet 1:297–308

    CAS  Google Scholar 

  15. Olsson R, Wiholm BE, Sand C, Zettergren L, Hultcrantz R, Myrhed M (1992) J Hepatol 15:154–161

    PubMed  CAS  Google Scholar 

CW

  1. Gloxhuber C, Offe HA, Rauenbusch E, Scholtan W, Schmid J (1965) Arzneim Forsch 15:322

    CAS  Google Scholar 

  2. Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Stoffe, Editio Cantor, Aulendorf

    Google Scholar 

  3. MuraiY, Nakagawa T, Okumura K, Uno T (1984) Chem Pharm Bull 32:3277–3280

    Google Scholar 

GU

  1. Link KP (1959) Circulation 19:97–109

    PubMed  CAS  Google Scholar 

  2. Suttie JW (1987) Adv Exp Med Biol 214:3–16

    PubMed  CAS  Google Scholar 

  3. Preusch PC, Smalley DM (1990) Free Radic Res Commun 8:401–415

    PubMed  CAS  Google Scholar 

  4. Myszka DG, Swenson RP (1991) J Biol Chem 266:4.789–4.797

    Google Scholar 

  5. Liska DJ, Suttie JW (1988) Biochemistry 27:8.636–8.641

    Google Scholar 

  6. Rockwell S, Keyes SR, Sartorelli AC (1989) Cancer Chemother Pharmacol 24:349–353

    PubMed  CAS  Google Scholar 

  7. Sartorelli AC (1988) Cancer Res 48:775–778

    PubMed  CAS  Google Scholar 

  8. Mar 29, Anticoagulants, S. 338–349

    Google Scholar 

  9. Otagiri M, Miyoshi T, Yamamichi R, Maruyama T, Perrin JH (1991) Biochem Pharmacol 42:729–733

    PubMed  CAS  Google Scholar 

  10. Majerus PW, Broze GJ, Miletich JP, Tollefsen DM (1990) Anticoagulant, Thrombolytic, and Antiplatelet Drugs. In: Goodman-Gilman A, Rall W, Nies AS, Tay lor P (Hrsg.) The Pharmacological Basis of Theapeutics, 8. Aufl., Pergamon Press, New York, S. 1.311–1.331

    Google Scholar 

  11. American College of Chest Physicians and the National Heart. Lung, Blood Institute. National Conference on antithrombotic therapy (1986) Chest 89 Suppl:1s-106s

    Google Scholar 

  12. Arfvidsson B, Lundgren F, Drott C, Schersten T, Lundholm K (1990) Am J Surg 159:556–560

    PubMed  CAS  Google Scholar 

  13. Kretschmer G, Wenzl E, Huk I, Polterauer P, Ehringer H, Minar E, Schemper M (1987) Wien Klin Wochenschr 99:591–595

    PubMed  CAS  Google Scholar 

  14. Levine MN, Hirsh J (1986) Semin Thromb Hemost 12:39–57

    PubMed  CAS  Google Scholar 

  15. Griffin JP, D’Arcy PF, Speirs CJ (1988) Anticoagulants. In: A Manual of Adverse Drug Interactions. 4. Aufl., John Wright, London, S. 137–158

    Google Scholar 

EH

  1. Bohlmann F, Herbst P, Arndt C, Schönowsky H, Gleinig H (1961) Chem Ber 94:3193–3212

    CAS  Google Scholar 

  2. Bohlmann F, Mönch H, Blaskiewicz P (1967) Chem Ber 100:611–617

    PubMed  CAS  Google Scholar 

  3. Breinlich J, Scharnagel K (1968) Arzneim Forsch 18:429–431

    CAS  Google Scholar 

  4. Mitteilung der Asta Pharma (1991) Frankfurt

    Google Scholar 

  1. Bohlmann F, Herbst P, Arndt C, Schönowski H, Gleinig H (1961) Chem Ber 94:3193–3212

    CAS  Google Scholar 

  2. Bohlmann F, Mönch H, Blaskiewicz P (1967) Chem Ber 100:611–617

    PubMed  CAS  Google Scholar 

  3. Mitteilung der Asta Pharma (1991), Frankfurt

    Google Scholar 

  1. Tilford M et al (1947) J Am Chem Soc 69:2903–2905

    Google Scholar 

  2. Kopp M, Tchouber B (1952) Bull Soc Chim France 1952:84–89

    Google Scholar 

  3. Yoshida Y, Iwashige M (1955) Pharm Bull (Tokyo) 3:417–425

    CAS  Google Scholar 

  4. Verrier M (1959) Bull Soc Chim France 1959:1863–1865

    Google Scholar 

  5. Mills III T, Roberson J C (1987) Instrumental Data for Drug Analysis, 2. Aufl., Bd. 1 Elsevier, New York-Amsterdam-London, S.654–655

    Google Scholar 

  6. Meffin P J, Moore G, Thomas J (1973) Anal Chem 45:1964–1966

    PubMed  CAS  Google Scholar 

Gb

  1. Kilbinger H, Stein A (1988) B J Pharmacol 94:1.270–1.274

    Google Scholar 

  2. Nilvebrant L, Sparf B (1986) Eur J Pharmacol 123:133–143

    PubMed  CAS  Google Scholar 

  3. Freedman SB, Beer MS, Harley EA (1988) Eur J Pharmacol 156:133–142

    PubMed  CAS  Google Scholar 

  4. Delmendo RE, Michel AD, Whiting RL (1989) Br J Pharmacol 96:457–464

    PubMed  CAS  Google Scholar 

  5. Anticholinergics/Spasmodics. In: Drug Information for the health care professional (USPDI) (1990) Bd. IA, The United States Pharmacopeial Convention, Rockville Maryland (USA), S. 312–332

    Google Scholar 

  6. Smith JM (1980) J Cln Psychiatry 41:351–354

    CAS  Google Scholar 

  7. Greenblatt DJ, Shrader RI (1973) N Engl J Med 288:1.215–1.219

    Google Scholar 

  8. Mar 29, S. 530

    Google Scholar 

  9. Noronha-Blob L, Lowe VC, Peterson JS, Hanson RC (1989) J Pharmac Exp Ther 249:843–851

    CAS  Google Scholar 

RJ

  1. Dibbern HW, Wirlitzki E (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf

    Google Scholar 

  2. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London

    Google Scholar 

  3. Mills III T, Roberson IC (1987) Instrumental Data for Drug Analysis, 2. Aufl., Bd. 1, Elsevier, New York Amsterdam London

    Google Scholar 

  4. SchmidtF (1968) Arch Pharm (Weinheim) 301:940–942

    Google Scholar 

  5. MeffinPJ, Moore G, Thomas J (1973) Anal Chem 45:1964–1966

    PubMed  CAS  Google Scholar 

  6. Oza SP, Dave MP, Vakil HN (1991) Indian Drugs 28:198–200

    CAS  Google Scholar 

  7. Shingbal DM, Barad UG (1985) Indian Drugs 22:609–610

    CAS  Google Scholar 

  8. Raggi MA, Cavrini V, Di Pietra AM (1985) J Pharm Biomed Anal 3:287–291

    PubMed  CAS  Google Scholar 

  9. Hanna GM (1984) J Assoc Off Anal Chem 67:222–224

    PubMed  CAS  Google Scholar 

  10. Jane I, Mc Kinnon A, Flanagan RJ (1985) J Chromatogr 323:191–225

    PubMed  CAS  Google Scholar 

Gb

  1. Hübner M, Ponsold K, Oettel M, Freund R (1980) Arzneimittelforschung/Drug Res 30:401–406

    Google Scholar 

  2. OettelM,Kurischko A (1980) Contraception 21:61–75

    Google Scholar 

  3. Oettel M, Komor A, Goncharov NP, Kurischko A, Strecke J, Schubert K (1980) Contraception 21:537–549

    PubMed  CAS  Google Scholar 

  4. Freund H, Hesse G, Oettel M (1980) Contraception 21:641–650

    PubMed  CAS  Google Scholar 

  5. Majumdar SS, Chaudhary J, Sharma RK, Das RP (1990) Contraception 41:641–649

    PubMed  CAS  Google Scholar 

  6. Hobe G, Hillesheim HG, Schumann W, Ritter P, Claussen C (1983) Exper Clin Endocrinol 81:158–167

    CAS  Google Scholar 

  7. Hobe G, Klinger G, Reddersen G, Erdmann A, Klinger G (1986) Pharmazie 41:772–774

    PubMed  CAS  Google Scholar 

  8. Klinger G, Carol W (1985) Wiss. Beiträge der Friedrich-Schiller-Universität, Jena, IV. Jenaer Symp. Horm. Kontrazeption, S. 125–141

    Google Scholar 

  9. Klinger G, Carol W (1989) Wiss. Beiträge der Friedrich-Schiller-Universität, Jena, IV. Jenaer Symp. Horm. Kontrazeption, S. 30–51

    Google Scholar 

  10. Klinger G (1989) Wiss. Beiträge der Friedrich-Schiller-Universität, Jena, IV Jenaer Symp. Horm. Kontrazeption, S. 141–144

    Google Scholar 

  11. Hillesheim HG, Hoffmann H (1983) Exper Clin Endocrinol 81:175–178

    CAS  Google Scholar 

  12. Hoffmann H, Hillesheim HG, Güttner J, Stade K, Merbt EM, Holle K (1983) Exper Clin Endocrinol 81:179–196

    CAS  Google Scholar 

OM

  1. Clarke CGC (Hrsg.) (1969/1975) Isolation and Identification of Drugs, Pharmaceutical Press, London

    Google Scholar 

  2. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, London

    Google Scholar 

PA

  1. Testa E, Fontanella L, Christiani G, Gallo G (1959), J Org Chem 24:1928–1936

    CAS  Google Scholar 

NE

  1. Mar 29, S.531

    Google Scholar 

vB

  1. Charpentier P (Rhone Poulenc) Fr Pat 986, 718 (ert. 1951); CA50:7880d (1956)

    Google Scholar 

  2. Clarke CGC (1969/1975), Isolation and Identification of Drugs, Pharmaceutical Press, London

    Google Scholar 

  3. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, London

    Google Scholar 

PA

  1. Maxim R (1929) Bull Soc Chim Romania 11:29–32

    CAS  Google Scholar 

  2. Mc Cabe ET et al. (1954) J Org Chem 19:493–496

    CAS  Google Scholar 

  3. Moffat AC (hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, London

    Google Scholar 

  4. eigene Messungen

    Google Scholar 

  5. Wu A et al. (1979) J High Resolut Chromat Commun 2:558–562

    CAS  Google Scholar 

QO

  1. Kushner S et al (1948) J Org Chem 13:144

    PubMed  CAS  Google Scholar 

sb/Ni

  1. Denham DA (1986) Nematode infections in man, extraintestinal infections. In: Campbell WC, Rew RS (Eds.) Chemotherapy of parasitic diseases, Plenum Press, New York London, p. 277–286

    Google Scholar 

  2. Bossche H van den (1981) Ann Soc Belg Med Trop 61:287–296

    PubMed  Google Scholar 

  3. Hawking F, Sewell P, Thruston JP (1950) Br J Pharmacol 5:217–238

    CAS  Google Scholar 

  4. Mehlhorn H, Steinhorst U, Lindenblatt B, Grüntzig J, Thomas H (1981) Zentralbl Bakteriol Hyg I Abb Orig A 251:263–272

    CAS  Google Scholar 

  5. Kobayashi J, Matsuda H, Fujita K, Sakai T, Shinoda K (1969) Jpn J Parasitol 18:563–574

    CAS  Google Scholar 

  6. Piessens WF, Beldekas M (1979) Nature 282:845–847

    PubMed  CAS  Google Scholar 

  7. Beckenridge A, Awadzi K, Back DJ, Edwards G, Gilles H, Orme M, Ward S (1984) Biochem Soc Trans 12:90–95

    Google Scholar 

  8. Roberson EL (1988) Chemotherapy of parasitic diseases. In: Booth NH, McDonald LE (Eds.) Veterinary Pharmacology and Therapeutics, Iowa State University Press, Ames, S. 877–968

    Google Scholar 

  9. Adam D, Christ W (1987) Antiinfektiöse Therapie. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, Wissenschaftsverlag, Mannheim Wien Zürich, S. 580–715

    Google Scholar 

  10. Rote Liste (1989)

    Google Scholar 

  11. Andrews P (1985) Anthelmintics, Ullmanns’s encyclopedia of industrial chemistry, VCH Verlagsgesellschaft 2:329–342

    Google Scholar 

ha

  1. Baveja SK, Rao KVR (1981) Analyst 106:726

    CAS  Google Scholar 

  2. Allen GD, Goodchild TH, Weatherly BC (1979) J Chromatogr 164:521

    PubMed  CAS  Google Scholar 

  3. BulbuleMV, Kasture A, Wadodkar SG (1981) Indian Drugs 19:27, zit. nach CA (1982) 96:129.876b

    Google Scholar 

sb/Ni

  1. Handbook of Pharmaceutical Excipients (1986), American Pharmaceutical Association, Washington, USA, S.105

    Google Scholar 

BK

  1. Korn 2, S. 1.442

    Google Scholar 

Eb/kp

  1. Westerholm B (1980) Pharmac Ther 10:337–349

    CAS  Google Scholar 

  2. Beral V,Colwell L(1980) Br Med J 281:1.098–1.106

    Google Scholar 

  3. Fachinformation Merbentul, Merrel Dow Pharma GmbH, Juni 1990

    Google Scholar 

  4. Haspels AA (1972) IPFF med Bull 6:3–7

    CAS  Google Scholar 

  5. Oettel M (1975) Pharmazie 30:42–47

    PubMed  CAS  Google Scholar 

  6. Konturri M, Sotaniemi E, Ahlqvist J (1972) Scand J Urol Nephrol 6:289–294

    Google Scholar 

  7. Herbst AL, Cole P, Colton T, Robboy SJ, Scully RE (1977) Am J Obstet Gynec 119:713–720

    Google Scholar 

  8. Oelschläger H, Rothley D, Dunzendorfer U (1984) Arzneim Forsch/Drug Res 34:1.333–1.336

    Google Scholar 

  9. Mar 29, S. 1.433–1.435

    Google Scholar 

  10. Brandes LJ, Hermonat MW (1983) Cancer Res 43:2.831–2.835

    Google Scholar 

  11. Griffiths K, Peeling WB, Harper ME, D Avies P, PierrePoint CG (1981) Prostatic cancer: rational for hormonal therapy. in: Stoll BA (Hrsg.) Hormonal management of endocrine-related cancer, Lloyd-Luke, London, S. 131–147

    Google Scholar 

  12. Schneider MR, Humm A, Graf AH (1990) J Cancer Res Clin Oncol 116:159–167

    PubMed  CAS  Google Scholar 

  13. Forth W, Henschler D, Rummel W (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut & FA. Brockhaus AG, S.416

    Google Scholar 

  14. Oettel M (1971) Mh Vet med 26:670–672

    Google Scholar 

  15. Vangils APG, Tham RTO, Falke THM, Peters AAW (1990) Am J Roentgenol 153:1.235–1.238

    Google Scholar 

  16. Sharp GB, Cole P (1990) Am J Obstet Gynecol 162:994–999

    PubMed  CAS  Google Scholar 

  17. Thorp JM, Fowler WC, Donehoo R, Sawicki C, Bowes WA (1990) Obstet Gynecol 76:828–832

    PubMed  Google Scholar 

  18. Liehr JG (1990) Mut Res 238:269–276

    CAS  Google Scholar 

  19. Hailing A, Forsberg JG (1990) J Reprod Fert 88:399–405

    Google Scholar 

  20. Sharp GB, Cole P (1990) Am J Obstet Gynecol 162:994–1.001

    PubMed  CAS  Google Scholar 

  21. De Sario A, Vagnarelli P, De Carli L (1990) Mut Res 243:127–131

    Google Scholar 

  22. Walker BE (1990) J Natl Cancer Inst 82:50–54

    PubMed  CAS  Google Scholar 

  23. Bergsjo P, Brodtkorb C (1974) Acta Obstet Gynec Scand 53:77–80

    PubMed  CAS  Google Scholar 

OM

  1. Oda T, Murai T, Sato Y (1988) Chem Parm Bull 36:1534–1539

    CAS  Google Scholar 

  2. Inamori Y (1985) Chem Pharm Bull 33:4478–4483

    PubMed  CAS  Google Scholar 

  3. McLachlan JA (1982) Cancer Res 42:3040–3045

    PubMed  CAS  Google Scholar 

JM/Mo/Wc

  1. Kuznetsov SG, El’tsov AV (1962) Zh Obshch Khim 32:511–515, zit. nach CA (1963) 58:470b

    CAS  Google Scholar 

  2. Hoffmann C (1965) Fr M 3406, zit. nach CA (1965) 63:13163a

    Google Scholar 

gs

  1. Hoffmann C (1965) Fr M 3406, CA (1965) 63:1.3163a

    Google Scholar 

  2. Kuznetsov SG, El’tsov AV (1962) Zh Obshch Khim 32:511–515, CA (1963) 58:470b

    CAS  Google Scholar 

  3. van Wijngaarden I, Soujdin W (1972) Arzneim-Forsch 22:513–516

    Google Scholar 

  4. Eisner M, Ferrat E (1976) Arzneim-Forsch 26:1.642–1.644

    Google Scholar 

  5. van Nueten JM, Janssen PAJ (1972) Arzneim-Forsch 22:518–520

    Google Scholar 

  6. Bianchi C, Goi A (1977) Arzneim-Forsch 27:1.040–1.043

    Google Scholar 

  7. Niemegeers CJE, Lenaerts FM, Janssen PAJ (1972) Arzneim-Forsch 22:516–518

    CAS  Google Scholar 

  8. Stransky M, Schwarzenbach FH (1979) Therap Umschau 36:267–270

    CAS  Google Scholar 

  9. Schenker H (1976) Schweiz med Wschr 106:1.650–1.653

    Google Scholar 

  10. Rubens R, Verhaegen H, Brugmans J, Schuermans V (1972) Arzneim-Forsch 22:513–516

    Google Scholar 

  11. Awouters F, Niemegeers CJE, Janssen PAJ (1983) Ann Rev Pharmacol Toxicol 23:279–301

    CAS  Google Scholar 

  12. Mar 29, S. 1.087

    Google Scholar 

  13. Heykants J, Brugmans J, Verhaegen H (1972) Arzneim-Forsch 22:529–531

    CAS  Google Scholar 

  14. Heykants J, Lewi PJ, Janssen PAJ (1972) Arzneim-Forsch 22:520–526

    CAS  Google Scholar 

PK

  1. Janel, Mc Kinnon A, Flanagan RJ (1985) J Chromatogr 323(2):191–225

    Google Scholar 

WP

  1. Mar29,S.662

    Google Scholar 

vB

  1. Barquin A, Jose J (1982), S.31

    Google Scholar 

  2. Mitteilungen der Fa. Upjohn, 6148 Heppenheim

    Google Scholar 

  3. Van de Vaart FY, Hultshoff A, Indemans AWM (1983) Pharm Weekbl Sci Ed 5:113–118

    Google Scholar 

  4. Heintz B, Kalusa R (1978) Dtsch Apoth Ztg 118:1.000–1.006

    Google Scholar 

  5. Kirschmann Y, Poet R, Bush K, Petrie G (1980) J Chromatogr 190:481–485

    Google Scholar 

  6. Shaw MC, Van der Wielen AJ (1984) J Pharm Sci 73:1.606–1.608

    Google Scholar 

As

  1. Miller JA, Munro DD (1980) Drugs 19:119–134

    PubMed  CAS  Google Scholar 

  2. Goa KL (1988) Drugs 36 S5:51–61

    PubMed  Google Scholar 

  3. Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533

    CAS  Google Scholar 

  4. Tronnier H (1987) Aerztl Kosmetol 17:458–482

    CAS  Google Scholar 

  5. Leiferman KM, Schroeter A, Kirschner MK, Speisberg TC (1983) J Invest Dermatol 81:355–360

    PubMed  CAS  Google Scholar 

  6. Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10

    PubMed  CAS  Google Scholar 

  7. Bowen DL, Fauci AS (1988) Adrenal corticosteroids. In: Gallin JI, Goldstein IM, Snyderman R (Hrsg.) Inflammation: basic principles and clinical correlates, Raven Press, New York, S. 877–896

    Google Scholar 

  8. Bluefarb SM, Howard FJ, Leibsohn E, Schlagel CA (1976) J Int Med Res 454

    Google Scholar 

  9. Turi JS, Danielson D, Wolterson JW (1979) J Pharm Sci 68:375

    Google Scholar 

  10. Niedner R (1989) Dtsch Aerztebl 86:1798–1803

    Google Scholar 

  11. Teller E (1983) Dtsch Dermatol 31:56–62

    Google Scholar 

  12. Eichenberger-de Beer H (1982) Schweiz Rundsch Med 32:1266–1268

    Google Scholar 

  13. Chan MM, Hall JH, Kirschenbaum MB, Klein L, Leibsohn E, Peng VT, Roth H, Savin RC, Schlagel CA (1977) Curr Ther Res 22:297

    Google Scholar 

  14. Squires JP, Masson EL (1981) J Int Med Res 9:79

    PubMed  CAS  Google Scholar 

GM

  1. Kapp JF, Koch H, Casals-Stenzel J, Töpert M, Gerhards E (1976) Arzneim Forsch 26:1.463–1.475

    Google Scholar 

  2. Reckers R, Wendt H (1976) Arzneim Forsch 26:1.499–1.504

    Google Scholar 

  3. Miller JA, Munro DD (1990) Drugs 19:119–134

    Google Scholar 

  4. Goa KL (1988) Drugs 36 S5:51–61

    PubMed  Google Scholar 

  5. Pichl J, Schell H (1990) Z Hautkrankheiten 65:527–533

    CAS  Google Scholar 

  6. Tronnier H (1987) Aerztl Kosmetol 17:458–482

    CAS  Google Scholar 

  7. Leiferman KM, Schroeter A, Kirschner MK, Speisberg TC (1983) J Invest Dermatol 81:355–360

    PubMed  CAS  Google Scholar 

  8. Munck A, Mendel DB, Smith LI, Orti E (1990) Am Rev Respir Dis 141 S2:S2–10

    PubMed  CAS  Google Scholar 

  9. Lavker RM, Schechter NM, Lazarus GS (1986) Br J Dermatol 115 S31:101–107

    PubMed  Google Scholar 

  10. Hahn HL (1990) Wirkungsmechanismen der Glukokortikoide bei Asthma, bronchialer Entzündungsreaktion und Hyperreaktivität. In: Nolte D (Hrsg.) Glukokortikoide bei obstruktiven Atemwegserkrankungen, de Gruyter, Berlin New York, S. 23–56

    Google Scholar 

  11. Schleimer RP (1990) Am Rev Respir Dis 141 S2:59–69

    Google Scholar 

  12. Täuber U (1976) Arzneim Forsch 26:1.479–1.483

    Google Scholar 

  13. Täuber U (1983) Arzneim Forsch 33:1.503–1.507

    Google Scholar 

  14. Täuber U, Amin M, Fuchs P, Speck U (1976) Arzneim Forsch 26:1.492–1.494

    Google Scholar 

  15. Täuber U, Toda T (1976) Arzneim Forsch 26:1.484–1.487

    Google Scholar 

  16. Mützel W (1976) Arzneim Forsch 26:1.487–1.492

    Google Scholar 

  17. Langen ML (1979) Clinical Ther 2:124–133

    Google Scholar 

  18. Kesczkes K, Teasdale P, Wiseman RA, Mugglestone CJM (1978) Br J Dermatol 99:417–420

    Google Scholar 

  19. Reckers R, Wendt H (1976) Arzneim Forsch 26:1.504–1.509

    Google Scholar 

  20. Takeda K, Arase S, Takahashi S (1988) Drugs 36 S5:15–23

    PubMed  Google Scholar 

GM

  1. Cotton M, Hux R in Florey 14:491

    Google Scholar 

  2. Ruyle, William V, Sarett, Lewis H: Matzuk, Alexander S; African 67 01, 021

    Google Scholar 

Rh

  1. Stone CA, Van Arman CG, Lotti VJ, Minsker DH, Risley EA, Bagdon WZ, Bokelman DL, Zensen RD, Mendlowski B, Tak CL, Peck HM, Zwickey RE, McKinney SE (1977) Br J Clin Pharmacol 4:19S–29S

    PubMed  Google Scholar 

  2. Forbes JA, Calderazzo JP, Bowser MW, Foor VM, Shackleford RW, Beaver WT (1982) Z Clin Pharmacol 22:89–96

    CAS  Google Scholar 

  3. Honig WJ, Van Ochten J (1986) J Clin Pharmacol 26:700–705

    PubMed  CAS  Google Scholar 

  4. DeVroey P (1978) Curr Med Res Opin 5:544–547

    CAS  Google Scholar 

  5. Brodgen RN, Heel RC, Pakes GE, Speight TM, Avery GS (1980) Drugs 19:84–106

    Google Scholar 

  6. Majerus PW, Stanford N (1977) Br J Clin Pharmacol 4:15S–18S

    PubMed  Google Scholar 

  7. Forrest M, Brooks PM (1988) Basilliére’s Clinical Rheumatology 2:275–294

    CAS  Google Scholar 

  8. Schultz P, Perrier CV, Ferber-Perret F, Vanden Heuvel WZA, Steelman SL (1979) J Int Med Res 7:61–68

    Google Scholar 

  9. Smit Sibinga CT, Tempero KF, Breault GO (1976) Effect of flunisal, a novel salicylate, on platelet function and blood coagulation. In: Grayson Z, Zingg W (ed.) Microcirculation. Vol.1, Plenum Press, London, New York, S. 211–212

    Google Scholar 

  10. Smit Sibinga CT (1977) Br J Clin Pharmacol 4:37S–38S

    Google Scholar 

  11. Green D, Davies RO, Holmes GI, Kohl H, Lee RB, Reynolds N, Schmid FR, Ts’ao C (1981) Clin Pharmacol Ther 30:378–384

    PubMed  CAS  Google Scholar 

  12. Green D, Davies RO, Holmes GI, Kohl H, Lee RB, Reynolds N, Schmid FR, Ts’ao C (1983) Pharmacotherapy 3:65S–69S

    PubMed  CAS  Google Scholar 

  13. Tempero KF, Cirillo VJ, Steelman SL (1977) Br J Clin Pharmacol 4:31 S-36S

    PubMed  Google Scholar 

  14. Tempero KF, Cirillo VJ, Steelman SL (1978) The clinical pharmacology of diflunisal. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 23–39

    Google Scholar 

  15. Dresse A, Gerard MK, Lays A, Tempero KF, Verhaest L(1978) Pharm Acta Helv 53:177–181

    PubMed  CAS  Google Scholar 

  16. Nuernberg B, Koehler G, Brune K (1991) Clin Pharmacokin 20:81–89

    CAS  Google Scholar 

  17. Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, DeSchepper PJ (1979) Br J Clin Pharmacol 7:519–522

    PubMed  CAS  Google Scholar 

  18. Tobert JA, DeSchepper P, Tjandramaga TB, Mullie A, Buntiux AP, Meisinger MAP, Huber PB, Hall TLP, Yeh KC (1981) Clin Pharmacol Ther 30:385–389

    PubMed  CAS  Google Scholar 

  19. Verbeeck R, Tjandramaga TB, Mullie A, Verbesselt R, Verbeckmoes R, DeSchepper PJ (1979a) Br J Clin Pharmacol 7:273–282

    PubMed  CAS  Google Scholar 

  20. Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Perrier CU (1975) Drug Metab Disposition 3:453–466

    CAS  Google Scholar 

  21. DeSchepper PJ, Mullie A, Tjandramaga TB, Verbeeck R, Verbeckmoes R (1977) Br J Clin Pharmacol 4:645P

    Google Scholar 

  22. Steelman SL, Breault GO, Tocco DJ, Besselaar GH, Tempero KF, Lutterbeck PM, Perrier CU, Gribman FW, Hinseimann M (1975) Clin Pharmacol Ther 17: 245

    Google Scholar 

  23. Buck ME, Paintin DB (1978) Curr Med Res Opin 5:548–549

    PubMed  CAS  Google Scholar 

  24. Goutallier D, Dedeyre J, Bock F (1978) A doubleblind study comparing the efficacy and safety of diflunisal and of glafenine in the relief of postoperative pain. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 119–129

    Google Scholar 

  25. Ackermann K, Braun HD (1978) Diflunisal in the treatment of postoperative pain in oral surgery. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 143–148

    Google Scholar 

  26. Peterson JK (1979) Int J Oral Surgery 8:102–113

    Google Scholar 

  27. Peterson JK (1978) Diflunisal in the treatment of postoperative pain in oral surgery. In: Diflunisal in clinical practice. Proceedings of a special symposium at 14th Congress of Rheumatology, Futura Publishing, New York, S. 133–142

    Google Scholar 

  28. Jaegemann V (1979) Diflunisal compared with placebo in acute untreated lumbago. In: Diflunisal. Royal Society of Medicine, International Congress and Symposium Series, No 6, Academic Press/Royal Society of Medicine, London, S. 45–19

    Google Scholar 

  29. Cirillo VJ, Bahous I, Franchimont P, Baumgartner H, Van Gemert J, Lutterbeck PM, Hwang I, Tempero KF (1978) Clin Trials J 15:40–48

    Google Scholar 

  30. Bahous I, Lutterbeck PM, Tempero KF (1978) Clin Ther(SupplA)l:10–19

    Google Scholar 

  31. Lee P, Davis P, Prat A (1985) J Rheumatol 12:544–548

    PubMed  CAS  Google Scholar 

  32. Poe TE, Limpert GH, Winkler GJ (1989) J Fam Pract 28:104–105

    PubMed  CAS  Google Scholar 

  33. Huskisson EC (1979) Practitioner 222:415–418

    PubMed  CAS  Google Scholar 

  34. McLean CA, Begley CG, Harris RA (1986) Aust NZ J Med 16:811–812

    CAS  Google Scholar 

  35. Rider JA (1983) Pharmacotherapy 3:61S–64S

    PubMed  CAS  Google Scholar 

  36. O’Brien WM, Bagby GF (1985) J Rheumatol 12:785–790

    PubMed  Google Scholar 

  37. Warren JS (1978) Br Med J 2:736–737

    PubMed  CAS  Google Scholar 

  38. Chan LK, Winearls CG, Oliver DO, Dunnill MS (1980) Br Med J 1:84–85

    Google Scholar 

  39. Steelman SL, Cirillo VJ, Tempero KF (1978) Curr Med Res Opin 5:506–514

    PubMed  CAS  Google Scholar 

  40. Serlin MJ, Mossman S, Sibeon RG, Breckenridge AM (1980) Clin Pharmacol Ther 28:493–498

    PubMed  CAS  Google Scholar 

  41. Upadhayay HP, Gupta SK (1978) Br Med J 2:640

    Google Scholar 

Me

  1. Zeliha I, Türkan Y (1986) Planta Med 53:43–46

    Google Scholar 

  2. Kiliani H (1892) Arch Pharm 230:250

    Google Scholar 

  3. Rittel W, Hunger A, Reichstein T (1952) Helv Chim Acta 35:434

    CAS  Google Scholar 

AG

  1. Bloch R, Steimer C, Spach MO, Schwartz J (1978) Coeur Med Interne 17:403–409

    PubMed  CAS  Google Scholar 

  2. Bloch R, Steimer C, Schwartz J (1981) Rev Med Interne 2:349–355

    PubMed  CAS  Google Scholar 

  3. Chiche P, Baligadoo S, Lamelle P, Borgard JP (1976) Coeur Med Interne 15:249–262

    PubMed  CAS  Google Scholar 

  4. Scholz H (1989) Herzinsuffizienz. In: Fülgraff G, Palm D (Hrsg.) Pharmakotherapie, Klinische Pharmakologie, 7. Aufl., Gustav Fischer Verlag, Stuttgart, S.42–57

    Google Scholar 

  1. Brown L, Cheung HTA, Thomas R, Watson TR, Nemorin JLE (1981) J Chem Soc Perkin Trans 1:1779–1781

    Google Scholar 

  2. Kedde DL (1947) Pharm Weekbl 82:741

    CAS  Google Scholar 

  3. Keller CC (1895) Ber Dtsch Pharm Ges 5:275

    Google Scholar 

  4. Kiliani H (1899) Arch Pharm 237:446

    CAS  Google Scholar 

AG

  1. Braunwald E, Bloodwell RD, Goldberg LJ (1961) J Clin Invest 40:52–60

    PubMed  CAS  Google Scholar 

  2. Mason DT (1974) Ann Int Med 80:520–530

    PubMed  CAS  Google Scholar 

  3. Covell JW, Braunwald E, Ross J Jr (1966) J Clin Invest 45:1.535–1.543

    Google Scholar 

  4. Bailey JC, Anderson GJ, Fisch C (1973) Am J Cardiol 32:202–208

    PubMed  CAS  Google Scholar 

  5. Higgins CB, Vatner SF, Braunwald E (1973) Pharm Rev 25:119–155

    PubMed  CAS  Google Scholar 

  6. Hordorf HJ, Spotnitz A, Mary-Rabine L, Edie RN, Rosen MR (1978) Circulation 57:223–229

    Google Scholar 

  7. Weidmann S (1974) Ann Rev Physiol 36:155–169

    CAS  Google Scholar 

  8. Ferguson DW, Berg WJ, Sanders JS, Roach PJ, Kempf JS, Kienzle MG (1989) Circulation 80:65–77

    PubMed  CAS  Google Scholar 

  9. Haasis R, Larbig D (1975) Dtsch Med Wochenschr 100:1.768–1.773

    Google Scholar 

  10. Amelie JP, Storstein L, Heldaas O (1979) J Cardiovasc Pharmacol 1:529–540

    Google Scholar 

  11. Aronson JK (1983) Clin Sci 64:253–258

    PubMed  CAS  Google Scholar 

  12. Scholz H (1984) J Am Coll Cardiol 4:389–397

    PubMed  CAS  Google Scholar 

  13. Kim D, Cragoe EJ Jr, Smith TW (1987) Circ Res 60:185–193

    PubMed  CAS  Google Scholar 

  14. Allen DG, Blinks JR (1978) Nature (London) 273:509–513

    CAS  Google Scholar 

  15. Eisner DA, Lederer WJ (1985) Am J Physiol 248:C189–C202

    PubMed  CAS  Google Scholar 

  16. Fabiato A, Fabiato F (1975) J Physiol (London) 249:469–495

    CAS  Google Scholar 

  17. Smith TW, Butler VP Jr, Haber E (1982) N Engl J Med 307:1.357–1.362

    Google Scholar 

  18. Mulrow CD, Feussner JR, Velez R (1984) Ann Int Med 101:113–117

    PubMed  CAS  Google Scholar 

  19. Parmly WW (1989) J Am Coll Cardiol 13:771–785

    Google Scholar 

  20. Chai CY, Hsu PL, Wana SC (1973) Neuropharmacol 12:1.187–1.193

    Google Scholar 

  21. Mooradian AD (1988) Clin Pharmacokinet 15:165–179

    PubMed  CAS  Google Scholar 

  22. Belz GG,PfledererW (1975) Basic Res Cardiol 70:142

    PubMed  CAS  Google Scholar 

  23. Kuemmerle HP (1989) Klinische Pharmakologie. Datenhandbuch für Klinik und Praxis, ecomed-verlagsgesellschaft mbH, Landsberg München Zürich

    Google Scholar 

  1. BAz, Nr. 22a vom 03.02.1988

    Google Scholar 

GS

  1. Brown L, Cheung HTA, Thomas R, Watson TR, Nemorin JLE (1981) J Chem Soc Perkin Trans 1:1.779–1.781

    Google Scholar 

  2. Kedde DL (1947) Pharm Weekbl 82:741

    CAS  Google Scholar 

  3. Keller CC (1895) Ber Dtsch Pharm Ges 5:275

    Google Scholar 

  4. Kiliani H (1899) Arch Pharm 237:446

    CAS  Google Scholar 

  5. Baljet H (1918) Schweiz Apoth Ztg 56:71,84

    CAS  Google Scholar 

AG

  1. Aronson JK,Gaham-Smith DG (1976) Br J Clin Pharmacol 3:639–648

    PubMed  CAS  Google Scholar 

  2. Larbig D, Haasis R, Kochsiek K (1978) Die Glykosidkonzentration und ihre klinsche Bedeutung: Neue Erkenntnisse für die Digitalistherapie durch radioimmunologische Bestimmung von Lanata-Glykosiden, forum cardiologicum 15:Studienreihe Boehringer-Mannheim

    Google Scholar 

  3. Mooradian AD (1988) Clin Pharmacokinet 15:165–179

    PubMed  CAS  Google Scholar 

  4. Ferrer MJ, Conroy RJ, Harvey RM (1960) Circulation 21:372–385

    PubMed  CAS  Google Scholar 

  5. Scholz H (1984) J Am Coll Cardiol 4:389–397

    PubMed  CAS  Google Scholar 

  6. Buschauer A (1989) Pharm Ztg Wiss 134:3–16

    Google Scholar 

  7. Kuemmerle HP (1989) Klinische Pharmakologie, Datenhandbuch für Klinik und Praxis, ecomed-verlagsgesellschaft mbH, Landsberg München Zürich

    Google Scholar 

  8. Doherty JE, Parkins WH (1962) Am Heart J 63:528–536

    PubMed  CAS  Google Scholar 

  9. Kuhlmann I, Rietbrock N, Schnieders B (1979) J Cardiovasc Pharmacol 1:219–234

    PubMed  CAS  Google Scholar 

  10. Brurion PF, Morgan LM, Stevenson HM, Fletcher E (1969) Brit Heart J 31:633–640

    Google Scholar 

  11. Allonen H, Andersson KE, Gisalo E, Kanto I, Stomblad LG, Wettrell G (1977) Acta Pharmacol Toxicol (Kbh) 41:193–201

    CAS  Google Scholar 

  12. Peters U, Falk LC, Kaiman SM (1978) Arch Intern Med 138:1.074–1.076

    Google Scholar 

  13. Zilly W, Richter E, Rietbrock N (1975) Clin Pharmacol Ther 17:302–309

    PubMed  CAS  Google Scholar 

  14. Aronson JK (1978) Brit J Clin Pharmacol 5:55–64

    CAS  Google Scholar 

  15. Johnston GD (1989) Drugs 37:577–582

    PubMed  CAS  Google Scholar 

  16. Steiness E (1978) Clin Pharmacol Ther 23:511–514

    PubMed  CAS  Google Scholar 

  17. Leahey EB jr, Reiffei JA, Heissenbuthe RH, Drusin RE, Lovejoy WP, Bigger T jr (1979) Arch Intern Med 139:519–521

    PubMed  Google Scholar 

  1. Sharp ME (1986) Can Soc Forensic Sci J 19:83–101

    CAS  Google Scholar 

  2. Kopp M, Tchouber B (1952) Bull Soc Chim Fr :84–86

    Google Scholar 

gs

  1. Mar 29, S. 531

    Google Scholar 

EH

  1. Drew HDK, Hatt HH, J Chem Soc (1937) 16; Haworth RD, Robinson S, J Chem Soc (1948) 777; Ciba DBP 847.748 (1949) Zentralbl. (1953) 53 85, U.S.Pat. 2484 785 (1949) CA (1950) 44:2573i

    Google Scholar 

hh

  1. Tripod J, Meier R (1954) Arch int Pharmacodyn 99:104–125

    PubMed  CAS  Google Scholar 

  2. Bein HJ, Gross F, Tripod J, Meier R (1953) Schweiz Med Wochenschr. 83:336–340

    PubMed  CAS  Google Scholar 

  3. Kolloch R (1983) Vasodilatatoren. In: Stumpe KO (Hrsg.) Therapie mit Antihypertensiva, Springer-Verlag, Berlin Heidelberg New York Tokyo, S. 55–105

    Google Scholar 

  4. Esselier AF, Luscher W, Morandi L (1053) Schweiz Med Wochenschr 83:28–37

    Google Scholar 

  5. Schaub F, Nager F, Schrithin W, Völlm K, Hany A (1964) Schweiz Med Wochenschr 94:769–775

    PubMed  CAS  Google Scholar 

  6. Van Zwieten PA (1968) Arzneim Forsch 18:79–84

    Google Scholar 

  7. Koch-Weser J (1974) Arch Int Med 133:1.017–1.027

    Google Scholar 

  8. Reimann IW, Ratge D, Wisser H, Fröhlich JC (1985) Clin Exp Pharmacol Physiol 12:79–89

    PubMed  CAS  Google Scholar 

  9. Gross F (1977) Drugs acting on arteriolar smooth muscle (vasodilator drugs). In. Gross F (Hrsg.) Antihypertensive Agents, Springer-Verlag, Berlin Heidelberg New York, S. 397–476

    Google Scholar 

  10. Struyker-Boudier HAJ, Van Essen H, Smits JFM (1983) Eur J Pharmacol 95:151–159

    PubMed  CAS  Google Scholar 

  11. Heidland A, Heidbreder E (1985) Therapie des hypertensiven Notfalls und der malignen Hypertonie. In: Ganten D, Ritz E (Hrsg.) Lehrbuch der Hypertonie, Schattauer Verlag, Stuttgart New York, S. 705–725

    Google Scholar 

  12. Schroeder T, Sillesen H (1987) Eur J Clin Invest 17(3):214–217

    PubMed  CAS  Google Scholar 

  13. Reubi FC (1950) Proc Soc exp Biol (N.Y.) 73:102–103

    CAS  Google Scholar 

  14. Fries ED (1953) Circulation 8:199–204

    Google Scholar 

  15. Heidbreder E, Heidland A (1985) Behandlung der Hypertonie bei chronischer Niereninsuffizienz. In. Ganten D, Ritz E (Hrsg.) Lehrbuch der Hypertonie, Schattauer Verlag, Stuttgart New York, S. 726–742

    Google Scholar 

  16. Curtis JR (1979) Drugs 18(5):377–391

    PubMed  Google Scholar 

  17. Shultz PJ, Raij L (1989) Br J Clin Pharmacol 28(2):151S–157S

    PubMed  CAS  Google Scholar 

  18. Fachinformation Nepresol/Nepresol forte CIBA Pharma, Feb 1991, Editio Cantor Verlag, Aulendorf

    Google Scholar 

  19. Schneider T, Siegmund W, Zschiesche M, Kallwellis R, Scherber A (1988) Pharmazie 43(1):33–36

    PubMed  CAS  Google Scholar 

  20. Palm D, Hellenbrecht D (1987) Pharmakologie des noradrenergen und adrenergen Systems. In: Forth W, Henschler D, Rummel W (Hrsg.) Allgemeine und spezielle Pharmakologie und Toxikologie, BI Wissenschaftsverlag, Mannheim Wien Zürich, S. 124–168

    Google Scholar 

  21. Franke G, Pietsch P, Schneider T, Siegmund W, Grabow D, Schutz H (1986) Biol Res Pregnancy Perinatol 7(1)30–33

    PubMed  CAS  Google Scholar 

  22. Ashe RG, Moodley J, Richards AM, Philpott RH (1987) S Afr Med J 71(6):354–356

    PubMed  CAS  Google Scholar 

  23. Jamieson MJ, Shepherd AMM (1987) Vasodilators: first or second choice therapy? In: Drayer JIM, Lowenthal DT, Weber MA (Hrsg.) Drug Therapy in Hpertension, Marcel Dekker, Inc., New York Basel, S. 163–190

    Google Scholar 

  24. Salvadeo A, Villa G, Segagni S, Piazza W, Criscuolo D (1981) Int J Clin Pharmacol Ther Toxicol 19(8):372–376

    PubMed  CAS  Google Scholar 

  25. Mauro F (1990) Listing of antihypertensive medications. In: Ganten D, Mulrow PJ (Hrsg.) Handbook of Experimental Pharmacology, Bd. 93, Pharmacology of Antihypertensive Therapeutics, Springer-Verlag, Berlin Heidelberg, S. 861–874

    Google Scholar 

  26. Pariente EA, Pessayre D, Bernuau J, Degott C, Benhamou JP (1983) Digestion 27:47–52

    PubMed  CAS  Google Scholar 

  27. Baumgartner R, Siegmund W, Frengler JD (1988) Z Klin Med 43(2):87–89

    Google Scholar 

GW

  1. Hartke K, Mutschier E (Hrsg.) (1986) Kommentar zum Deutschen Arzneibuch 9.Ausg., Bd. 1 bis 3, Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  2. Skita A, Franck HH (1911) Chem Ber 44:2861–2865

    Google Scholar 

  3. Budĕšinský, Protiva A (1961) Synthetische Arzneimittel, Akademie Verlag, Berlin, S. 192

    Google Scholar 

  4. Stein A (1955) Pharmazie 10:180–186

    PubMed  CAS  Google Scholar 

  5. Ehrhart G, Ruschig H (1972) Arzneimittel, 2. Aufl., Verlag Chemie, Weinheim, S. 118

    Google Scholar 

  6. Takagi Y, Ueda J (1936) J Pharm Soc Jpn 56:44–56

    CAS  Google Scholar 

  7. Bobbitt JM, Weiss U, Hanessian DD (1959) J Org Chem 24:1582–1584

    CAS  Google Scholar 

  8. Okuda S, Yamaguchi S, Kawazoe Y, Tsuda K (1964) Chem Pharm Bull 12:104–112

    PubMed  CAS  Google Scholar 

  9. Caroll JI, Moreland ChG, Brine GA, Kepler JA (1976) J Org Chem 41:996–1001

    Google Scholar 

Gb

  1. Friebel H, Reichle C, Graevenitz A v (1955) Naunyn-Schmiedeberg’s Arch Exper Path Pharmak 224:384–400

    CAS  Google Scholar 

  2. Haas, H (1955) Dtsch Apoth Ztg 95:1143–1148; 1171–1175

    Google Scholar 

  3. Haas H (1955) Naunyn-Schmiedeberg’s Arch Exper Path Pharmak 225:442–452

    CAS  Google Scholar 

  4. Seymour RA, Rawlins MD, Rowell FJ (1982) Lancet 1:1425

    PubMed  CAS  Google Scholar 

  5. Vaughan DP, Beckett AH (1973) J Pharm Pharmacol 25 (Suppl.):104P–108P

    PubMed  Google Scholar 

  6. Johnson MA, Woodcock AA, Geddes DM (1983) Br Med J 286:675–677

    CAS  Google Scholar 

  7. Supinski G, Dimarco A, Bark H, Chapman K, Clary S, Altose M (1990) Am Rev Respir Dis 141:1516–1521

    PubMed  CAS  Google Scholar 

  8. Rowell FJ, Seymour RA, Rawlins MD (1983) Eur J Clin Pharmacol 25:419–424

    PubMed  CAS  Google Scholar 

  9. Marks P, Ashraf H, Root TR (1978) Brit Med J i:1594

    Google Scholar 

  10. Kurz H (1989) Antitussiva und Expektoranzien, Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

SZ

  1. Wieland H, Koralek E (1923) Liebigs Ann Chem 433:267–271

    CAS  Google Scholar 

Gb

  1. Stein A, (1955) Pharmazie 10:180–186

    PubMed  CAS  Google Scholar 

  2. Dibbern HW, Wirlitzki E (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf

    Google Scholar 

  3. Crone TA, Purdie N (1981) Anal Chem 53:17–21

    CAS  Google Scholar 

  4. Okuda S, Yamaguchi S, Kawazoe Y, Tsuda K (1964) Chem Pharm Bull 12:104–112

    PubMed  CAS  Google Scholar 

  5. Carroll FI, Moreland ChG, Brine GA, Kepler JA (1976) J Org Chem 41:996–1001

    PubMed  CAS  Google Scholar 

  6. Pesez M (1935) J Pharm Chim 21:542–544

    CAS  Google Scholar 

  7. Philippi I, Auterhoff H (1976) Dtsch Apoth Ztg 116:206–206

    Google Scholar 

  8. Böhme H, Hocke H (1960) Arch Pharm 293:342

    Google Scholar 

  9. Sakano I, Kokubo S (1989) Anal Sci 5:623–624

    CAS  Google Scholar 

  10. Jane I, McKinnon A, Flanagan RJ (1985) J Chromatogr 323:191–225

    PubMed  CAS  Google Scholar 

Gb

  1. Goldstein M, Lew JY, Hata F, Liebermann A (1978) Gerontology (Basel) 24(Suppl. l):76–85

    CAS  Google Scholar 

  2. Markstein R (1983) Eur J Pharmacol 86:145–155

    Google Scholar 

  3. Weil C (1989) Hydergin-Pharmakologische und klinische Befunde, Springer-Verlag, Berlin Heidelberg New York, S. 137–147

    Google Scholar 

KC

  1. Stoll A, Hoffmann A (1943) Helv Chim Acta 26:2070–2081

    CAS  Google Scholar 

SH

  1. Markstein R (1983) Eur J Pharmcol 86:145–155

    Google Scholar 

  2. Müller-Schweinitzer E (1982) Naunyn-Schmiedebergs Arch Pharmacol 318:225–233

    PubMed  Google Scholar 

  3. Rothlin E (1947) Bull Schweiz Akad Med Wiss 2:246–273

    Google Scholar 

  4. Spagnolis A, Tognoni G (1983) Drugs 26:44–69

    Google Scholar 

  5. Rachmann A, Kellmann L, Kriegelstein J (1984) J Cerebral Blood Flow Metab 4:610–614

    Google Scholar 

  6. Kiechel JR (1979) J Pharmacol (Paris) 10:533–565

    Google Scholar 

  7. Mailland F, Poli A, Zottino G (1984) Curr Ther Res 42:857–861

    Google Scholar 

KC

  1. Stoll A, Hoffmann A (1943), Helv 26:2070, 2080

    CAS  Google Scholar 

  2. Sandoz, USP 2507832 (1946)

    Google Scholar 

  3. Cousse H et al. (1972), Bull Soc Chim Fr, S.3131

    Google Scholar 

  4. Dibbern HW (1984), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, Aulendorf

    Google Scholar 

SH

  1. Stoll A, Hofmann A (1943) Helv Chim Acta 26:2070–2081

    CAS  Google Scholar 

  2. Yamatodani, Abe (1959) J Agri Chem Soc Japan 33:1036, zit. nach CA (1958) 52:2878

    CAS  Google Scholar 

SH

  1. Müller-Schweinitzer E, Weidmann H (1978) Basic pharmacological properties. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Realted Compounds, Handb Exp Pharmacol, Bd. 49, Springer-Verlag, Berlin Heidelberg New York, S. 87–232

    Google Scholar 

  2. Eckert H, Kiechel JR, Rosenthaler J, Schmidt R, Schreier B (1978) Biopharmaceutical aspects. Analytical methods, pharmacokinetics, metabolism and bioavailability. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and Related Compounds, Handb Exp Pharmacol, Bd. 49, Springer-Verlag, Berlin Heidelberg New York, S. 719–803

    Google Scholar 

  3. Weil C (1989) Hydergin-Pharmakologische und klinische Befunde, Springer-Verlag, Berlin Heidelberg New York, S. 143–147

    Google Scholar 

KC

  1. Stoll A, Hoffmann A (1943), Helv Chim, Acta 26:2070 ff.

    CAS  Google Scholar 

HÄ/pb

  1. Rall TW (1990) Oxytocin, prostaglandins, ergot alkaloids and other drugs; tocolytic agents. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) The pharmacological basis of therapeutics, 8. Aufl., Pergamon Press, New York Oxford Beijing Frankfurt Sao Paulo Sydney Tokyo Toronto, S. 933–953

    Google Scholar 

  2. Glusa E, Markwardt F (1984) Pharmacology 29:336–342

    PubMed  CAS  Google Scholar 

  3. Müller-Schweinitzer E (1984) Naunyn-Schmiedeberg’s Arch Pharmacol 327:299–303

    Google Scholar 

  4. Mellander S, Nordenfelt I (1970) Clin Sci 39:183–201

    PubMed  CAS  Google Scholar 

  5. Andersen AR, Tfelt-Hansen P, Lassen NA (1987) Stroke 18:120–123

    PubMed  CAS  Google Scholar 

  6. Nordenfelt I, Mellander S (1976) Cardiology 61(Suppl.l):316–321

    PubMed  Google Scholar 

  7. Barthel W, Großmann K (1982) Int J Clin Pharmacol Ther Tox 20:458–464

    CAS  Google Scholar 

  8. Partsch H (1981) Med Welt 32:1.668–1.671

    Google Scholar 

  9. Eichlisberger R, Huber P, Jäger K (1989) Vasa 18:221–226

    PubMed  CAS  Google Scholar 

  10. Barthel W (1984) Z Ges Inn Med 39:417–428

    PubMed  CAS  Google Scholar 

  11. Müller-Schweinitzer E (1984) Int J Clin Pharmacol Ther Tox 22:677–682

    Google Scholar 

  12. Aeilig WH, Nüesch E (1977) Int J Clin Pharmacol Ther Tox 15:106–112

    Google Scholar 

  13. Bobik A, Jennings G, Skews H, Esler M, McLean A (1981) Clin Pharmacol Ther 30:673–679

    PubMed  CAS  Google Scholar 

  14. Schran HF, Tse FLS (1985) Int J Clin Pharmacol Ther Tox 23:1–4

    CAS  Google Scholar 

  15. Little PJ, Jennings GL, Skews H, Bobik A (1982) Br J Clin Pharmacol 13:785–790

    PubMed  CAS  Google Scholar 

  16. Olver IN, Jennings GL, Bobik A, Esler M (1980) Br Med J 2:275–276

    Google Scholar 

  17. Wyss PA, Rosenthaler J, Nüesch E, Aellig WH (1991) Eur J Clin Pharmacol 41:597–602

    PubMed  CAS  Google Scholar 

  18. Hilke H, Kanto J, Kleimola T, Mäntylä R (1978) Int J Clin Pharmacol Ther Tox 16:277–278

    CAS  Google Scholar 

  19. Kanto J, Allonen H, Koski K, Koulu M, Lammintausta R, Mäntylä R, Kleimola T, Siirtola T (1981) Int J Clin Pharmacol Ther Tox 19:127–130

    CAS  Google Scholar 

  20. Hilke H, Kanto J, Mäntylä R, Kleimola T, Syvälahti E (1978) Acta Anaesthesiol Scand 22:215–220

    PubMed  CAS  Google Scholar 

  21. Aellig WH (1984) Eur J Clin Pharmacol 26:239–242

    PubMed  CAS  Google Scholar 

  22. Jennings G, Esler M, Holmes R (1979) Br Med J 2:307–308

    PubMed  CAS  Google Scholar 

  23. de Marées H, Welzel D, de Marées A, Klotz U, Tiedjen KU, Knaup G (1986) Eur J Clin Pharmacol 30:685–689

    PubMed  Google Scholar 

  24. Müller-Schweinitzer E (1984) Eur J Clin Pharmacol 26:699–705

    PubMed  Google Scholar 

  25. Labayle D, Chalas J, Lavène D, Humbert M, Azria M, Lindenbaum A, Chaput JC (1982) Gastroenterol Clin Biol 6:129–134

    PubMed  CAS  Google Scholar 

  26. Dumont M, De Couët G, Le Bigot JF, Erlinger S (1985) J Pharmacol Exp Ther 234:239–243

    PubMed  CAS  Google Scholar 

  27. Heuser B, Middendorf E (1985) Fortschr Med 103:966–970

    PubMed  CAS  Google Scholar 

  28. Wörz R (1986) Fortschr Med 104:838–842

    PubMed  Google Scholar 

  29. Thulesius O, Berlin E (1986) Int J Clin Pharmacol Ther Tox 24:465–467

    CAS  Google Scholar 

  30. Goeschen K, Jäger A, Saling E (1984) Geburtshilfe Frauenheilkde 44:351–355

    CAS  Google Scholar 

  31. Comerota AJ, White JV (1986) Chest 89(Suppl.):389S–395S

    PubMed  CAS  Google Scholar 

  32. Kakkar VV, Stamatakis JD, Bentley PG, Lawrence D, de Haas HA, Ward VP (1979) JAMA 241:39–41

    PubMed  CAS  Google Scholar 

  33. Gent M, Roberts RS (1986) Chest 89(Suppl.):396S–400S

    PubMed  CAS  Google Scholar 

  34. Wolf H, Welzel D, Kaiser H, Majer M, Schäfer D, Husfeldt KJ, Voigt J, Sunder-Plassmann L (1988) Arzneim Forsch 38:1.516–1.519

    Google Scholar 

  35. Emory CE, Cuddy PG (1987) Drug Intell Clin Pharm 21:427–431

    PubMed  CAS  Google Scholar 

  36. Barthel W, Glusa E, Koth W (1987) Int J Clin Pharmacol Ther Tox 25:63–69

    CAS  Google Scholar 

GE/BW

  1. Dibbern H W (1978), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf

    Google Scholar 

  2. Ergebnisse der Firma Boehringer Ingelheim

    Google Scholar 

HÄ/pb

  1. Mitteilung der Firma Boehringer Ingelheim

    Google Scholar 

HÄ/pb

  1. v. Békésy N (1940) Biochem Zschr 303,368

    Google Scholar 

SH

  1. Flückinger E, Balthasar HU (1967) Arzneim Forsch 17:6–9

    Google Scholar 

  2. Aeilig WH, Berde B (1969) Br J Pharmacol 36:561–570

    Google Scholar 

  3. Berde B, Stürmer E (1978) Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO (Hrsg.) Handbook of Experimental Pharmacology, Springer-Verlag, Berlin Heidelberg New York, S. 1–28

    Google Scholar 

  4. Rothlin E (1947) Bull Schweiz Akad Med Wiss 2:249–273

    PubMed  CAS  Google Scholar 

  5. Rothlin E, Brügger J (1945) Helv Physiol Pharmacol Acta 3:C43–C44

    CAS  Google Scholar 

  6. Fregman BG, Gläser AH (1964) J Pharm Pharmacol 16:744–750

    Google Scholar 

  7. Pacha W, Salzmann R (1970) Br J Pharmacol 38:439P–440P

    PubMed  CAS  Google Scholar 

  8. Rothlin E, Cerletti A (1949) Verh Dt Ges Kreislauf-Forsch 15:158–185

    Google Scholar 

  9. Whitney B (1965) J Pharm Pharmacol 17:465–473

    PubMed  CAS  Google Scholar 

  10. Cripps H, Dearnaley DP (1972) J Physiol (London) 227:647–664

    CAS  Google Scholar 

  11. Gillespie JS, Kirkepar SM (1965) J Physiol (Lond) 176: 205–227

    CAS  Google Scholar 

  12. Wennmalm A (1971) Acta Physiol Scand 82:532–538

    PubMed  CAS  Google Scholar 

  13. Clark BJ, Bucher T, Weite R (1984) Kardiovaskuläre Wirkungen von Co-Dergocrin. In: Bergener M, Grobecker H (Hrsg.) Hypertonie im Alter: Normvariante oder Krankheit? F.K. Schattauer Verlag, Stuttgart New York, S. 155–165

    Google Scholar 

  14. Mchedlishvili GI, Ormotsadze LG (1974) Pat Fiziol éksp Ther 5:79–81

    Google Scholar 

  15. Karlsberg P, Elliott HW, Adams JE (1963) Neurology (Minneap) 13:772–778

    CAS  Google Scholar 

  16. Gaddum JH;, Paasonen MK (1955) Br J Pharmacol 10:474–483

    CAS  Google Scholar 

  17. Duret RL (1951) Acta Clin Belg 6:85–106

    PubMed  CAS  Google Scholar 

  18. Marques MG, Rato JA (1954) Cardiologica (Basel) 24:196–206

    CAS  Google Scholar 

  19. Clark BJ, Chu DH, Aellig WH (1978) Actions on the heart and circulation. In: Berde B, Schild HO (Hrsg.) Ergot Alkaloids and related Compounds, Handb Exp Pharmacol, Bd. 49, Springer-Verlag, Berlin Heidelberg New York, S. 321–420

    Google Scholar 

  20. Müller-Schweinitzer E (1982) Naunyn-Schmiedebergs Arch Pharmacol 318:225–233

    Google Scholar 

  21. Memo M, Saghedu G, Cappuba MO, Spano PF (1985) Life Sci 36:1.515–1.522

    Google Scholar 

  22. Georges D, Lallemand A, Coustenoble J, Loria J (1977) Thérapie 32:173–180

    PubMed  CAS  Google Scholar 

  23. Siegl H (1985) J Pharmacol (Paris) 16(Suppl.III):129–144 (Engl ed 113–127)

    CAS  Google Scholar 

  24. Jubert-Gruart J, Suner F, Gairin J, Fabrega MT, Oiler M (1975) VIIº Symposium Internacional “Insuficienca Circulatoria Cerebral”, Sandoz S.A.E., Barcelona, S. 83–108

    Google Scholar 

  25. Markstein R, Wagner H (1975) FEBS Letters 55:255–257

    Google Scholar 

  26. Iwangoff P, Enz A, Chappuis A (1975) Int Res Commun System Med Sci 3:403

    CAS  Google Scholar 

  27. Depoorter H, Loew DM, Vigouret JM (1975) Triangle 14:73–79

    Google Scholar 

  28. Loew DM, Depoortere H, Bürki HR (1976) Arzneim Forsch 26:1.080–1.083

    Google Scholar 

  29. Loew DM, Vigouret JM, Jaton AL (1976) Postgrad Med J 52(Suppl.I):40–46

    PubMed  CAS  Google Scholar 

  30. Wang SC, Glaviano VV (1954) J Pharmacol Exp Ther 111:329–334

    PubMed  CAS  Google Scholar 

  31. Loew DM, Vigouret JM, Jaton AL (1979) Topics Gerontol 15:85–103

    CAS  Google Scholar 

  32. Cerletti A, Emmenegger H, Enz A, Iwangoff P, MeierRuge W, Musil J (1973) Effects of ergot DH-alkaloids on the metabolism and function of the brain. An approach based on studies with DH-ergonine. In: Genazzani E, Herken H (Hrsg.) Central Nervous System-Studies on Metabolic Regulation and Function, Springer-Verlag, Berlin Heidelberg New York, S.201–212

    Google Scholar 

  33. Roubicek J, Geiger CH, Abt K (1972) J Am Geriatr Soc 20:222–229

    PubMed  CAS  Google Scholar 

  34. Meier-Ruge W, Enz A, Gygax P, Hunziker O, Iwangoff P, Reichelmeier K (1975) Experimantal pathology in basic research of the ageing brain. In: Gershon S, Raskin A (Hrsg.) Genesis and Treatment of Physiologic Disorders in the Elderly, Raven Press, New York, S. 55–126

    Google Scholar 

  35. Emmenegger H, Meier-Ruge W (1968) Pharmacology (Basel) 1:65–78

    CAS  Google Scholar 

  36. Van den Driessche J, Allain H, Bentué-Ferrer D, Feuillu A, Pape D, Milon D, Reymann JM, Sublet Y (1985) J Pharmacol (Paris) 16(Suppl. III):99–113 (Engl ed 85–99

    Google Scholar 

  37. Weil C (1989) Hydergin-Pharmakologische und klinische Befunde, Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo, S. 137–147

    Google Scholar 

  38. Zoglio MA, Maulding HV (1970) J Pharm Sci 59:215–218

    PubMed  CAS  Google Scholar 

  39. Meier-Ruge W, Schieweck C, Iwangoff P (1973) Int Res Comm Service Med Sci 7–10–3

    Google Scholar 

  40. Rothlin E (1947) Schweiz Med Wochenschr 77:1.161–1.163

    Google Scholar 

  41. Luntschli HJ, Goetz RH(1948) Am Heart J 35:873–894

    Google Scholar 

  42. Loew DM, Weil C (1982) Gerontology 18:54–74

    Google Scholar 

  43. Venn RD (1978) Clinical pharmacology of ergot alkaloids in senile cerebral insufficiency. In: Berde B, Schild HO (Hrsg.) Handbook of Experimental Pharmacology, Bd.49, Springer-Verlag, Berlin Heidelberg New York, S. 533–566

    Google Scholar 

  44. Oswald WD, Lang E (1980) Muench Med Wochenschr 122:59–62

    CAS  Google Scholar 

  45. Fanchamps A (1983) Controlled studies with dihydroergotoxin in senile cerebral insufficiency. In: Agnoli A, Crepaldi C, Spano PF, Trabucchi M (Hrsg.) Aging Brain and Ergot Alkaloids, Aging, Bd.23, Raven Press, New York, S. 311–322

    Google Scholar 

  46. Hamot HB, Patin JR, Singer JM (1984) Psychopharmacol Bull 20:142–150

    PubMed  CAS  Google Scholar 

  47. Biel LM, Seus R, Struppler A (1976) Med Klin 71:2.177–2.184

    Google Scholar 

  48. Manolidis L, Themelis C, Tsiptsios I, Tsaligolpoulos M (1982) Galenos 24:1.095–1.108

    Google Scholar 

  49. Arranz Munecas T, Ganoza Garcia C, Forcadell Puyo F(1979) Inform Psychat 77:250–258

    Google Scholar 

  50. Hajioff J, Wallace MG (1982) Br J Clin Pract (Suppl.16):43–46

    Google Scholar 

  51. Gouret C, Raynaud GJ (1976) J Pharmacol (Paris) 7:161–175

    CAS  Google Scholar 

  52. Kappert A (1949) Helv Med Acta Ser A 16(Suppl.22):66–67

    Google Scholar 

  53. Von Storch TJC (1938) J Am Med Ass 111:293–300

    Google Scholar 

KC

  1. Peck RL, Hoffhine CE, Folkers K (1946) J Am Chem Soc 68:1390

    PubMed  CAS  Google Scholar 

  2. Bartz QR, Controulis J, Crooks HM, Rebstock MC (1946) J Am Chem Soc 68:2163

    PubMed  CAS  Google Scholar 

  3. Fried J, Wintersteiner O (1947) J Am Chem Soc 69:79

    PubMed  CAS  Google Scholar 

  4. Ikeda H (1956) Proc Jap Acad 32, 48 und 53, zit. nach CA (1956) 50:13765

    Google Scholar 

  5. Moffat AC (Hrsg.) Clarkes Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London

    Google Scholar 

  6. Bock K, Pedersen C, Heding H (1974) J Antibiot 27: 139–140

    PubMed  CAS  Google Scholar 

GU

  1. Mar 29, S.216

    Google Scholar 

vB

  1. Ikeda H (1956) Proc Jap Acad 31, 48 und 53, zit. nach (1956) CA 50:13765

    Google Scholar 

  2. Moffat AC (Hrsgb.) Clarkes Isolation and Identification of Drugs (1986) The Pharmaceutical Press, London

    Google Scholar 

  3. Bock K, Pedersen C, Heding H (1974) J Antibiotics 27:139–140

    CAS  Google Scholar 

  4. Bartz QR, Controulis J, Crooks HM, Rebstock MC (1946) J Am Chem Soc 68:2163

    PubMed  CAS  Google Scholar 

GU

  1. Brockhaus ABC Chemie, Bd.2 (1971) VEB F.A. Brockhaus Verlag, Leipzig

    Google Scholar 

  2. Westerhof P, Buisman JAK (1956) Recueil Trav. Pays-Bas 15:453

    Google Scholar 

  3. Mills III T, Roberson JC (1987) Instrumental data for drug analysis, 2. Aufl., Vol 1, Elsevier, New York, Amsterdam, London

    Google Scholar 

  4. Berman E, Luz Z, Mazur Y, Sheves M (1977) J Org Chem 42:3325

    PubMed  CAS  Google Scholar 

WO

  1. Suda T, Hallick RB, DeLuca HF, Schnoes HK (1970) Biochemistry 9:1.651–1.657

    Google Scholar 

  2. Hallick RB, DeLuca HF (1972) J Biol Chem 247:91–97

    PubMed  CAS  Google Scholar 

  3. Bosch R, Thijssen JHH, Duursma SA (1987) J Steroid Biochem 27:829–836

    PubMed  CAS  Google Scholar 

  4. Pierides AM (1981) Drugs 21:241–256

    PubMed  CAS  Google Scholar 

  5. Harrison HE, Lifshitz F, Blizzard RM (1967) N Engl J Med 276:894–900

    PubMed  CAS  Google Scholar 

  6. Taylor A, Bikle DD, Norman ME (1988) J Clin Endocrinol Metab 67:198–202

    PubMed  CAS  Google Scholar 

bm

  1. Roth HJ (1959) Arch Pharm 292:234–238

    CAS  Google Scholar 

  2. Jeske J, Jakimowska K, Kakolewski J, Stochla K, Trawkowski J (1961) Acta Polon Pharm 18:335

    CAS  Google Scholar 

  3. Patent Pol 59,071 (Cl.C07d),15 Mar 1970, Appl. 02 May 1967, zit. nach CA 73:45544d

    Google Scholar 

  4. Farbenfabriken Bayer & Co Elberfeld (1905–1907) Friedländer 8:1136–1137

    Google Scholar 

  5. Ott R (1958) Sci Pharm 26:217–224

    CAS  Google Scholar 

  6. Stuchlik M, Csiba J, Krasnec L (1967) Cesk Farm 16(4):187–189, zit. nach CA 67:67530z

    PubMed  CAS  Google Scholar 

  7. Stuchlik M, Csiba J, Krasnec L (1969) Cesk Farm 18(2):91–92, zit. nach CA 71:24754r

    PubMed  CAS  Google Scholar 

  8. Schunack W, Mutschier E, Rochelmeyer H (1965) Dtsch Apoth Ztg 44:1551–1552

    Google Scholar 

  9. Raber H (1964) Sci Pharm 32(2):122–127

    CAS  Google Scholar 

  10. Raber H (1967) Sci Pharm 35:220–224

    CAS  Google Scholar 

LD

  1. Mar 29, S. 1526

    Google Scholar 

EH

  1. Mar 29, S.662

    Google Scholar 

vB

  1. Mar 29, S.685

    Google Scholar 

vB

  1. Buczkowski Z, Gryff-Keller A, Zajaczkowska E (1972) Rocz Chem 46:1047–1057

    CAS  Google Scholar 

  2. Salman S, Bayradkar N (1983) Eczacilik Bul 25:30–33

    CAS  Google Scholar 

  3. Hartvig P, Handl W (1975) Acta Pharm Suecica 12:349–360

    CAS  Google Scholar 

  4. Vessmann J, Hartvig P, Strömberg S (1970) Acta Pharm Suecica 7:373–388

    Google Scholar 

  5. Hartvig P, Sundin H, Vessmann J (1972) Acta Pharm Suecica 9:269–282

    CAS  Google Scholar 

gs

  1. Buczkowski Z, Gryff-Keller A, Zajaczkowska E (1972) Rocz Chem 46:1047–1057

    CAS  Google Scholar 

  2. Egli RA, Tanner S (1979) Fresenius Z Anal Chem 295:398–401

    CAS  Google Scholar 

gs

  1. Patent Toyo Rayon Co. Fr. 1, 542, 199, v. 11.10. 1968, zit. nach CA (1969) 71:80.716s

    Google Scholar 

  2. Patent S.Wakamatsu, S.Hosaka Japan 6908, 207 v. 17.4. 1969, zit. nach CA (1969) 71:90.852x

    Google Scholar 

  3. Patent K.Maruyama, T.Kominami, T.Watanabe Japan v. 7.2. 1970, zit. nach CA (1970) 73:3.479f

    Google Scholar 

  4. Eryshev BY (1978) Zh. Khim. 1973, zit. nach CA (1979) 90:103.350b

    Google Scholar 

NP

  1. Husain S, Pratop G, Rao NR (1989) J. Chromatogr 475: 426–31, zit. nach CA (1990) 112:90.948y

    CAS  Google Scholar 

NP

  1. Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2. Aufl., Noyes Publications, Park Ridge, New Jersey USA, S. 494

    Google Scholar 

  2. EGIS Gyogyszergyar (1990) Jap Kokai Tokkyo Koho JP 02,221,266,zit. nach CA (1991) 114:81.898w

    Google Scholar 

  3. EGIS Gyogyszergyar (1990) Jap Kokai Tokkyo Koho JP 02,221,265, zit. nach CA (1991) 114:81.899x

    Google Scholar 

  4. Amos K, Auterhoff H (1979) Dtsch Apoth Ztg 119:1440

    CAS  Google Scholar 

RE

  1. Fogari R (1980) G Ital Cardiol 10:1.675–1.678

    Google Scholar 

  2. Taddei L, L’Abbate A (1985) Pharmacology 31:82–87

    PubMed  Google Scholar 

  3. Cargini A, Condorelli E, Ceconi C, Curello S, Albertini A, Ferrari R (1987) Pharmacol Res Commun 19:341–357

    Google Scholar 

  4. Gupta JB, Seth SD, Singh U, Vyas DS (1989) Int Cardiol 23:165–171

    CAS  Google Scholar 

  5. Okluma M, Kanji K, Ushikubi F, Ishibashi T, Uchino H (1989) Arzneim Forsch 39:898–950

    Google Scholar 

  6. Nakagawa Y, Gudenzi M, Mustafa SJ (1986) Eur J Pharmacol 122:51–58

    PubMed  CAS  Google Scholar 

  7. Nakagawa Y, Gudenza M ,Mustafa SJ (1986) Pharmacology 33:148–156

    PubMed  CAS  Google Scholar 

  8. Tonini M, Perucca E, Manzo L, Marcoli M, D’ Angelo L, Saltarelli P, Onori L (1983) J Pharm Pharmacol 35:434–439

    PubMed  CAS  Google Scholar 

  9. Yamauchi Y, Ikuta J, Shimizu S, Nakamura M (1990) Nippon Yakurigaku Zasshi 95:239–246

    PubMed  CAS  Google Scholar 

  10. Poggesi L, Masotti G, Serneri GG, Carnovali M (1988) J Clin Pharmacol 28:43–47

    PubMed  CAS  Google Scholar 

  11. Ibba GV, Terrosu P, Franceschino V, Contini GM (1986) Int J Cardiol 11:337–347

    PubMed  CAS  Google Scholar 

  12. Saito D, Kusachi S, Magashima H, Haraoka S (1982) Arzneim Forsch 32:1.029–1.032

    Google Scholar 

  13. Kokayashi A, Ogawa K, Yamazaki N (1980) Jpn Heart J 21:85–94

    Google Scholar 

  14. Sambhi MP, Kannan R, Thananopavarn C, Ookhtens M, Gudenzi M (1989) J Pharm Sci 78:281–284

    PubMed  CAS  Google Scholar 

  1. Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia 2. Aufl., Noyes Publications, Park Ridge, New Jersey USA, S. 494

    Google Scholar 

  2. EGIS Gyogyszergyar (1990) Jpn Kokai Tokkyo Koho JP 02,221,266, zit. nach CA (1991) 114:81898w

    Google Scholar 

  3. EGIS Gyogyszergyar (1990) Jpn Kokai Tokkyo Koho JP 02, 221, 265, zit. nach CA (1991) 114:81899x

    Google Scholar 

  4. Amos K, Auterhoff H (1979) Dtsch Apoth Ztg 119: 1440

    CAS  Google Scholar 

  5. Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf; Spektr.-Nr. 1.419

    Google Scholar 

  6. Schriewer H, Rauen HM (1972) Arzneim Forsch 22:1455

    CAS  Google Scholar 

  7. Mannhold R, Rodenkirchen R, Bayer R, Haas W (1984) Arzneim Forsch 34:407

    CAS  Google Scholar 

  8. Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308:413

    CAS  Google Scholar 

  9. Sadana GS, Kunhipurayil PS, Sane RT (1986) Indian Drugs 23:427, zit. nach CA (1986) 105:12243f

    CAS  Google Scholar 

RE

  1. Kle82

    Google Scholar 

sb

  1. Webster LT (1985) Drugs used in the chemotherapy of protozoal infections, amebiasis, giardiasis, and trichomomiasis. In: Goodman and Gillman’s the pharmacological basis of therapeutics, 7. Aufl., McMillan Publ, New York, S. 1.050–1.051

    Google Scholar 

  2. Woodruff AW, Bell S (1960) Trans R Soc Trop Med Hyg 54:389–395

    PubMed  CAS  Google Scholar 

  3. Khalil, HM, Fawzy AFA, Sarwat MA (1987) J Egypt Soc Parasitol 17:417–425

    PubMed  CAS  Google Scholar 

  4. Nigam P, Dubey AL, Jain AK, Bajpeyi HS, Kala RP, Goyal BM (1978) Clinician 42:309–316

    Google Scholar 

  5. Shaldon S (1960) Trans R Soc Trop Med Hyg 54:469–470

    PubMed  CAS  Google Scholar 

  6. Marsden PD (1960) Trans R Soc Trop Med Hyg 54:396–399

    PubMed  CAS  Google Scholar 

  7. Ata AH, El-Haieg HO, Aboul Magd LA, Mansour AH (1984) J Egypt Soc Parasitol 14:213–218

    PubMed  CAS  Google Scholar 

  8. Pehrson P, Bengston E (1983) Trans R Soc Trop Med Hyg 77:845–846

    PubMed  CAS  Google Scholar 

  9. Pain AK, McKendrick GW (1979) J Infection 1:87–89

    Google Scholar 

  10. Salaki JS, Shirey JL, Strickland GT (1979) Am J Trop Med Hyg 28:190–193

    PubMed  CAS  Google Scholar 

  11. Mason PR, Patterson BA (1987) Am J Trop Med Hyg 37:277–282

    PubMed  CAS  Google Scholar 

  12. Viens P, Beal CC, Doucet J, Pichard JJ, Leonarth T, Musto K, N’Diri AG, Pothier MA (1972) Mèdecine d’Afrique Noire 19:541–547

    Google Scholar 

  13. Agrawal A, Pandey VC, Sagar P (1989) Zbl Bakt 271:244–248

    CAS  Google Scholar 

  14. Ey IL (1977) Ethiopian Medical J 15:101–105

    CAS  Google Scholar 

  15. Foll CV (1957) J Trop Med Hyg 60:216–217

    PubMed  CAS  Google Scholar 

HA

  1. Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, Aulendorf

    Google Scholar 

SH

  1. Chaffman M, Brogden RN (1985) Drugs 29:387–454

    PubMed  CAS  Google Scholar 

  2. Buckley MMT, Grant SM, Goa KL, McTavish D, Sorkin EM (1990) Drugs 39:757–806

    PubMed  CAS  Google Scholar 

  3. Fleckenstein A (1983) Calcium antagonism in heart and smooth muscle, John Wiley & Sons, Inc. New York

    Google Scholar 

  4. Nayler W (1990) Calcium-Antagonisten, Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  5. Kazda S, Knorr A (1990) Calcium antagonists. In: Ganten D, Mulrow PJ (Hrsg.) Handbook of Experimental Pharmacology, Bd.93, Pharmacology of Antihypertenive Therapeutics, Springer-Verlag, Berlin Heidelberg New York, S. 301–375

    Google Scholar 

  6. Hermann P, Morselli PL (1985) Acta Pharmacol Toxicol 57(Suppl.II):12–20

    Google Scholar 

  7. Smith MS, Verghese CP, Shand DG, Pritchett ELC (1983) Am J Cardiol 51:1.369–1.374

    Google Scholar 

  8. Kölle EV, Ochs HR, Vollmer KO (1983) Arzneim Forsch 33:972–977

    Google Scholar 

  9. Morselli PL, Rovei V, Mitchard M, Durand A, Gomeni R, Larribaud J (1979) Pharmacokinetics and metabo lism of diltiazem in man (observation on healthy volunteers and angina pectoris patients). In: Bing RJ (Hrsg.) New drug therapy with a calcium antagonist; Diltiazem Hakone Symposium 78, Excerpta Medica, Amsterdam-Princeton, S.152–167

    Google Scholar 

  10. Bloedow DC, Piepho RW, Nies AS, Gal J (1980) Pharmacologist 22:3–13

    Google Scholar 

  11. Schwartz JB, Abernethy DR, Egan JM, Mitchel JR (1985) Circulation 72:50–56

    Google Scholar 

js

  1. Dibbern HW (1978), UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor, Aulendorf

    Google Scholar 

  2. Japan Med Gaz (1974) 11(1),12

    Google Scholar 

SH

  1. FR M5878 (1968), zit. nach CA 71:13145s

    Google Scholar 

  2. Quevauviller A, Foussard-Blanpin O, Garcet S, Levrier-Pottier J, Huyen-Vu-Ngnoc, Besancon M, Muller P (1967) Arch Int Pharmacodyn Ther 166:398–416

    PubMed  CAS  Google Scholar 

Ba

  1. Mar 29, S.422

    Google Scholar 

vB

  1. Da Re P, Verlicchi L, Setnikar I (1960) Arzneim Forsch 10:800–802.

    Google Scholar 

My/Ms

  1. Vieira da Silva MJJ, Carvalho Nogueira MT, Leite Inacio MM, Marques Leal A (1965) Rev Port Farm 15:295–300

    CAS  Google Scholar 

  2. Moffat AC (Hrsg.) Clarke’s Isolation and Identification of Drugs, 2. Ed. (1986) The Pharmaceutical Press, London

    Google Scholar 

My/Ms

  1. Cusic JW (1949) Science 109:574–Cusic JW US Pat 2499058, zit. nach CA (1950) 44:4926g-Cusic JW US Pat 2534813, zit. nach CA (1951) 45:4268h

    PubMed  CAS  Google Scholar 

  2. Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf

    Google Scholar 

  3. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London

    Google Scholar 

MP

  1. Rochae Silva M, Antonio A (1978) Handbuch der Experimentellen Pharmakologie, Bd. 18/2, S. 417

    Google Scholar 

  2. Scarone JM, Luna BG, Harmatz JS, von Moltke L, Greenblatt DJ (1990) Biopharmaceutics and drug dispos 11:185–189

    Google Scholar 

  3. Faingold CL (1978) Handbuch der Experimentellen Pharmakologie, Bd. 18/2, S.567

    Google Scholar 

  4. Pyykko I, Magnusson M, Schalén L, Enbom H (1988) Acta Otolaryngol 455(Suppl.):77–81

    CAS  Google Scholar 

hr

  1. Aaseth J (1983) Human Toxicol 2:257–272

    CAS  Google Scholar 

  2. Berlin M, Lewander T (1965) Acta Pharmacol Toxicol 22:1–7

    CAS  Google Scholar 

  3. Eybl V, Sýkora J, Mertl F (1965) Naunyn-Schmiedebergs Arch Exp Path Pharmak 252:79–84

    CAS  Google Scholar 

  4. Gabard B (1976) Arch Toxicol 35:15–24

    PubMed  CAS  Google Scholar 

  5. Cherian MG, Vostal JJ (1973) Fed Proc 32:261

    Google Scholar 

  6. Giesen J, Koelzer P (1949) Ärztl Forsch 3:133–143

    Google Scholar 

  7. Hook G (1953) Zschr Haut Geschlkrankh 14:357–364

    Google Scholar 

  8. Wexler J, Eagle H, Tatum HJ, Magnuson HJ, Watson EB (1946) J Clin Invest 25:467–473

    CAS  Google Scholar 

  9. Carleton AB, Peters RA, Stocken LA, Thompson RHS, Williams DI, Storey IDE, Levvy GA, Chance AC (1946) J Clin Invest 25:497–527

    CAS  Google Scholar 

  10. Longcope WT, Luetscher JA, Calkins E, Grob D, Bush SW, Eisenberg H (1946) J Clin Invest 25:557–567

    CAS  Google Scholar 

  11. Orzechowski G (1964) Pharmaz Rundsch 6:41–46

    Google Scholar 

  12. Sulzberger MB, Baer RL, Kanof A (1946) J Clin Invest 25:474–479

    CAS  Google Scholar 

  13. Modell W, Gold H, Cattell M (1946) J Clin Invest 25:480–487

    CAS  Google Scholar 

Fk

  1. Ger. Offen.2, 933, 027 (1981)

    Google Scholar 

  2. Bystryakov VP, Lanin SN, Arzamastsev AP (1991) Khim Farm Zh 25:81–84

    CAS  Google Scholar 

  3. Ryabykh L, Trokhimchuck VV, Farmatsiya (Moscow) (1983) 32(3):63–66

    Google Scholar 

  4. Nazarenko VA, Rybalka VB, Medinets VI, Lepeshkin VI (1984) Zh Anal Khim 39:1.449–1.454

    Google Scholar 

Rh

  1. Wronski, Mieczyslaw (1986) Chem. Anal. (Warsaw) 31:561–566

    CAS  Google Scholar 

Rh

  1. Aaseth J (1983) Hum Toxicol 2:257–272

    PubMed  CAS  Google Scholar 

  2. Aposhian HV (1983) Ann Rev Pharmacol Toxicol 23:193–215

    CAS  Google Scholar 

  3. Wiedemann P, Fichtl B, Szinicz L (1982) Biopharm Drug Dispos 3:267–274

    PubMed  CAS  Google Scholar 

  4. Gabard B (1978) Arch Toxicol 39:289–298

    PubMed  CAS  Google Scholar 

  5. Reuther H, Wildenauer DB, Weger N (1982) Chem Biol Interact 42:179–194

    PubMed  CAS  Google Scholar 

  6. Wildenauer DB, Reuther H, Weger N (1982) Chem Biol Interact 42:165–177

    PubMed  CAS  Google Scholar 

  7. Maiorino RM, Barry TJ, Aposhian HV (1987) Anal Biochem 160:217–226

    PubMed  CAS  Google Scholar 

  8. Planas-Bohne F, Gabard B, Schäffer EH (1980) Arzneim Forsch 30:1291–1294

    CAS  Google Scholar 

  9. Domingo JL, Ortega A, Bosque MA, Corbella J (1990) Life Sci 46:1287–1296

    PubMed  CAS  Google Scholar 

  10. Nadig J, Knutti R, Hany A (1985) Schweiz Med Wschr 115:507–511

    PubMed  CAS  Google Scholar 

  11. Lund ME, Banner WJ, Clarkson TW, Berlin M (1984) J Toxicol Clin Toxicol 22:31–49

    PubMed  CAS  Google Scholar 

  12. Campbell JR, Clarkson TW, Omar MD (1986) J Am Med Ass 256:3127–3130

    CAS  Google Scholar 

  13. Goebel HH, Schmidt PF, Bohl J, Tettenborn B, Kramer G, Gutmann L (1990) J Neuropath Exp Neurol 49:137–149

    PubMed  CAS  Google Scholar 

  14. Iffland R, Bösche G (1987) Monatsschr Kinderheilkd 135:227–230

    PubMed  CAS  Google Scholar 

  15. Chisolm JJ, Thomas DJ (1985) J Pharmacol Exp Ther 235:665–669

    PubMed  CAS  Google Scholar 

  16. Donner A, Hruby K, Pirich K, Kahls P, Schwarzacher K, Meisinger V (1987) Vet Hum Toxicol 29:37

    Google Scholar 

  17. Donner A, Meisinger V, Scholtz I, Pirich K, Hruby K (1986) Toxicol Lett 31(Suppl.):154

    Google Scholar 

  18. Walshe JM (1985) Br Med J 290:673–674

    CAS  Google Scholar 

  19. Aaseth J, Halse J, Falch J (1986) Acta Pharmacol Toxicol (Copenh) 59(Suppl.7):471–474

    Google Scholar 

  20. Playford RJ, Matthews CH, Campbell MJ, Delves HT, Hla KK, Hodgson HJ, Calam J (1990) Gut 31:359–360

    PubMed  CAS  Google Scholar 

  21. Bertram HP (1977) Arch Pharmacol 297(Suppl.2), R 19, No 75

    Google Scholar 

  22. Mant TGK (1985) Hum Toxicol 4:346

    Google Scholar 

  23. Schiele R, Schaller KH, Weltle D (1989) Arbeitsmed Sozialmed Präventivmed 24:249–251

    Google Scholar 

Fk

  1. Mar 29, S. 360

    Google Scholar 

vB

  1. Senoh S, Mita I (1952) J Pharm Soc Japan 72:1096–1098

    CAS  Google Scholar 

  2. Takamatsu H (1956) J Pharm Soc Japan 76:1227–1229

    CAS  Google Scholar 

  3. Parham WE, Hunter WT, Hanson R, Lahr T (1952) J Am Chem Soc 74:5646–5648

    CAS  Google Scholar 

  4. Abou El-Ella D (1983) Master Thesis, Universität Kairo

    Google Scholar 

  5. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

NE

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Senoh S, Mita I (1952) J Pharm Soc Japan 72:1096–1098

    CAS  Google Scholar 

  2. Takamatsu H (1956) J Pharm Soc Japan 76:1227–1229

    CAS  Google Scholar 

  3. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

NE

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie Verlag, Berlin, Nr. 2142

    Google Scholar 

vB

  1. Mannich C, Lesser B, Silten F (1932) Ber 65:378–385

    Google Scholar 

TR

  1. Fromherz K (1930) Naunyn-Schmiedeberg’s Arch Pharmacol 158:369–380

    Google Scholar 

  2. Dietrichs H (1931) Naunyn-Schmiedeberg’s Arch Pharmacol 161:206–213

    CAS  Google Scholar 

  3. Geßner O, Klenke J, Wurbs FR (1932) Naunyn-Schmiedeberg’s Arch Pharmacol 168:447–472

    Google Scholar 

  4. Schaumann O (1938) Naunyn-Schmiedeberg’s Arch Pharmacol 190:30–51

    CAS  Google Scholar 

  5. Hansson E (1971) Absorption, Distribution, Metabolism and Excretion of Local Anesthetics. In: International Encyclopedia of Pharmacology and Therpeutics, Section 8, Vol.1, Pergamon Press, Oxford New York Toronto Sydney Braunschweig, S. 239–260

    Google Scholar 

FM

  1. Von Seemann K (1957) US Pat 2.778.824; CA (1957) 51:10.591h

    Google Scholar 

  2. Kuhnert-Brandstaetter M, Geiler M, Wurian I (1928) Sci Pharm 50(4):324–331

    Google Scholar 

  3. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

  4. Jane I, McKinnon A, Flanagan Rj (1985) J Chromatogr 323(2):191–225

    PubMed  CAS  Google Scholar 

KU

  1. Eyer P, Kiese M, Lipowsky G, Weger N (1974) Chem Biol Interact 8:41–59

    PubMed  CAS  Google Scholar 

  2. Weger N (1983) Fundam Appl Toxicol 3:387–396

    PubMed  CAS  Google Scholar 

  3. Eyer P, Kiese M (1976) Chem Biol Interact 14:165–178

    PubMed  CAS  Google Scholar 

  4. Eyer P (1977) Naunyn-Schmiedebergs Arch Pharmacol (Suppl II) 297:R 21, No 83

    Google Scholar 

  5. Eyer P (1978) Biotransformation of 4-dimethylaminophenol in the erythrocyte: Covalent binding and interaction with glutathione. In: Fouts JR, Gut J (Hrsg.) Industrial and environmental xenobiotics, Excerpta Medica, Amsterdam, S. 290

    Google Scholar 

  6. Jansco P, Szinicz L, Eyer P (1981) Arch Toxicol 47:39–45

    Google Scholar 

  7. Weger N (1968) Arch Toxikol 24:49–50

    PubMed  CAS  Google Scholar 

  8. Kiese M, Weger N (1969) Eur J Pharmacol 7:97–105

    PubMed  CAS  Google Scholar 

  9. Kiese M, Schöber JG, Weger N (1968) Naunyn-Schmiedebergs Arch Exp Path Pharmak 260:152–153

    CAS  Google Scholar 

  10. Kiese M, Szinicz L, Thiel N, Weger N (1975) Arch Toxicol 34:337–340

    PubMed  CAS  Google Scholar 

  11. Elbers R, Kampffmeyer HG, Rabes H (1980) Xenobiotica 10:621–632

    PubMed  CAS  Google Scholar 

  12. Szinicz L, Weger N, Schneiderhan W, Kiese M (1979) Arch Toxicol 42:63–73

    PubMed  CAS  Google Scholar 

  13. Szinicz L, Weger N (1980) Xenobiotica 10:611–620

    PubMed  CAS  Google Scholar 

  14. Klimmek R, Fladerer H, Weger N (1979) Arch Toxicol 43:121–133

    PubMed  CAS  Google Scholar 

  15. Klimmek R, Fladerer H, Szinicz L, Weger N, Kiese M (1979) Arch Toxicol 42:75–84

    PubMed  CAS  Google Scholar 

Fk

  1. Dauderer M (1981) Fortschr Med 99:1.590–1.597

    Google Scholar 

Rk

  1. Ebel S (1988) in Ebel S, Dorner W (Hrsg) Parat-Jahrbuch Chemielabor, S. 127

    Google Scholar 

Eb/Jö

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

DG

  1. Standardzulassung Nr. 6399.99.99

    Google Scholar 

  2. Standardzulassung Nr. 6399.98.98

    Google Scholar 

HU

  1. Mar 29, S. 1.325

    Google Scholar 

vB

  1. Standardzulassung Nr. 6399.99.99

    Google Scholar 

  2. Standardzulassung Nr. 6399.98.98

    Google Scholar 

FA/BK

  1. Huebner CF, Donoghue E, Wenk P, Sury E, Nelson IA (1960) J Am Chem Soc 82:2077–2078

    CAS  Google Scholar 

  2. Schmid HJ, Hunger A, Hoffman K (1956) Helv Chim Acta 39:607–618

    CAS  Google Scholar 

  3. Siek FJ, Osiewcz RJ, Bath RJ (1976) J Forensic Sci 21:525–551

    PubMed  CAS  Google Scholar 

  4. Buchmann M, Kesselring UW (1978) Pharm Acta Helv 53:261

    PubMed  CAS  Google Scholar 

  5. Beilsteins Handbuch der Organischen Chemie E V 22/11, 123 (System-Nr. 3.399), Springer Verlag, Berlin

    Google Scholar 

MB

  1. Reinhardt D, Borchard U (1982) Klin Wochenschr 60:983–990

    PubMed  CAS  Google Scholar 

  2. Schlicker E, Schunack W, Göthert M (1990) Naunyn Schmiedebergs Arch Pharmacol 342:497–501

    PubMed  CAS  Google Scholar 

  3. Malinowska B, Schlicker E (1991) Eur J Pharmacol 205:307–310

    PubMed  CAS  Google Scholar 

  4. Schlicker E, Lümmen G, Behling A, Göthert M (1992) Agents Actions, Special Conference Issue:C339–C342

    Google Scholar 

  5. Nicholson AN (1991) Br J Pharamcol 104:270–276

    CAS  Google Scholar 

  6. Kubo N, Shirakawa O, Kuno T, Tanaka C (1987) Japan J Pharmacol 43:277–282

    CAS  Google Scholar 

  7. Sautel M, Towart R, Theraulaz-Lacroix M, Weitsch AF (1992) Agents Actions, Special Conference Issue:C428–C430

    Google Scholar 

  8. Thermann M, Lorenz W, Schmal A, Schingale F, Dormann P, Hamelmann H (1977) Agents and Actions 7/1:97–101

    Google Scholar 

  9. Thermann M, Lorenz W, Schmal A, Schingale F, Dormann P, Hamelmann H (1975) Agents and Actions 5/5:450–454

    PubMed  CAS  Google Scholar 

  10. Lui WL, Tainsh KR, Towart R, Pearce FL (1992) Agents Actions Special Conference Issue, C302–C304

    Google Scholar 

  11. Aniol M, Riesener KP, Eichelberg D, Schmutzler W (submitted) Compararive studies of H1-antihistamines in human adenoidal mast cells (HAMC)

    Google Scholar 

  12. Leuschner F, Neumann BW, Brunnauer H, Rehn D (1992) Agents Actions, Special Conference Issue:C431–C433

    Google Scholar 

  13. Rehn D,Geißler H, Schuster O, Lukas H, Hennings G (1990) Fundam Clin Pharmacol 4:673–683

    PubMed  CAS  Google Scholar 

  14. Rehn D, Geißler H, Schönbrunn U, Lukas H, Hen nings G (1990) Eur J Clin Pharmacol 39:137–141

    PubMed  CAS  Google Scholar 

  15. Lorenz W, Doenicke A (1985) NER Allergy Proc 6:174–194

    PubMed  CAS  Google Scholar 

  16. Lorenz W, Stinner B, Dietz W, Koller M, Rothmund M, Dick W (1992) Agents Actions, Special Conference Issue:C213–C218

    Google Scholar 

  17. Hersteller-Angaben (unveröffentlicht)

    Google Scholar 

  18. Arnera V, Wermeille M, Wellman M, Llull JB, Althaus A, Balant LP (1990) Arzneim Forsch/Drug Res 40:1.346–1.348

    Google Scholar 

  19. Radler S, Blaschke G (1991) J Chromatogr 567:229–239

    PubMed  CAS  Google Scholar 

  20. May KL, Nelemans FA (1966) Acta Allergologica 21:337–342

    PubMed  CAS  Google Scholar 

  21. Holzhüter H (1979) Archiv f Arzneitherap 1:74–77

    Google Scholar 

  22. Horak F, Jäger S, Andresen I (1991) Schweiz med Wschr 121 Suppl 40/II:13

    Google Scholar 

  23. Poisson A, Brunei CM (1984) Gaz Med Fr 91:65–70

    Google Scholar 

  24. Adt M, Baumert JH, Reimann HJ (1992) Brit J Anaesth 68:155–160

    PubMed  CAS  Google Scholar 

  25. Tryba M, Zenz M, Thole H (1992) Agents Actions, Special Conference Issue:C238–C241

    Google Scholar 

  26. Lorenz W, Doenicke A, Schöning B, Röher D, Ohmann C, Grote B, Schmal A (1985) Prospektive Studien mit Histamin H1-und H2-Rezeptorantagonisten. In: Doenicke A, Lorenz W (Hrsg.) Histamin und Histamin-Rezeptor-Antagonisten, Springer, Berlin Heidelberg, S. 253–291

    Google Scholar 

  27. Lee A, Lader M, Kitler ME (1988) Human Psychopharmacol 3:111–117

    Google Scholar 

  28. Bieber T, Ring J (1987) Med Klin 82:683–686

    CAS  Google Scholar 

  29. Menzel K (1981) Dtsch Ärtzebl 34:1591–1596

    Google Scholar 

  30. Niederle J (1968) Dtsch Med Wschr 93:1005–1013

    PubMed  CAS  Google Scholar 

  31. Würmli K (1973) Pharm Acta Helv 48:4, 200–222

    PubMed  Google Scholar 

sw

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London

    Google Scholar 

  2. Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf

    Google Scholar 

  3. Buchmann M, Kesselring UW (1978) Pharm Acta Helv 53:261–272

    PubMed  CAS  Google Scholar 

MP

  1. Cheney LC, Wheatley WB, Speeter ME, Byrd WM, Fitzgibbon WE, Minor WF, Binkley SB (1952) J Org Chem 17:770–777

    CAS  Google Scholar 

  2. Walton E, Ofner P, Thorp RH (1949) J Chem Soc:648–655

    Google Scholar 

  3. Wheatley WB, Minor WF, Byrd WM, Fitzgibbon WE, Speeter ME, Cheney LC, Binkley SB (1954) J Org Chem 19:794–801

    CAS  Google Scholar 

  4. Loomans J, Demoen P (1962) Mededel Vlaamse Chem Ver 24:54–64

    CAS  Google Scholar 

  5. Picco S, Villa F (1970) Boll Chim Farm 109:17–20

    PubMed  CAS  Google Scholar 

gs

  1. Cheney LC, Wheatley WB, Speeter ME, Byrd WM, Fitzgibbon WE, Minor WF, Binkley SB (1952) J Org Chem 17:770–777

    CAS  Google Scholar 

  2. Montequi R, Serrano J (1961) Anal Real Acad Farm 27:165–172

    CAS  Google Scholar 

gs

  1. Bauer F (1955) Z Tropenmed Parasitol 6:129–150

    PubMed  CAS  Google Scholar 

  2. Raether W, Seidenath H (1971) Z Tropenmed Parasitol 22:66–81

    PubMed  CAS  Google Scholar 

  3. Janssens PG, DeMuynck A (1977) Annales de la Societe Beige de Medecine Tropicale 57:589–592

    CAS  Google Scholar 

  4. Boch J, Supperer R (1983) Veterinärmedizinische Parasitologic, 3. Aufl., Paul Parey, Berlin Hamburg

    Google Scholar 

  5. Raether W, Hajdu P, Seidenath H, Damm D (1972) Z Tropenmed 23:418–427

    CAS  Google Scholar 

  6. Raether W, Hajdu P, Seidenath H, Damm D (1974) Tropenmed Parasiol 25:42–48

    CAS  Google Scholar 

  7. Rogers DJ (1985) Acta Tropica 42:5–23

    PubMed  CAS  Google Scholar 

  8. Janssens PG, De Muynck A (1977) Ann Soc beige Mèd Soc 57:589–592

    CAS  Google Scholar 

  9. Janssens PG, Wery M, van Meirvenne N (1984) Current knowledge and prospects in the field of african trypanosomiasis. In: Boch J (Hrsg.) Tropenmedizin, Parasitologic Medizin in Entwiclungsländern ed. Diesfeld HJ Peter Lang Verlag, Frankfurt Bern New York, 11:21–37

    Google Scholar 

  10. Bailey NM (1968) Trans Roy Soc Trop Med Hyg 62:122

    Google Scholar 

  11. McDougald LR, Roberson EL (1988) Antiprotozoan drugs. In: Booth NH, McDonald LE (Hrsg.) Veterinary Pharmacology and Therapeutics, 6. Aufl., Iowa State University Press, Ames/Iowa, S. 950–968

    Google Scholar 

  12. Kuttler KL (1988) Chemotherapy of Babesiosis. In: Ristic M (Hrsg.) Babesiosis of domestic animals and man, CRC Press, Boca Raton, Florida, S. 227–243

    Google Scholar 

  13. Ruebush II TK, Rubin RH, Wolpow ER, Cassaday PB, Schultz MG (1979) Am J Trop Med Hyg 28:184–189

    PubMed  Google Scholar 

  14. Newton BA (1973) Symposia Brit Soc Parasitology 11:29–51

    CAS  Google Scholar 

  15. Newton BA, Le Page RWF (1968) Trans R Soc Trop Med Hyg 62:131–132

    Google Scholar 

  16. Balana-Fouce R, Ordonez D, Alunda JM (1989) Mol Biochem Parasitol 35:43–50

    PubMed  CAS  Google Scholar 

  17. Aliu YO, Oedegaard S (1985) J Pharmacokinet Biopharm 13:173–184

    PubMed  CAS  Google Scholar 

  18. Aliu YO, Oedegaard S, Soegnen E (1984) Acta Vet Scand 25:593–596

    PubMed  CAS  Google Scholar 

  19. Gilbert RJ, Newton BA (1982) Vet Rec 111:397

    PubMed  CAS  Google Scholar 

  20. Kellner HM, Eckert HG, Volz MH (1985) Trop Med Parasitol 36:199–204

    PubMed  CAS  Google Scholar 

  21. Anika SM, Onyeyili PA (1989) Trop Med Parasitol 40:419–421

    PubMed  CAS  Google Scholar 

  22. Gilbert RJ (1983) Br J Pharmacol 80:133–139

    PubMed  CAS  Google Scholar 

  23. Naudé TW, Basson PA, Pienaar JG (1970) Onderstepoort J Vet Res 37:173–184

    PubMed  Google Scholar 

  24. Newton BA, Gilbert RJ (1982) Agrochem: Fate Food Environ Proc Int Symp 1982:255–265

    Google Scholar 

  25. Rakhmatullin EK (1989) Veterinariya (Moskau) 6:52–53

    Google Scholar 

  26. Rakhmatullin EK, Tsvetkova NI (1989) Veterinariya (Moskau) 9:60–61

    Google Scholar 

  27. Akanji MA, Ngaha EO (1989) Pharmacol Toxicol (Kopenhagen) 64:272–275

    CAS  Google Scholar 

HA

  1. Gysin H, Margot A (JR Geigy AG) Brit 713, 278 (1954); US Pat 27544343 (1956), zit. nach CA (1956) 50:1092 h

    Google Scholar 

  2. Gasser R (1953) Z Naturforschung 86:225–232

    Google Scholar 

  3. Moffat AC (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, Pharmaceutical Press, London

    Google Scholar 

  4. Stan HJ et al. (1977) Z Anal Chem 287:271–285

    CAS  Google Scholar 

QO

  1. Ero M (1974) Organophosphorus Pesticides: Organic and Biological Chemistry. Chapt. V, CRC Press, Cleveland

    Google Scholar 

  2. Food and Agriculture Organization and World Health Organization (1965) Expert Committee on Pesticide Residues, FAO Meeting Report No. PL/1965/10/1:77–83

    Google Scholar 

  3. Food and Agriculture Organization and World Health Organization (1967) Evaluation of some pesticide residues in food, FAO Meeting Report No. PL: CP/15:229–231

    Google Scholar 

  4. Food and Agriculture Organization and World Health Organization (1975) WHO Expert Committee on Pesticide Residues, WHO Techn Report Ser No. 574:11–12

    Google Scholar 

  5. Davies DB, Holub BJ (1980) Arch Environ contam Toxicol 9:637–650

    PubMed  CAS  Google Scholar 

  6. Hussain MA, Oloffs OC, Blatherwick FJ, Gaunce AP, Mackenzie CGJ (1981) J Environ Sci Health 316:1–19

    Google Scholar 

  7. Boch J, Supperer, R (1983) Veterinärmed. Parasitol., Verlag Paul Parey

    Google Scholar 

  8. Ungemach FR (1991) Antiparasitika, in “Grundlagen der Pharmakotherapie bei Haus-und Nutztieren”, Hrsg. Löscher W, Ungemach FR, Kroker R, Verlag Paul Parey

    Google Scholar 

  9. Rajendra W, Oloffs PC, Banister EW (1986) Drug Chem Toxicol 9:117–131

    PubMed  CAS  Google Scholar 

  10. Stalberg E, Hilton-Brown P, Kolmondin-Hedman B, Holmstedt B, Augustinsson KB (1978) Scand J Work Environ Health 4:255

    PubMed  CAS  Google Scholar 

  11. Iverson F, Grant DL, Lacroix J (1975) Bull Environ Contam Toxicol 13 (5):611–618

    PubMed  CAS  Google Scholar 

  12. Raffo A (1987) Obiettivi Documenti Veterinari 10:21–26

    Google Scholar 

  13. Hart RJ, Cavey WA, Ryan KJ, Moore B, Strong MB (1979) Wool Technology Sheep Breeding 27:23–27

    Google Scholar 

  14. Kirkwood AC, Quick MP (1981) Vet Rec 108:279–280

    PubMed  CAS  Google Scholar 

  15. Niemand HG, Niemand S, Wendel E (1979) Kleintierpraxis 24:173–175

    Google Scholar 

  16. Rust MK, Reierson DA (1989) J Med Entomol 26:301–305

    PubMed  CAS  Google Scholar 

  17. Braye G, Ndatho AK, Ansay M (1986) Ann Med Vet 130:85–89

    CAS  Google Scholar 

  18. Anthony J, Banister E, Oloffs PC (1986) Bull Environ Contam Toxicol 37:501–507

    PubMed  CAS  Google Scholar 

  19. Misawa M, Doull J, Kitos PA, Uyeki EM (1981) Toxicol Appl Pharmacol 57:20–29

    PubMed  CAS  Google Scholar 

rk

  1. Sojka SA, Wolfe RA (1978) Anal Chem 50(4):585–587

    CAS  Google Scholar 

  2. Neumüller AO (1985) Römpp’s Chemielexikon, Bd. 4, 8. Aufl., Franckh’sche Verlagshandlung, Stuttgart

    Google Scholar 

QO

  1. Schrör K (1984) Prostaglandine und verwandte Verbindungen, Georg Thieme Verlag Stuttgart New York, S.8,80

    Google Scholar 

  2. Corey EJ, Weinshenker NM, Schaaf TK, Huber W (1969) J Am Chem Soc 91:5675–5677

    PubMed  CAS  Google Scholar 

  3. Corey EJ, Varma RK (1971) Ibid 93:7.319

    Google Scholar 

  4. BudavariS, The Merck Index (1989) 11. Aufl.Merck & Co. Inc., Rahway New Jersey

    Google Scholar 

  5. BindraJS, Bindra R (1973) Prostaglandins. In: Jukker E (Hrsg.) Fortschritte in der Arzneimittelforschung, Bd. 17, Birkhäuser Verlag, Basel Stuttgart, S. 410–487; eidem (1977) Prostaglandin Synthesis, Academic Press, New-York

    Google Scholar 

  6. Pike JE, Lincoln FH, Schneider WP (1969) J Org Chem 34:3552–3557

    CAS  Google Scholar 

  7. Schneider WP, Murray HC (1973) J Org Chem 38:397–398

    PubMed  CAS  Google Scholar 

  8. Morozowich W, Douglas SL (1975) Prostaglandins 10:19–23

    PubMed  CAS  Google Scholar 

  9. Leovey EMK, Anderson NH (1975) J Amer Chem Soc 97:4148–4150

    CAS  Google Scholar 

  10. Lukacs G, Piriou F, Gero SD, Van Dorp D, Hagaman E, Wenkert E (1973) Tetrahedron Lett 515–518

    Google Scholar 

  11. Salmon JA, Flower RJ (1982) Methods in Enzymology 86:477–482

    PubMed  CAS  Google Scholar 

  12. Eick H (1985) Beitrag zur Analytik und Trennung von synthetischen Prostaglandinen und Begleitsubstanzen, Diplomarbeit, FB Pharmazie der Humboldt-Universität zu Berlin, S. 21

    Google Scholar 

  13. Rudzik R, Terragno A, Tacket R (1984) J Chromatogr 308:31–34

    Google Scholar 

  14. Hatsumi M, Kimata SI, Hirosawa K (1982) Ibid 253:271–274

    CAS  Google Scholar 

  15. Ikenoya S, Hiroshima O, Ohmae M, Kawabe K (1980) Chem Pharm Bull 28:2941–2945

    PubMed  CAS  Google Scholar 

Gb

  1. Oettel M (1982) Pharmakologie der Fortpflanzung. In: Bentz H (Hrsg.) Veterinärmedizinische Pharmakologie, Gustav Fischer Verlag, Jena

    Google Scholar 

  2. Standardinformationen für Krankenhausapotheker über Minprostin® der Fa. Upjohn, Oktober 1987

    Google Scholar 

  3. Forth W, Henschler D, Rummel W (Hrsg.) (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, Bibliographisches Institut & FA. Brockhaus, Mannheim Wien Zürich

    Google Scholar 

  4. Caldwell BV, Anderson GG, Hobbins JC, Speroff L (1972) F prostaglandin levels in women receiving PGF2α for therapeutic abortion. In: Bergström S, Green K, Samuelsson B (Hrsg.) Prostaglandin in Fertility Control, 2nd WHO-Symposium, Karolinska Institute, Stockholm, S. 182

    Google Scholar 

  5. Green K (1972) Analysis of prostaglandin F2α.-In: Bergström S, Green K, Samuelsson B (Hrsg.) Prostaglandin in Fertility Control, 2nd WHO-Symposium, Karolinska Institute, Stockholm, S. 182

    Google Scholar 

  6. Beazley JM (1972) J Obstet Gynaecol Br Commonw 79:800–807

    PubMed  CAS  Google Scholar 

  7. Nishibori T, Matsuoka Y (1971) Iyakuhin Kenkuyu 2:397

    Google Scholar 

  8. Green K, Hansson E, Samuelsson B (1967) Prog Biochem Pharmacol 3:85–90

    CAS  Google Scholar 

  9. Persaud TN (1978) Exp Pathol 15:46–53

    CAS  Google Scholar 

  10. Puri CP (1975) Contraception 12:697–702

    Google Scholar 

  11. Pace-Asciak C, Wolfe LS, Gilett PG, Kinch RA (1972) Prostaglandins 1:469–475

    PubMed  CAS  Google Scholar 

  12. Kindahl H, Ganström E (1983) Acta Obstet Gynecol Scand Suppl 113:15–22

    PubMed  CAS  Google Scholar 

  13. Raz A (1972) Biochem J 130:631–640

    PubMed  CAS  Google Scholar 

  14. Simmons KR, Moses SC, Perkins BL (1979) J Dairy Science 62:1.443–1.449

    Google Scholar 

  15. Grandström E, Samuelsson B (1971) J Biol Chem 246:7.470–7.475

    Google Scholar 

  16. Grandström E, Samuelsson B (1969) J Am Chem Soc 91:12–18

    Google Scholar 

  17. Grandström E (1972) Eur J Biochem 27:462–470

    Google Scholar 

  18. Brash AR (1976) Biochem Med 16:77–82

    PubMed  CAS  Google Scholar 

  19. Jose P (1976) Brit J Clin Pharmacol 3:342P

    CAS  Google Scholar 

  20. Samuelsson B (1971) Ann NY Acad Sci 180:138–142

    CAS  Google Scholar 

  21. Tagaki S (1976) Prostaglandins 12:565–573

    Google Scholar 

  22. Zahradnik HP (1977) Geburtsh Frauenheilk 37:493–500

    PubMed  CAS  Google Scholar 

  23. Corson SL (1977) Am J Obstet Gynecol 129:918–925

    PubMed  CAS  Google Scholar 

  24. Jacobs MM (1980) Obstetrics & Gynecology 55:665–672

    CAS  Google Scholar 

  25. Adrinopoulos GC (1983) Am J Obstet Gynecol 147:217–222

    Google Scholar 

  26. Smith ID, Temple DM, Shearman RP (1975) Prostaglandins 10:41–50

    PubMed  CAS  Google Scholar 

  27. Brash AR, Conolly ME (1978) Prostaglandins 15:983–987

    PubMed  CAS  Google Scholar 

  28. Weinstein L, Drögemüller W, Greer B (1976) Obstet & Gynecol 48:469–474

    CAS  Google Scholar 

  29. Shaala S, Khowessah M, El-Damarawy H (1977) Prostaglandins 14:523–530

    PubMed  CAS  Google Scholar 

  30. Laudanski T, Akerlund M (1980) Br J Obstet & Gynecol 87:132–140

    CAS  Google Scholar 

  31. Karim SMM, Sharma SD (1972) J Obstet Gynaecol Br Commonw 78:251–260

    Google Scholar 

OM

  1. Schrör K (1984) Prostaglandine und verwandte Verbindungen, Georg Thieme Verlag, Stuttgart New York, S.8

    Google Scholar 

  2. Corey EJ, Schaaf TK, Huber W, Koelliker U, Weinshenker NM (1970) J Amer Chem Soc 92:397–398

    CAS  Google Scholar 

  3. Buckingham J (Hrsg.) (1982) Dictionary of Organic Compounds, 5. Aufl., Chapman and Hall, New-York-London-Toronto, S. 1994

    Google Scholar 

  4. Gennaro AR (Hrsg.) (1990) Remington’s Pharmaceutical Sciences, 18. Aufl., Mack Publishing Company, Easton Penns., S. 944–945

    Google Scholar 

  5. Terragno A, Rydzik R, Terragno NA (1981) Prostaglandins 21:101–103

    PubMed  CAS  Google Scholar 

  6. Uekema K, Hirayama F, Yamasaki S, Otagiri M, Ikeda K (1977) Chem Lett S. 1389–1392

    Google Scholar 

  7. Uekema K, Hirayama F, Tanaka H, Takamatsu K (1978) Chem Pharm Bull 26:3779–3784

    Google Scholar 

  8. ChenSML, Schaub RE, Grudzinska V (1978) J Org Chem 43:3450–3454

    CAS  Google Scholar 

  9. NakamuraN, Kiyoshi S (1978) Tetrahedron Lett,S. 1549–1552

    Google Scholar 

  10. Lukacs G, Piriou F, Gero SD, van Dorp D, Hagaman E,Wenkert E (1973) ibid., S.515–518

    Google Scholar 

  11. Takeguchi C, Kohno E, Sih Ch J (1971) Biochemistry 10:2372–2373

    PubMed  CAS  Google Scholar 

  12. Eick H (1985) Beitrag zur Analytik und Trennung von synthetischen Prostaglandinen und Begleitsubstanzen, Diplomarbeit, FB Pharmazie der Humboldt-Universität zu Berlin

    Google Scholar 

  13. Siegenthaler C (1989) Pharm Acta Helv 64:345–347

    CAS  Google Scholar 

  14. Monkhouse DC, van Campen L, Aguiar AJ (1973) J Pharm Sci 62:576–580

    PubMed  CAS  Google Scholar 

Gb

  1. Forth W, Henschler D, Rummel W (Hrsg.) (1987) Allgemeine und spezielle Pharmakologie und Toxikologie, 5. Aufl., Bibliographisches Institut & F.A. Brockhaus, Mannheim Wien Zürich

    Google Scholar 

  2. Standardinformation für Krankenhausapotheker über Minprostin E2 der Fa. Upjohn, Oktober 1987

    Google Scholar 

  3. Raz A (1972) Biochem J 130:631–640

    PubMed  CAS  Google Scholar 

  4. Gordon D (1977) Prostaglandins 13:399–403

    PubMed  CAS  Google Scholar 

  5. Samuelsson B (1987) Ann NY Acad Sci 180:138–142

    Google Scholar 

  6. Hamberg M, Samuelsson B (1969) J Am Chem Soc 91:2.177

    PubMed  CAS  Google Scholar 

  7. Goeschen K (1984) Prostaglandins 28:209–215

    Google Scholar 

  8. Gordon-Wright AP, Elder MG (1979) Prostaglandins 18:153–159

    PubMed  CAS  Google Scholar 

  9. Reichel R, Husslein P, Göschen K (1985) Wiener klin Wschr 97:500–507

    CAS  Google Scholar 

  10. Husslein P, Reichel R, Goeschen K, Rasche M, Sinzinger H (1984) Prostaglandins 28:209–218

    PubMed  CAS  Google Scholar 

  11. Nishiburi T, Matsuoka Y, Matsumoto T (1974) Pharmacometrics 8:797–803

    Google Scholar 

  12. Nagata I, Furuya K, Imaizumi E, Seki K, Makimura N, Kato K (1988) Gynecol Obstet Invest 26:21–29

    PubMed  CAS  Google Scholar 

  13. Noah ML, De Coster JM, Frase TJ, Orr JD (1987) Acta Obstet Gynecol Scand 66:3–12

    PubMed  CAS  Google Scholar 

  14. Bung P, Baer S, Djahhaschahi D, Huch R, Huch A, Huber JF, Extermann P, Beguin F, Delaloye JF, Germond M, Bossart H, De Grandi P, Pfisterer A, Ehrsam A, Haller U (1986) Geburtsh u Frauenheilk 46:93–99

    CAS  Google Scholar 

  15. Goeschen K (1989) Am J Perinat 6:181–188

    CAS  Google Scholar 

  16. Rath W (1989) Gyne Aug:242–249

    Google Scholar 

  17. Hackett GA, Reginald P, Paintin DB (1989) Br J Obstet Gynaecol 96:1.432–1.439

    Google Scholar 

  18. High WB (1988) Bone 8:363–369

    Google Scholar 

OM

  1. Zemplen G, Bognar R (1943) Ber Dtsch Chem Ges 76:452

    Google Scholar 

  2. Lorette NB (1951) J Org Chem 16:930

    CAS  Google Scholar 

  3. Horowitz M (1956) J Org Chem 21:1184–1185

    CAS  Google Scholar 

  4. Briggs LH, Cambie RC, Holdgate RH, Seelye RN (1960) J Chem Soc 2:1955–1956

    Google Scholar 

  5. Nieto JL, Gutierrez AM (1986) Spectroscop Letters 19:427–434

    CAS  Google Scholar 

  6. Geiiman A (1962) Chemistry of Flavonoid Compounds, Pergamon Press, Oxford London New York Paris, S. 325

    Google Scholar 

  7. Neu R (1956) Z Anal Chem 151:328–332

    CAS  Google Scholar 

  8. Neu R (1957) Mikrochim Acta, 2. Heft:196

    Google Scholar 

  9. Casteel HW, Wender SH (1953) Anal Chem 25:508–509

    CAS  Google Scholar 

  10. Vande CK, Geiger H, Van Sumere CF (1982) J Chrom 240(l):81–94

    Google Scholar 

MA

  1. Duperay B (1982) J Proceedings of Int. Symp. on venous Disorders of lower limbs. Florence (Italy) March 1982

    Google Scholar 

  2. Heusser J, Osswald W (1977) Arch Pharmacol Toxicol III:33–40

    Google Scholar 

  3. Boudet C, Peyrin L (1986) Arch Int Pharmacodyn Ther 283:312–320

    PubMed  CAS  Google Scholar 

  4. Godfraind T (1988) Inter Angio 7 (Suppl.2):17–19

    CAS  Google Scholar 

  5. Casley-Smith JR, Casley-Smith RJ (1985) Agent Actions 17:14–20

    CAS  Google Scholar 

  6. Damon M, Flandre O, Michel F, Pedrix L, Labrid C, Crastes De Paulet A (1987) Arzneim Forsch 37:1149–1153

    CAS  Google Scholar 

  7. Michel F, Mecklein L, Rey R, Crastes de Paulet A (1985) In: Farkas L, Gabor M, Kallay F (Hrsg.) Flavonoids and Bioflavonoids, Elsevier Amsterdam S. 389–401

    Google Scholar 

  8. Vargaftig BB (1988) Inter Angio 7 (Suppl.2):7–9

    CAS  Google Scholar 

  9. Witte S (1988) Thromb Res 52:111–117

    PubMed  CAS  Google Scholar 

  10. Huget AI, Máñez S, Alcaraz J (1990) Z Naturforsch 45e:19–24

    Google Scholar 

  11. Lonchampt M, Guardiola B, Sicot N, Bertrand M, Perdrix L, Duhault J (1989) Arzneim Forsch 39:882–885

    CAS  Google Scholar 

  12. Mora A, Payá M, Rios JL, Alcaraz MJ (1990) Biochem Pharmacol 40:793–797

    PubMed  CAS  Google Scholar 

  13. Marescaux J, Maamer M, Trenque T, Evrard S, Mutter D, Furderer C (1987) Phlebologie 40:1043–1055

    PubMed  CAS  Google Scholar 

  14. Cospite M, Dominici A (1989) Inter Angio 8(Suppl.4):61–65

    CAS  Google Scholar 

  15. Muschietti B (1978) Schweiz Rundschau Med (Praxis) 67:125–128

    Google Scholar 

  16. Tajana H, Boccasanta P, Micheletto G, Orio A (1988) Min Med 79:387–390

    CAS  Google Scholar 

GA

  1. Hess K, Frahm H (1938) Chem Ber 71:2627–2636

    Google Scholar 

  2. Pouchert ChJ (1970) The Aldrich Library of Infrared Spectra

    Google Scholar 

  3. Pouchert ChJ, Campbell JR (1974) The Aldrich Library of NMR Spectra

    Google Scholar 

Et

  1. Lespagnol A, Cuingnet E (1960), Ann Pharm Fr 18:445

    PubMed  CAS  Google Scholar 

  2. Hutzinger O, Heacock RA (1969), Can J Chem 47:2003–2007

    CAS  Google Scholar 

  3. Cantin D, Alary J, Coer A (1975), Analysis 3:241–245

    CAS  Google Scholar 

Ba

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Rider TH (1930) J Am Chem Soc 52:1528–1530

    CAS  Google Scholar 

TR

  1. Mar 29, S. 1.215

    Google Scholar 

vB

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 557

    Google Scholar 

  2. Kuhnert-Brandstätter M, Geiler M, Wurian I (1982) Sci Pharm 50:324–331

    Google Scholar 

  3. Solomonova SG, Turkevich NM, Kurinaya NV (1973) Farm Zh (Kiev) 28:56–58, zit. nach CA 79:35.196b

    CAS  Google Scholar 

  4. Clarke EGC (1969) Isolation and Identification of Drugs, Vol. 1, The Pharmaceutical Press, London, S. 315

    Google Scholar 

  5. Daenens P, Van Boven M (1971) J Chromatogr 57:319–321

    PubMed  CAS  Google Scholar 

  6. Hunter K (1985) J Chromatogr 321:255–272

    PubMed  CAS  Google Scholar 

  7. Houglum JE, Larson RD, Neal RM (1989) J Chromatogr 481:458–460

    CAS  Google Scholar 

us

  1. Goeber B et al. (1972) Pharmazie 27:222,230–232

    CAS  Google Scholar 

  2. Dankowa X et al. (1951) Zh Obshsh Kim 21:570,571, engl. Ausgabe S. 631,632

    Google Scholar 

SH

  1. Schild HO (1947) Br J Pharmacol 2:191–206

    Google Scholar 

  2. von Schlichtegroll A (1957) Arzneim Forsch 7:237–252

    Google Scholar 

  3. Wells JH, Morris HC, Dragstedt CA (1946) Proc Soc expBiol(N.Y) 61:104–106

    CAS  Google Scholar 

  4. Winder CV, Daiser ME, Anderson MM, Glassco EM (1946) J Pharmacol Exp Ther 87:121–131

    PubMed  CAS  Google Scholar 

  5. Rekker RF, Timmerman H, Harms AF, Nauta WT (1971) Arzneim Forsch 21:688–961

    CAS  Google Scholar 

  6. Weidmann H, Petersen PV (1953) J Pharmacol Exp Ther 108:201–216

    PubMed  CAS  Google Scholar 

  7. Moscati RM, Moore GP (1990) Ann Emerg Med 19:12–25

    PubMed  CAS  Google Scholar 

  8. Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartseil SC (1992) Ann Emerg Med 21:237–242

    PubMed  CAS  Google Scholar 

  9. Packman EW, Ciccone PE, Wilson J, Masurat T (1991) Int J Clin Pharmacol Ther Toxicol 29:218–222

    PubMed  CAS  Google Scholar 

  10. Omote K, Namiki A, Iwasaki H, Ujike Y (1991) Can J Anaesth 38:210–212

    PubMed  CAS  Google Scholar 

  11. Tsavaris N, Zamanis N, Zinelis A, Tsoutsos E, Mylonakis N, Baccoyannis C, Valilis P, Sarafidou M, Kosmidis P (1991) J Pain Symptom Manag 6:461–465

    CAS  Google Scholar 

  12. Berman BA (1990) J Allergy Clin Immunol 86:1004–1008

    PubMed  CAS  Google Scholar 

  13. Gengo FM, Manning C (1990) J Allergy Clin Immunol 86:1034–1039

    PubMed  CAS  Google Scholar 

  14. Montgomery LC, Deuster PA (1992) Med Sci Sports Exerc 24:383–388

    PubMed  CAS  Google Scholar 

  15. Scavone JM, Luna BG, Harmatz JS, von Moltke L, Greenblatt DJ (1990) Biopharm Drug Dispos 11:185–189

    PubMed  CAS  Google Scholar 

  16. Simons KJ, Watson WT, Martin TJ, Chen XY, Simons FE (1990) J Clin Pharmacol (1990) 30:665–671

    CAS  Google Scholar 

  17. Mar 29, Diphenhydramine, S. 452–453

    Google Scholar 

  18. Glazko AJ, Dill WA, Young RM, Smith TC, Ogilrie RI (1974) Clin Pharmacol Ther 16:1066–1087

    PubMed  CAS  Google Scholar 

  19. Wagner JG (1977) J Pharmacokinet Biopharm 5:161–182

    PubMed  CAS  Google Scholar 

  20. Saxen I (1974) Lancet 1:407–408

    PubMed  CAS  Google Scholar 

  21. Editorial (1979) Br med J 1:459

    Google Scholar 

  22. Borkenstein M, Haidvogl M (1978) J Pediatr 92:167–168

    PubMed  CAS  Google Scholar 

sw

  1. Dibbern HW (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Verlag Editio Cantor Aulendorf

    Google Scholar 

  2. Andrews AC, Lyons TD, O’Brien TD (1962) J Chem Soc, 1776

    Google Scholar 

  3. de Roos AM, Recker RF, Nauta WT (1970) Arzneim Forsch 20:1763

    Google Scholar 

  4. Goeber B et al. (1972) Pharmazie 27:222,230–232

    CAS  Google Scholar 

  5. Knobloch E et al. (1954) Collect Czech Chem commun 19:976,980, zit. nach CA (1955) 49:2425e

    CAS  Google Scholar 

  6. Gruhzit OM, Fisken RA (1947) J Pharmacol Exp Ther 89:277

    Google Scholar 

SH

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 558–559

    Google Scholar 

  2. Janssen PAJ (4.8.1959) U.S.Patent 2898340, zit. nach CA (1960) 54:2367a

    Google Scholar 

  3. Stead AH, Gill R, Wright T, Gibbs JP, Moffat AC (1982) Analyst 107:1106–1168

    PubMed  CAS  Google Scholar 

  4. Jane I, Mc Kinnon A, Flanagan RJ (1985) J Chromatogr323(2):191–225

    PubMed  CAS  Google Scholar 

WP

  1. Awouters F, Niemegeers CJE, Janssen PAJ (1983) Ann Rev Pharmacol Toxicol 23:279–301

    CAS  Google Scholar 

  2. Bianchi C, Goi A (1977) Arzneim-Forsch 27:1.040–1.043

    Google Scholar 

  3. Niemegeers CJE, McGuire JL, Heykants J, Janssen PAJ (1979) J Pharmacol Exp Ther 210:327–333

    PubMed  CAS  Google Scholar 

  4. Rubens R, Verhaegen H, Brugmans J, Schuermans V (1972) Arzneim-Forsch 22:513–516

    Google Scholar 

  5. Dajani EZ, Roge EA, Bertermann RE (1975) Eur J Pharmacol 34:105–113

    PubMed  CAS  Google Scholar 

  6. Ylitalo P, Svinhufvud U, Anttila P, Laasonen L, Gothoni G (1975) Arzneim-Forsch 25:1.081–1.082

    Google Scholar 

  7. Valiulis E, Long JF (1973) Physiologist 16:475

    Google Scholar 

  8. Zavecz JH, Jackson TE, Limp GL, Yellin TO (1982) Eur J Pharmacol 78:375–377

    PubMed  CAS  Google Scholar 

  9. Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) (1990) Goodman and Gilman’s The pharmacological basis of therapeutics, 8. Aufl., Pergamon, New York, S.507

    Google Scholar 

  10. van Wijngaarden I, Soujdin W (1972) Arzneim-Forsch 22:513–516

    Google Scholar 

  11. Heykants J, Brugmans J, Verhaegen H (1972) Arzneim-Forsch 22:529–531

    CAS  Google Scholar 

  12. Karim A, Ranney RE, Evensen KL, Clark ML (1972) Clin Pharmacol Ther 13:407–419

    PubMed  CAS  Google Scholar 

  13. Karim A, Garden G, Trager W (1971) J Pharmacol Exp Ther 177:546–555

    PubMed  CAS  Google Scholar 

  14. Mar 29, S. 1.087

    Google Scholar 

  15. Harford WV, Krejs GJ, Santa Ana CA, Fordtran JS (1980) Gastroenterol 78:440–443

    CAS  Google Scholar 

  16. Palmer KR, Corbett CL, Holdsworth CD (1980) Gastroenterol 79:1.272–1.275

    Google Scholar 

  17. Glatt MM, Lewis DM, Wilson TS (1973) Br J Addict 65:237–243

    Google Scholar 

  18. Ammon HPT (Hrsg.) (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 386–388

    Google Scholar 

  19. Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) (1990) Goodman and Gilman’s The pharmacological basis of therapeutics, 8. Aufl., Pergamon, New York, S. 925

    Google Scholar 

  20. Curtis JA, Goel KM (1979) Arch Dis Child 54:222–225

    PubMed  CAS  Google Scholar 

  21. Ahmad S (1980) JAMA 243:1.036

    Google Scholar 

  22. Ammon HPT (Hrsg.) (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 575

    Google Scholar 

  23. Ammon HPT (Hrsg.) (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 91

    Google Scholar 

  24. McGuire JL, Awouters F, Niemegeers CJE (1978) Arch Int Pharmacodyn Ther 236:51–59

    PubMed  CAS  Google Scholar 

  25. Wasserman GS, Green VA, Wise GW (1975) Am Farn Physician 11:93–97

    CAS  Google Scholar 

  26. Anonymus (Leading Article) (1973) Br Med J II:678–679

    Google Scholar 

  27. Figiel LS; Figiel SJ (1973) Am J Gastroenterol 59:267–270

    PubMed  CAS  Google Scholar 

  28. Rubinstein JS (1979) West J Med 131:148–150

    PubMed  CAS  Google Scholar 

PK

  1. Mills III T, Roberson JC (1987) Instrumental Data for Drug Analysis 2. Aufl., Elsevier Science Publishing Co, New York, S. 762–763

    Google Scholar 

  2. Jalal IM, Sa’sa SI, Abusaleh AH, Khalil H (1985) Anal Lett 18:2551–2568

    CAS  Google Scholar 

WP

  1. Schuler WA (1951) DBP 934890 (Promonta), zit. nach CA (1958) 52:20065I

    Google Scholar 

  2. Beil Erg.Werk 3/4, Bd.21, Teil 1,S.42III/IV21/l,S.42

    Google Scholar 

  3. Testa B, Murset-Rossetti L (1978) Helv Chim Acta 61:2530–2537

    CAS  Google Scholar 

MP

  1. Lung MA, Wang JC (1987) Rhinology 25:95–100

    PubMed  CAS  Google Scholar 

  2. Mattes J (1979) Psychopharmacol Bull 15:5–6

    PubMed  CAS  Google Scholar 

  3. Mar 29, Diphenylpyraline, S.454

    Google Scholar 

EH

  1. Siek TJ, (1974) J Forensic Sci 19:193–214

    CAS  Google Scholar 

  2. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, The Pharmaceutical Press, London

    Google Scholar 

MP

  1. Mar 29, S. 1.459

    Google Scholar 

vB

  1. Barrelet C, Saner H, Surber W, Ursprung R, Wagner Jauregg T (1959) Ind Chim Beige Suppl 2:428–431, zit. nach CA (1960) 54:3758i

    CAS  Google Scholar 

  2. Imai Z, Natori M, Saito K, Miyagi Y, Shinohara K (1966) Japan 71006:417, zit. nach CA (1971) 75:63236a

    Google Scholar 

  3. Daldrup T, Susanto F, Michalke P (1981) Fresenius Z Anal Chem 308:413–427

    CAS  Google Scholar 

  4. Attali B, Vogel Z (1990) Brain Res 517(1–2): 182–188

    PubMed  CAS  Google Scholar 

  5. Chesis PL, Griffeth LK, Mathias CJ, Welch MJ (1990) J Nucl Med 31(2):192–201

    PubMed  CAS  Google Scholar 

  6. Cunningham VJ, Hume SP, Price GR, Ahier RG, Cremer JE, Jones AK (1991) J Cereb Blood Flow Metab ll(l):1–9

    Google Scholar 

  7. Dissanayake VU, Hughes J, Hunter JC (1991) Mol Pharmacol 40:93–100

    PubMed  CAS  Google Scholar 

  8. Herman BH, Holtzman SG (1984) Life Sci 34(1):1–12

    PubMed  CAS  Google Scholar 

  9. Jones AK, Luthra SK, Maziere B, Pike VW, Loc’h C, Crouzel C, Syrota A, Jones T (1988) J Neurosci Methods 23 (2): 121–129

    PubMed  CAS  Google Scholar 

  10. Jones AK, Qi LY, Fujirawa T, Luthra SK, Ashburner J, Bloomfield P, Cunningham VJ, Itoh M, Fukuda H, Jones T (1991) Neurosci Lett 126:25–28

    PubMed  CAS  Google Scholar 

  11. Leander JD, Hynes MD (1983) Eur J Pharmacol 87(4):481–484

    PubMed  CAS  Google Scholar 

  12. Sadzot B, Mayberg HS, Frost JJ (1990) Neurophysiol Clin20(5):323–334

    PubMed  CAS  Google Scholar 

  13. Skorupska M, Langwinski R (1989) Pol J Pharmacol Pharm41(5):401–411

    PubMed  CAS  Google Scholar 

KG

  1. US 2575344 (1951), CA (1952) 46:1722

    Google Scholar 

  2. Roth HJ (1959) Arch Pharm 292:234–8

    CAS  Google Scholar 

  3. Holy A (1978) Cool Czechoslov Chem Commun 43:2054–61

    CAS  Google Scholar 

  4. Bram G, Bensaid Y, Combet-Farnoux C, Galons H, Miocque M (1985) Pharmazie 41:431

    Google Scholar 

  5. Holy A, Vanecek M (1979) Coll Czechoslov Chem Commun 44:2550–5

    CAS  Google Scholar 

  6. Brandstätter M, Grimm H (1956) Mikrochim Acta 1175–82

    Google Scholar 

  7. In Dibbern HW (Hrsg) (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf

    Google Scholar 

  8. In: Moffat AC (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press London

    Google Scholar 

  9. In: Pouchert CJ (Hrsg) The Aldrich Library of FT-IR Spectra, Aldrich Chemical Co., Inc., Milwaukee 1989, Bd2S.711

    Google Scholar 

  10. In: Hansch C, Sammes PG, Taylor JB (Hrsg) Comprehensive Medicinal Chemistry, Pergamon Press Oxford 1990, Bd. 6 S. 477

    Google Scholar 

  11. Paterson N (1982) J Chromatogr. 232:450–5

    PubMed  CAS  Google Scholar 

  12. Aldrich-Chemie GmbH, Katalog/Handbuch 1990–91

    Google Scholar 

  13. Simons KJ, Simons FER (1979) J Pharm Sci 68:1327–8

    PubMed  CAS  Google Scholar 

NP

  1. Maney RV, Jones JW, Gross EG, Korns HM (1946) J Am Pharm Ass 35:266–272

    PubMed  CAS  Google Scholar 

  2. Boardman LE (1980) Br J Pharmacol 70:120p–121p

    CAS  Google Scholar 

  3. Kukovetz WR, Pöch G, Holzmann S (1983) Arzneim Forsch 33:1450–1454

    CAS  Google Scholar 

  4. Levine ER (1965) Am Allergy 23:403–413

    CAS  Google Scholar 

  5. Simons FER, Biermann CW, Sprenkle AC, Simons KJ (1975) Pediadrics 56 (Suppl.):916–918

    CAS  Google Scholar 

  6. Furukawa CT, Shapiro GG, Weliky I, Pierson WE, Biermann CW (1982) J Allergy Clin Immunol 69:136

    Google Scholar 

  7. Stablein JJ, Samaan SS, Bukantz SC, Lockey RF (1983) Eur J Clin Pharmacol 25:281–283

    PubMed  CAS  Google Scholar 

SZ/KC

  1. Holy A, Vanecek M (1979) Coll Czechoslov Chem Commun 44:2550–2555

    CAS  Google Scholar 

Ba

  1. Klosa J (1955) Arch Pharm 288:301–303

    CAS  Google Scholar 

  2. DE 924085 (1953), zit. nach CA (1958) 52:2101

    Google Scholar 

Ba

  1. Kráčmar J, KráčmarovaJ, Bokovikova TN, Čičiro VE, Néstérova GA, Suranova AV, Trius NV (1989) Pharmazie 44(11):768–771

    Google Scholar 

  2. Moffat AC (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S.562–563

    Google Scholar 

  3. ImaiK,InukaiN,IshidaT, OzasaT,KawaharaS, Murakami M (1976) Yakugaku Zasshi 96(5):593–599, zit. nach CA (1976) 85:108.603t

    Google Scholar 

  4. Zoest AR, Wanwimolruk S, Watson JE, Hung CT (1991) J Liq Chromatogr 14:1967–1975

    CAS  Google Scholar 

  5. Tuncel M, Yazan Y, Dogrukol D, Atkosar Z (1991) Anal Lett 24:1837–1846

    CAS  Google Scholar 

  6. BararyMH, El-Sayed MAH, Abdel-Hay MH (1989) Anal Lett 22:1643–1664

    CAS  Google Scholar 

  7. Kigasawa K, Shimizu H, Hayashida S, Ohkubo K (1984) Yakugaku Zasshi 104:1191–1197, zit. nach CA (1984) 102:137.650f

    PubMed  CAS  Google Scholar 

WP

  1. Fitzgerald GA (1987) N Engl J Med 316:1.247–1.257

    Google Scholar 

  2. Harker LA, Kadatz RA (1983) Thromb Res Suppl 4:39–46

    PubMed  CAS  Google Scholar 

  3. Rivey MP, Alexander MR, Taylor JM (1984) Drug Intell Clin Pharm 18:869–880

    PubMed  CAS  Google Scholar 

  4. Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG (1990) Circulation 82:1–7

    PubMed  CAS  Google Scholar 

  5. Luthje J (1989) Blut 59:367–374

    PubMed  CAS  Google Scholar 

  6. Young JD, Jarvis SM (1983) Biosci Rep 3:309–322

    PubMed  CAS  Google Scholar 

  7. Chesebro JH, Adams PVC,FusterV (1986) J Am Coll Cardiol 8(Suppl. B):41B–56B

    PubMed  CAS  Google Scholar 

  8. Frishman WH, Miller KP (1986) Curr Probl Cardiol 11:69–136

    PubMed  CAS  Google Scholar 

  9. Weiss HJ (1980) Circulation 62 (6 Pt 2):V41–V43

    PubMed  CAS  Google Scholar 

  10. Rowe GG, Folts JD (1990) Clin Cardiol 13:165–170

    PubMed  CAS  Google Scholar 

  11. Iskandrian AS, Heo J, Askenase A, Segal BL, Auerbach N(1988) Am Heart J 115:432–443

    PubMed  CAS  Google Scholar 

  12. Nienaber CA, Spielmann RP (1988) Dtsch Med Wochenschr 113:1.029–1.033

    Google Scholar 

  13. Younis LT, Chaitman BR (1990) Clin Cardiol 13:3–10

    PubMed  CAS  Google Scholar 

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London, S. 565–566

    Google Scholar 

  2. Jane I, Mc Kinnon A, Flanagan RJ (1985) J Chromatogr 323(2):191–225

    PubMed  CAS  Google Scholar 

  3. PatelRB, Gandhi TP, Patel VC, Patel SK, Gilbert RN 1983 Indian J Pharm Sci 45(3):129–130

    CAS  Google Scholar 

  4. Vasiliades JW (1979) Clin Chem 25:1900–1904

    PubMed  CAS  Google Scholar 

WP

  1. Vaughan Williams EM (1975) Pharmac Ther B1:115–138

    Google Scholar 

  2. Kus T, Sasyniuk BI (1975) J Pharmacokinet Biopharm 4:231–242

    Google Scholar 

  3. Birkhead JS, Vaughan Williams EM (1977) Br Heart J 39:657–660

    PubMed  CAS  Google Scholar 

  4. Baines MW, Davies JE, Kellett DN, Munt PL (1976) J Int Med Res 4 (Suppl 1):5–7

    PubMed  CAS  Google Scholar 

  5. Böcker K, Köhler E, Seipel L, Loogen F (1982) Z Kardiol 71:839–845

    PubMed  Google Scholar 

  6. Bryson SM, Whiting B, Lawrence JR (1978) Br J Clin Pharmacol 6:409–419

    PubMed  CAS  Google Scholar 

  7. Hinderling PH, Garrett ER (1976) J Pharmacokin Biopharmac 4:199–230

    CAS  Google Scholar 

  8. Brogden RN, Todd PA (1987) Drugs 34:151–187

    PubMed  CAS  Google Scholar 

  9. Norris RLG, Ahokas JT, Ravenscroft PJ, Henry M (1984) J Pharm Sci 73:824–826

    PubMed  CAS  Google Scholar 

  10. Bonde J, Graudal NA, Pedersen LE, Balslov S, Angelo HR, Svendsen TL, Kampmann JP (1986) Eur J Clin Pharmacol 31:73–77

    PubMed  CAS  Google Scholar 

  11. Karim A (1975) Angiology 26:85–98

    PubMed  CAS  Google Scholar 

  12. Burk M, Peters U (1983) Clin Pharmacol Ther 34:331–340

    PubMed  CAS  Google Scholar 

  13. Ilett KF, Madsen BW, Woods JD (1979) Clin Pharmacol Ther 34:331–336

    Google Scholar 

  14. Landmark K, Bredesen JE, Thaulow E, Simonsen S, Amlie JP (1981) Eur J Clin Pharmacol 19:187–192

    PubMed  CAS  Google Scholar 

  15. Baumann JL, Gallastegui J, Strasberg B, Swiryn S, Hoff J, Welch WJ, Bauernfeind RA (1986) Am Heart J 111:654–660

    Google Scholar 

  16. Smith WS (1978) Herz 3:399–406

    Google Scholar 

  17. Kumana CR, Rambihar VS, Tanser PH, Cairns JA, Gupta RN, Wildeman RA, Johnston M, Johnson AL, Gent M (1982) Br J Clin Pharmacol 14:519–527

    PubMed  CAS  Google Scholar 

  18. Porterfield JG, Antman EM, Lown B (1980) N Engl J Med 303:584

    PubMed  CAS  Google Scholar 

  19. Podrid PJ, Schoeneberger A, Lown B (1980) New Engl J Med 303:614–617

    Google Scholar 

  20. Riccioni N, Castiglioni M, Bartolomei C (1983) Am Heart J 105:870–871

    PubMed  CAS  Google Scholar 

  21. Nicholson WJ, Martin CE, Gracey JG, Knoch HR (1979) Am J Cardiol 43:1.053–1.055

    Google Scholar 

  22. Camm J, Ward D, Spurrell RAJ (1979) Br J Clin Pharmacol 8:441–449

    PubMed  CAS  Google Scholar 

  23. Desai JM, Scheinman MM, Hirschfeld D, Gonzales S, Peters RW (1981) Chest 79:545–551

    PubMed  CAS  Google Scholar 

Kg/gl

  1. Dibbern HW (1991) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf, S. 1438

    Google Scholar 

  2. Harvey CS, Withrow CD (1990) Cardiovascular Drugs. In: Remington’s Pharmaceutical Sciences, 18. Aufl., Mack Publishing Company, Easton Pennsylvania, S. 849

    Google Scholar 

WP

  1. Miller KW, Paton WDM, Smith EB, Smith RA (1972) Anesthesiol 36:339–351

    CAS  Google Scholar 

  2. Gillman MA (1986) Life Sci 39:1.209–1.221

    Google Scholar 

  3. Gillman MA (1986) Am J Med 81:97–102

    PubMed  CAS  Google Scholar 

  4. Koblin DD (1990) Semin Surg Oncol 6:141–147

    PubMed  CAS  Google Scholar 

  5. Yagiela JA (1991) Anesth Progr 38:1–11

    CAS  Google Scholar 

  6. Ruprecht J, Erdmann W, Dzoljic M, van Stolk MA (1989) Anaesthesiol Reanim 14:251–259

    Google Scholar 

  7. Yasuda N, Lockhart SH, Eger EI, Weiskopf RB, Johnson BH, Freire BA, Fassoulaki A (1991) Anesthesiol. 74:489–498

    CAS  Google Scholar 

  8. Smiley RM (1992) Anesth Anaig 75:Suppl 4, S38–S44

    CAS  Google Scholar 

  9. Koren G, Sloan I (1985) Res Commun Chem Pathol Pharmacol 49:95–108

    PubMed  CAS  Google Scholar 

  10. Brodsky JB, Cohen EN (1986) Med Toxicol 1:362–374

    PubMed  CAS  Google Scholar 

  11. Meulenbelt J, Sangster B (1990) Neth J Med 37:132–138

    PubMed  CAS  Google Scholar 

  12. Schumann D (1990) Int Nurs Rev 37:214–217

    PubMed  CAS  Google Scholar 

  13. Aldridge LM, Tunstall ME (1986) Birt J Anaesth 58:1.348–1.356

    Google Scholar 

  14. Johnson RA (1979) Practitioner 222:681–683

    PubMed  CAS  Google Scholar 

  15. Ermens AA, Schoester M, Spijker LJ, Lindemans J, Abels J (1989) Cancer Res 49:6.337–6.341

    Google Scholar 

vB

  1. Schmid O (1957) US 2789981, zit. nach CA (1958) 52:2090b

    Google Scholar 

  2. Kuhnert-Brandstätter M, Kofier A, Kramer G (1974) Sci Pharm 42:150–163

    Google Scholar 

  3. Kracmar J, Kracmarova J, Stejskal Z (1987) Pharmazie 42:18–22

    PubMed  CAS  Google Scholar 

  4. Daltrup T, Michalke P, Boehme W (1982) Chromatogr Newsl 10:1–7

    Google Scholar 

  5. Abdelkader MA, Taha AM, Abdelfattah S (1980) Pharmazie 35:30–32

    CAS  Google Scholar 

  6. Dessouky YM, Gad el Rub LN (1980) Pharm Weekbl Sci Ed 2:153–156

    CAS  Google Scholar 

  7. Tokuji S, Yuichi T (1970) Yakugaku Zasshi 90:762–770, zit. nach CA (1970) 73:592600v

    Google Scholar 

  8. Goldstein A (1944) J Gen Physiol 27:529–580

    PubMed  CAS  Google Scholar 

  9. Grob D (1958) J Chron Dis 8:536–566

    PubMed  CAS  Google Scholar 

  10. Grob D (1963) Therapy of myasthenia gravis. In: Koelle GB (Hrsg.) Handbuch der experimentellen Pharmakologie. Ergänzungswerk XV, Springer, Berlin Göttingen Heidelberg, S. 1028–1050

    Google Scholar 

  11. Herzfeld E, Kraupp O, Pateisky K, Stumpf C (1957) Wien Klin Wschr 69:245–248

    PubMed  CAS  Google Scholar 

  12. Eyirik K, Taniguchi H, Ishihara K, Hara Y, Baba S (1990) Diabetes Res Clin Pract 8:193–199

    Google Scholar 

  13. Hampf G, Bowsher D, Nurmikko T (1989) Anesth Prog 36:58–62

    PubMed  CAS  Google Scholar 

  14. Yamaba H, Yasue H, Okumura K, Ogawa H, Obata K, Oshima S (1990) Am Heart J 120:211–213

    Google Scholar 

GA

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, 2nd Ed., The Pharmaceutical Press, London

    Google Scholar 

  2. Gupta VD (1981) Am J Hosp Pharm 38:363–364

    PubMed  Google Scholar 

  3. Agarwal RP, McPherson R, Phillips M (1983) Res Commun Chem Pathol Pharmacol 42:293–310

    PubMed  CAS  Google Scholar 

LA

  1. Kitson TM (1977) J Stud Alcohol 38:96–113

    PubMed  CAS  Google Scholar 

  2. Sauter AM, Boss D, von Wartburg J-P (1977) J Stud Alcohol 38:1.680–1.695

    Google Scholar 

  3. Anonym (1991) Disulfiram. In: Henschler D (Hrsg.) Gesundheitsschädliche Arbeitsstoffe, VCH Verlagsgesellschaft Weinheim, 1.-17. Lieferung, S. 1–11

    Google Scholar 

  4. Jacobsen E (1967) Med Welt 18(N.F.):2.169–2.173

    Google Scholar 

  5. Brien JF, Loomis CW (1983) Drug Metab Rev 14:113–126

    PubMed  CAS  Google Scholar 

  6. Kwentus J, Major LF (1979) J Stud Alcohol 40:428–446

    PubMed  CAS  Google Scholar 

  7. Jacobsen E (1967) Med Welt 18(N.F.):2.230–2.234

    Google Scholar 

  8. Deutsche Forschungsgemeinschaft (1992) MAK-und BAT-Werte-Liste 1992, Maximale Arbeitsplatzkonzentrationen und Biologische Arbeitsstofftoleranzwerte, Mitteilung 28 der Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, VCH Verlagsgesellschaft, Weinheim, S. 42

    Google Scholar 

Fk

  1. Klem EB (1978) J Invest Dermatol 70:27–32

    PubMed  CAS  Google Scholar 

  2. Reichert U, Jaques Y, Grangeret M, Schmidt R (1985) J Invest Dermatol 84:130–134

    PubMed  CAS  Google Scholar 

  3. Jaques Y, Reichert U (1981) Brit J Dermatol 105 (Suppl20):45–48

    Google Scholar 

  4. Fisher LB, Maibach HI (1975) J Invest Dermatol 64:338–341

    PubMed  CAS  Google Scholar 

  5. Fuchs J, Zimmer G, Wölbing RH, Miklbradt R (1986) Arch Dermatol Res 279:59–65

    PubMed  CAS  Google Scholar 

  6. Morlière P, Dubertret L, Sae Melo T, Salet C, Fosse M, Santus R (1985) Brit J Dermatol 112:509–515

    Google Scholar 

  7. Swanbeck G, Lindquist P (1972) Acta Derm Venerol 52:94–98

    Google Scholar 

  8. Morlière P, Dubertret L, Sae Melo T, Salet T, Santus R (1983) J Invest Dermatol 80:350

    Google Scholar 

  9. Steigleder KG, Schumann H, Lennartz KJ (1973) Arch Derm Forsch 246:231–235

    CAS  Google Scholar 

  10. Schäfer H, Schalla W, Shroot B (1981) Zbl Haut-Geschl Krankh 146:273–282

    Google Scholar 

  11. Schalla W, Bauer E, Schaefer H (1981) Brit J Dermatol 105(Suppl20):104–108

    CAS  Google Scholar 

  12. Selim MM, Goldberg LH, Schaefer H, Bishop SC, Farber EM (1981) Brit J Dermatol 105 (Suppl 20):101–103

    CAS  Google Scholar 

  13. Shroot B, Schaefer H (1989) Anthralin. In: Greaves MW, Shuster S (Eds.) Pharmacology of the skin II, Heffter-Heubner Hdbch exper Pharmak 87/II, Springer, Berlin Heidelberg New York

    Google Scholar 

  14. Kammerau B, Zesch A, Schaefer H (1975) J Invest Dermatol 64:145–149

    PubMed  CAS  Google Scholar 

  15. Krebs A, Schaltegger H, Schaltegger A (1981) Brit J Dermatol 105 (Suppl 20):6–11

    CAS  Google Scholar 

  16. Farber EM, Nall L (1984) Drugs 28:324–346

    PubMed  CAS  Google Scholar 

  17. Ippen H (1981) Brit J Dermatol 105 (Suppl 20):72–75

    CAS  Google Scholar 

  18. Schaefer H, Farber EM, Goldberg L, Schalla W (1980) Brit J Dermatol 102:571–573

    CAS  Google Scholar 

  19. Runne U, Kunze J (1982) Brit J Dermatol 106:135–140

    CAS  Google Scholar 

  20. Ingram JT (1953) Brit Med J 2:591

    PubMed  CAS  Google Scholar 

  21. Schauder S, Mahrle G (1982) Hautarzt 33:206–209

    PubMed  CAS  Google Scholar 

  22. Gay MW, Moore WJ, Morgan JM, Montes LF (1972) Arch Dermatol 105:213–215

    PubMed  CAS  Google Scholar 

  23. Lawlor F, Hindson C (1982) Contact Dermatits 8:137–138

    CAS  Google Scholar 

  24. Mar 29, S. 919–920

    Google Scholar 

  25. Green PG (1985) Brit J Dermatol 113 (Suppl 29):26

    Google Scholar 

Gs

  1. Sycheva TP, Savitskaya NV, Shchukina MN (1953) Sbornik Statei Obshchei Khim Akad Nauk S.S.S.R 1:568–71, zit. nach CA (1955) 49:955c

    CAS  Google Scholar 

  2. Tashika Y, Nitta Y, Yomoda J (1954) J Pharm Soc Japan 74:1193–1195

    CAS  Google Scholar 

  3. Dunstan S, Henbest HB (1957) J Chem Soc 4:4905–4908

    Google Scholar 

  4. Laboratoires Lumiere and Institut Merieux, Fr. M 2587 (C1.A 61k,C07c) 1964, Appl. 1963, zit. nach CA (1965) 62:489f

    Google Scholar 

  5. Singer GM, Lijinsky W, Rainey WT (1975) Org Mass Spectrom 10:473–479

    CAS  Google Scholar 

MA

  1. Ruigh WL, Major RT (1931) J Am Chem Soc 53:2662–2668

    CAS  Google Scholar 

  2. Clague ADH, Danti A (1967) J Mol Spectroscopy 22:371–382

    CAS  Google Scholar 

  3. Hull LA (1978) J Org Chem 43:2776–2780

    Google Scholar 

  4. Martin RW (1949) Anal Chem 21:921–922

    CAS  Google Scholar 

EK

  1. Mar 29, S. 1.127

    Google Scholar 

vB

  1. Barany G, Schroll AL, Mott AW, Halsrud DA (1983) J Org Chem 48:4750–4761

    CAS  Google Scholar 

  2. Beil Hauptwerk Bd. 3, S.215; Beil Erg. Werk 1, Bd. 3, Teil 4, S.85 Beil Erg. Werk 2, Bd. 3, Teil 4, S. 154 Beil Erg. Werk 3, Bd.3, Teil 1, S.349 Beil Erg. Werk 4, Bd. 3, Teil 1,S. 416

    Google Scholar 

PA

  1. Morren HG (1958) Belg Pat 566958, zit. nach CA (1960)54:594d

    Google Scholar 

  2. Clarke’s Isolation and Identification of Drugs, (1986) The Pharmaceutical Press, London

    Google Scholar 

  3. Ebel S (1977) Handbuch der Arzneimittel-Analytik, Verlag Chemie, Weinheim

    Google Scholar 

  4. Kreyenbühl B, Joshi RK, Perlia X (1979) Pharm Acta Helv 54:197–205

    Google Scholar 

  5. Eigene Messung

    Google Scholar 

  6. Musumarra G, Scarlata G, Cirma G, Romano G, Palazzo S, Clementi S, Giulietti G (1985) J Chromatogr 350:151–168

    PubMed  CAS  Google Scholar 

MP

  1. Larsson S, Hagerdal M, Lundberg D (1988) Acta Anaesthesiol Scand 32:131–134

    PubMed  CAS  Google Scholar 

  2. Kivalo I, Rosenberg P (1976) Ann Chir Gynaecol 65:28–29

    Google Scholar 

  3. Berg S, Dehlin O, Falkheden T, Gatzinska R, Nordquist P (1977) Scand J Soc Med Suppl 14:85–96

    PubMed  CAS  Google Scholar 

  4. Sorbe B, Hallen C, Skare NG, Underskog I (1989) Radiother Oncol 15:161–167

    PubMed  CAS  Google Scholar 

  5. Goransson AM (1979) Scand J Gastroenterol 14:961–967

    PubMed  CAS  Google Scholar 

  6. Westergren I, Johansson BB (1991) Acta Neurochir Wien 113:171–175

    PubMed  CAS  Google Scholar 

  7. Liedholm J, Liden A, Kroon L, Melander A, Wahlin-Boll E (1985) Drug Nutr Interact 3:87–92

    PubMed  CAS  Google Scholar 

  8. Poulsen J (1981) Acta Derm Vernereol Stockh 61:85–88

    CAS  Google Scholar 

EH

  1. Tuttle R R, Mills J (1973) French Patent 2, 182, 947; Ger Offen 2, 317, 710; (1976) U S Patent 2.987, 200, zit. nach CA (1977) 86:72167

    Google Scholar 

Gb

  1. Goldberg LT, Hsieh YY, Resnekov L (1977) Prog Cardiovasc Dis 19:327–340

    PubMed  CAS  Google Scholar 

  2. Lipman J, Plit M (1984) S afr Med J 65:506–509

    PubMed  CAS  Google Scholar 

  3. Majerus TC, Dasta JF, Mauman JL, Danzinger LH, Ruffolo RRjr (1989) Pharmacotherapy 9:245–259

    PubMed  CAS  Google Scholar 

  4. Rude RE (1983) Adv Shock Res 10:35–49

    PubMed  CAS  Google Scholar 

  5. Sonnenblick EH, Fristman WH, LeJemtal TH (1979) N Engl J Med 300:17–22

    PubMed  CAS  Google Scholar 

  6. Adams HR (1984) J Am Vet Assoc 185:966–974

    CAS  Google Scholar 

  7. Ruffolo RR jr (1987) Am J Sci 249:244–248

    Google Scholar 

  8. Sharp DN (1984) Methods Fin Exp Clin Pharmacol 6:215–218

    Google Scholar 

  9. Ruffolo RR, Kopia GA (1986) Am J Med 80:67–72

    PubMed  Google Scholar 

  10. Colucci WS (1990) Circulation 82(Suppl.): 144–151

    Google Scholar 

  11. Driscoll DJ (1987) Clin Perinatol 14:931–949

    PubMed  CAS  Google Scholar 

  12. Andersson KE (1986) Acta Med Scand (Suppl.)707:65–73

    CAS  Google Scholar 

  13. Dixon DW, Loeb HS, Gunnar RM (1979) Herz 4:385–396

    PubMed  CAS  Google Scholar 

  14. Bhatt-Mehta V, Nahata MC (1989) Pharmacotherapy 9:303–314

    PubMed  CAS  Google Scholar 

  15. Mauro VF, Mauro LS (1986) Drug Intell Clin Pharm 20:919–924

    PubMed  CAS  Google Scholar 

  16. Thomas LR, Watson D, Marshall LE (1987) Pharmacotherapy 7:47–53

    PubMed  CAS  Google Scholar 

  1. Moffat AC, Jackson JV, Moss MS, Widdop B (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London S. 568–569

    Google Scholar 

  2. Mills III T, Roberson JC (1987) Instrumental Data for Drug Analysis, 2. Aufl., Elsevier, New York Amsterdam London, S. 780–781

    Google Scholar 

  3. Hardee GE, Lai JW (1983) Analyt Lett (Part B) 16:69–75

    CAS  Google Scholar 

Gb

  1. Handbook of Pharmaceutical Excipients (1986) American Pharmaceutical Association, Washington, USA, S. 106–107

    Google Scholar 

BK

  1. Gilman AG, Rall TW, Nies AS, Taylor P (1990) Goodman and Gilman’s The pharmacogical basis of therapeutics, 8. Aufl., Pergamon, New York, S. 922

    Google Scholar 

  2. Mar 29, S. 1088

    Google Scholar 

  3. Tedesco FJ (1985) Am J Gastroenterol 80:303–309

    PubMed  CAS  Google Scholar 

  4. Chapman RW, Sillery J, Fontana DD, Matthys C, Saunders DR (1985) Gastroenterology 89:489–493

    PubMed  CAS  Google Scholar 

  5. Goodman J, Pang J, Bessmann AN (1976) J Chron Dis 29:59–63

    PubMed  CAS  Google Scholar 

  6. Mar 28, S. 1441

    Google Scholar 

  7. Lish PM (1961) Gastroenterology 41:580–584

    PubMed  CAS  Google Scholar 

  8. Gaginella TS, Stewart JJ, Gullikson GW, Olsen WA, Bass P (1975) Life Sci 16:1595–1606

    PubMed  CAS  Google Scholar 

  9. Bretagne JF, Vidon N, L’Hirondel CH, Bernier JJ (1981) Gut 22:264–269

    PubMed  CAS  Google Scholar 

  10. Moriarty KJ, Kelly MJ, Beetham R, Clark ML (1985) Gut 26:1008–1013

    PubMed  CAS  Google Scholar 

  11. Saunders DR, Sillery J, Rachmilewitz D (1975) Gastroenterology 69:380–386

    PubMed  CAS  Google Scholar 

  12. Beubler E, Juan H (1979) J Pharm Pharmacol 31:681–685

    PubMed  CAS  Google Scholar 

  13. Nell G, Rummel W (1984) Action mechanisms of secretagogue drugs. In: Handb Exp Pharmacol 70/II Csaky TZ (Hrsg.), Springer, Berlin, S. 482–487

    Google Scholar 

  14. Rachmilewitz D, Karmeli F, Okon E (1981) Isr J Med Sci 17:28–35

    PubMed  CAS  Google Scholar 

  15. Donowitz M, Binder HJ (1975) Gastroenterology 69:941–950

    PubMed  CAS  Google Scholar 

  16. SimonB,KatherH(1980) Eur J ClinInvest 10:231–234

    CAS  Google Scholar 

  17. Gullikson GW, Cline WS, Lorenzsonn V, Benz L, Olsen WA, Bass P (1977) Gastroenterology 73:501–511

    PubMed  CAS  Google Scholar 

  18. Gaginella TS, Lewis JC, Phillips SF (1977) Am J Dig Dis 22:781–790

    PubMed  CAS  Google Scholar 

  19. Landsverk T, Oltedal E, Sund RB (1984) Acta Pharmacol Toxicol 54:22–32

    CAS  Google Scholar 

  20. Anonymus (1974) Dioctyl sodium sulphosuccinate-Biological data. WHO food additives, series No. 6

    Google Scholar 

  21. DujovneCA, Shoeman DW (1972) Clin Pharmacol Ther 13:602–608

    Google Scholar 

  22. Ammon HPT (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 382–384

    Google Scholar 

  23. Schindler AM (1984) Lancet 2:822

    PubMed  CAS  Google Scholar 

  24. Jodhka GS, Gouda MW, Medora RS, Khalil SA (1975) J Pharm Sci 64:1858–1862

    PubMed  CAS  Google Scholar 

  25. Jodhka GS, Gouda MW, Medora RS, Khalil SA (1976) J Pharm Sci 64:1319–1332

    Google Scholar 

  26. Ammon HPT (1981) Arzneimittelneben-und Wechselwirkungen, Wissenschaftliche Verlagsgesellschaft, Stuttgart, S. 10

    Google Scholar 

  27. Khallafallah N, Gouda MW, Khalil SA (1975) J Pharm Sci 64:991–994

    Google Scholar 

PK

  1. Mar 29, S. 1.360

    Google Scholar 

vB

  1. Negwer M (1989) Organisch-chemische Arzneimittel und ihre Symptoma, 5. Aufl., Bd. 11, Akademie Verlag, Berlin, S. 1.018

    Google Scholar 

ak

  1. USA Patent (USP) 1976 Nr. 4066772

    Google Scholar 

  2. Vandenberk J, Kennis LEJ, Van der AMJMC, Van Heertum AAMTh (1977) Ger. Offen.:101–110, zit. nach CA (1984) 101:23274c

    Google Scholar 

  3. Zarapkar SS, Salunkhe BB (1990) Indian Drugs 27(10):537–540, zit. nach CA (1992) 116:28304q

    CAS  Google Scholar 

  4. Shah Y, Khanna S, Jindal KC, Dighe VS (1990) Indian J Pharm Sci 52(2):100–101, zit. nach CA (1991) 114: 109049w

    CAS  Google Scholar 

  5. Rao GR, Kini GR, Avadhanulu AB, Vatsa DK (1990) East Pharm 33(389):133–135, zit. nach CA (1991) 113: 218365w

    CAS  Google Scholar 

  6. Al-Khamis KI, Hagga MEM, Al-Khamees HA, Al-Awadi M (1990) Anal Lett 23(3):451–460, zit. nach CA (1991) 113:103520a

    CAS  Google Scholar 

mh

  1. Wienbeck M, Barnert J (1990) Z Gastroenterol 28(Suppl. l):22–26

    PubMed  CAS  Google Scholar 

  2. Champion MC (1988) Gen Pharmacol 19:499–505

    PubMed  CAS  Google Scholar 

  3. Huang YC, Colaizzi JL, Bierman RH, Woestenborghs R, Heykants JJP (1986) J Clin Pharmacol 26:628–632

    PubMed  CAS  Google Scholar 

hr

  1. Waser E, Sommer H (1923) Helv Chim Act 6:54–61

    CAS  Google Scholar 

  2. Schöpf C, Bayerle H (1934) Liebigs Ann Chem 513:190–202

    Google Scholar 

  3. Hahn G, Siehl K (1936) Chem Ber 69:2627–2654

    Google Scholar 

NE

  1. KohliJD, Glock D, Goldberg LI (1982) Adv Biochem Psychopharmacol 35:97–108

    Google Scholar 

  2. Stoof JC, Kebabian JW (1984) Life Sci 35:2.281–2.296

    Google Scholar 

  3. Dawson TM, Gehlert DR, Wamsley JK (1986) Adv Exp Med Biol 204:93–118

    PubMed  CAS  Google Scholar 

  4. Beart PM (1989) Clin Exp Pharmacol Physiol 16:511–515

    PubMed  CAS  Google Scholar 

  5. Brodde OE (1982) Life Sci 31:289–306

    PubMed  CAS  Google Scholar 

  6. Goldberg LI (1972) Pharmacol Rev 24:1–29

    PubMed  CAS  Google Scholar 

  7. Farah AE, Alousi AA, Schwarz RP jr (1984) Annu Rev Pharmacol Toxicol 243:275–328

    Google Scholar 

  8. Scholz H (1984) J Amer Coll Cardiol 4:389–397

    CAS  Google Scholar 

  9. Colucci WS (1989) Cardiol Clin 7:131–144

    PubMed  CAS  Google Scholar 

  10. Kleinschmidt R, Spannbrucker N, Vogel F (1985) Dtsch med Wochenschr 110:598–603

    PubMed  CAS  Google Scholar 

  11. Lee MR (1982) Clin Sci 62:439–448

    PubMed  CAS  Google Scholar 

  12. Smit AJ (1989) Neth J Med 34:47–58

    PubMed  CAS  Google Scholar 

  13. Lokhandwala MF, Barrett RJ (1982) J Auton Pharmacol 2:189–215

    PubMed  CAS  Google Scholar 

  14. Crexells C, Bourassa MG, Biron P (1973) Cardiovasc Res 7:436–445

    Google Scholar 

  15. Balakumaran K, Hugenholtz PG (1986) Drugs 32:372–382

    PubMed  CAS  Google Scholar 

  16. Pop T, Erbel R, Henrichs KJ, Esser MJ, Meyer J (1986) Dtsch Med Wochenschr 111:1.118–1.120

    Google Scholar 

  17. Smith CB, Jacobson JA (1986) Dis Mon 32:77–118

    PubMed  CAS  Google Scholar 

  18. Schwarz R, Aviado DM (1976) J Clin Pharmacol 16:88–98

    PubMed  CAS  Google Scholar 

  19. Loeb HS, Winslow EBJ, Rahimitoola SH (1971) Circulation 44:163–173

    PubMed  CAS  Google Scholar 

  20. Goldberg LI, Hsieh YY, Resnekov L (1977) Prog Cardiovasc Dis 19:327–340

    PubMed  CAS  Google Scholar 

  21. Rajfer SI, Goldberg LI (1982) Eur Heart J 3:103–106

    PubMed  Google Scholar 

  22. Dasta JF, Kirby MG (1986) Pharmacotherapy 6:304–310

    PubMed  CAS  Google Scholar 

  23. Horn AS (1976) Postgrad Med J 52:25–32

    PubMed  CAS  Google Scholar 

Mt

  1. Waser E, Sommer H (1923) Helv Chim Act 6:54–61

    CAS  Google Scholar 

  2. Hahn G, Siehl K (1936) Chem Ber 69:2627–2654

    Google Scholar 

  3. Carter JE, Johnson JH, Baaske DM (1982) Dopamine Hydrochloride. In Ana, Bd. 11, S. 257–272

    Google Scholar 

  4. Dibbern H W, Wirbitzki E (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor Aulendorf

    Google Scholar 

  5. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

NE

  1. Dahl LE, Dencker SJ, Lundin L (1981) J Int Med Res 9:103–107

    PubMed  CAS  Google Scholar 

  2. Blacker R, Shanks NJ, Chapman N, Davay A (1988) Psychopharmacology 95:S18–S24

    PubMed  Google Scholar 

  3. Deering RB, Vallè-Jones JC (1974) Curr Med Res Opin 2:471–473

    PubMed  CAS  Google Scholar 

  4. Dorman T (1980) J Int Med Res 8:286–292

    PubMed  CAS  Google Scholar 

  5. Lambourn J, Rees JA (1974) J Int Med Res 2:210–213

    Google Scholar 

  6. Mendlewicz J, Linkowski P, Rees JA (1980) Br J Psychiatry 136:154–160

    PubMed  CAS  Google Scholar 

  7. Eilenberg D (1980) New Zealand Med J 91:92–93

    PubMed  CAS  Google Scholar 

  8. Evans L, Cox J (1981) Med J Australia 2:147–148

    PubMed  CAS  Google Scholar 

  9. General Practitioner Research Group (1976) Practitioner 216:581–583

    Google Scholar 

  10. Shopsin B, Cassano GB, Conti L (1981) An overview of new „second generation“ antidepressant compounds: research and treatment implications. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 219–251

    Google Scholar 

  11. Lancaster SG, Gonzalez JP (1989) Drugs 38:123–147

    PubMed  CAS  Google Scholar 

  12. Lipsedge MS, Linford Rees W, Pike DJ (1971) Psychopharmacologia 19:153–162

    PubMed  CAS  Google Scholar 

  13. Takahashi R, Tsuiki D, Hironaka I, Kusumoto S, Kurihara M (1983) Clin Evaluations 11:201–228

    Google Scholar 

  14. Ishikawa K, Shibanoki S, Kubo T, Watanabe S, Matsumoto A, Kogure M (1986) Eur J Pharmacol 120:63–68

    PubMed  CAS  Google Scholar 

  15. Richelson E, Pfenning M (1984) Eur J Pharmacol 104:277–286

    PubMed  CAS  Google Scholar 

  16. Shein K, Smith SE (1978) Br J Pharmacol 62:567–571

    PubMed  CAS  Google Scholar 

  17. Richelson E, Nelson A (1984) J Pharmacol Exp Ther 230:94–102

    PubMed  CAS  Google Scholar 

  18. Sulser F (1983) Psychopharmacol Bull 19:300–304

    PubMed  CAS  Google Scholar 

  19. Yu DK, Dimmitt DC, Lanman RC, Giesing DH (1986) J Pharm Sci 75:582–585

    PubMed  CAS  Google Scholar 

  20. Maguire KP, Burrows GD, Norman TR, Scoggins BA (1981) Br J Clin Pharmacol 12:405–109

    PubMed  CAS  Google Scholar 

  21. Nakra BRS, Glass RC, Rees JA (1977) J Int Med Res 5:391–397

    PubMed  CAS  Google Scholar 

  22. Rees JA (1981) J Int Med Res 9:98–102

    PubMed  CAS  Google Scholar 

  23. Ogura C, Kishimoto A, Mizukawa R, Hazama H, Honma H (1983) Eur J Clin Pharmacol 25:811–814

    PubMed  CAS  Google Scholar 

  24. Sieberns S (1985) Therapiewoche 35:5.805–5.815

    Google Scholar 

RM

  1. DFG (1985) Gas Chromatographic Retentions Indices of Toxicologicaly Relevant Substances, Verlag Chemie

    Google Scholar 

Ab

  1. Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2.Aufl., Noyes Publications, Park Ridge, New Jersey, USA, S. 536

    Google Scholar 

  2. Lunsford CD, Cale AD jr, Ward JW, Franko BV, Jenkins H (1964) J Med Chem 7:302

    PubMed  CAS  Google Scholar 

  3. Tamada M, Morita K, Ishii S, Arikawa S (1975) Iyakuhin Kenkyu 6:17, zit. nach CA (1975) 88:141592y

    CAS  Google Scholar 

RE

  1. Locke RG, Salvia JV (1990) J Am Osteopath Assoc 90:602–604 und 607–612

    PubMed  CAS  Google Scholar 

hr

  1. Sittig M (1988) Pharmaceutical Manufacturing Encyclopedia, 2. Aufl., Noyes Publications, Park Ridge New Jersey, USA, S. 536

    Google Scholar 

  2. Salim EF, Martin AE (1967) J Pharm Sci 56:748

    PubMed  CAS  Google Scholar 

  3. Masumarra G, Scarlata G, Cirma G, Romano G, Palazzo S, Clementi S, Giulietti G (1985) J Chromatogr 350:151

    Google Scholar 

  4. Daldrup T, Susanto F, Michalke P (1981) Fresenius’ Z Anal Chem 308:413

    CAS  Google Scholar 

RE

  1. Goodman LS, US-Pat. 2,744,852 (1956), zit. nach CA (1957)51:487d

    Google Scholar 

PA

  1. Negwer M (1987) Organic-chemical Drugs and their Synonyms, Akademie-Verlag, Berlin

    Google Scholar 

vB

  1. Ribbentrop A, Schaumann W (1965) Arzneim Forsch 15:863–868

    CAS  Google Scholar 

  2. Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Drugs 13:161–218

    PubMed  CAS  Google Scholar 

  3. Sieberns S (1985) Therapiewoche 35:5.805–5.815

    Google Scholar 

  4. Sugrue MF (1981) Chronic antidepressant administration and adaptive changes in central monoaminergic systems. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 13–30

    Google Scholar 

  5. Richelson E, Pfenning M (1984) Eur J Pharmacol 104:277–286

    PubMed  CAS  Google Scholar 

  6. Baldessarini RJ (1989) J Clin Psychiatry 50:117–126

    PubMed  CAS  Google Scholar 

  7. Baldessarini RJ (1982) McLean Hosp J 7:1–27

    Google Scholar 

  8. Richelson E (1981) Tricyclic antidepressants: Interaction with histamine and muscarinic acetylcholine receptors. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 53–73

    Google Scholar 

  9. Peroutka SJ, Snyder SH (1981) Interactions of antidepressants with neurotransmitter receptor sites. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 75–90

    Google Scholar 

  10. Møller-Nielsen I (1980) Tricyclic antidepressants: General pharmacology. In: Born GVR, Farah A, Herken H, Welch AD (Hrsg.) Handbook of experimental pharmacology, vol. 55/I. Hoffmeister F, Stille G (Hrsg.) Psychotropic agents Part I: Antipsychotics and antidepressants. Springer-Verlag, Berlin Heidelberg New York, S. 399–414

    Google Scholar 

  11. Shein K, Smith SE (1978) Br J Pharmacol 62:567–571

    PubMed  CAS  Google Scholar 

  12. Schönhöder PS, Schwabe U (1989) Therapeutischer Einsatz von Psychopharmaka. In: Fülgraff G, Palm D (Hrsg.) Pharmakotherapie. Klinische Pharmakologie. Gustav Fischer Verlag, Stuttgart New York, S.232–251

    Google Scholar 

  13. Mobley PL, Sulser F (1981) Down regulation of central noradrenergic receptor system by antidepressant therapies: Biochemical and clinical aspect. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 31–51

    Google Scholar 

  14. Sulser F (1983) Psychopharmacol Bull 19:300–304

    PubMed  CAS  Google Scholar 

  15. Babington RG (1981) Neurophysiologic techniques and antidepressive activity. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 157–173

    Google Scholar 

  16. Ziegler VE, Biggs JT, Wylle LT, Rosen SH, Hawf DJ, Coryell WH (1978) Clin Pharmacol Ther 23:573–579

    PubMed  CAS  Google Scholar 

  17. Abernethy DR, Todd EL (1986) J Clin Psychopharmacol 6:8–12

    PubMed  CAS  Google Scholar 

  18. Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The pharmacological basis of therapeutics, 8th edition. Macmillan, New York, S. 383–435

    Google Scholar 

  19. Faulkner RD, Pitts WM, Lee CS, Lewis WA, Fann WE (1983) Clin Pharmacol Ther 34:509–515

    PubMed  CAS  Google Scholar 

  20. Pollock BG, Perel JM (1989) Can J Psychiatry 34:609–617

    PubMed  CAS  Google Scholar 

  21. Friedel RO, Raskind MA (1975) Relationship of blood levels of Sinequan® to clinical effects in the treatment of depression in aged patients. In: Mendels J (Hrsg.) Sinequan: A monograph of recent clinical studies. Elsevier, New York, S. 51–53

    Google Scholar 

  22. Sutherland DL, Remillard AJ, Haight KR, Brown MA, Old L (1987) Eur J Clin Pharmacol 32:159–164

    PubMed  CAS  Google Scholar 

  23. Scheinin M, Virtanen R, Iisalo E (1985) Int J Clin Pharmacol Ther Toxicol 23:38–42

    PubMed  CAS  Google Scholar 

  24. Hobbs CD (1969) Biochem Pharmacol 18:1.941–1.954

    Google Scholar 

  25. Kimura Y, Kume M, Kageyama K (1972) Pharmacometrics 6:955–971

    CAS  Google Scholar 

  26. Biggs JT, Preskom SH, Ziegler VE, Rosen SH, Meyer DA (1978) J Clin Psychiatry 39:740–742

    PubMed  CAS  Google Scholar 

  27. Risch SC, Janovsky DS, Huey LY (1981) Plasma levels of tricyclic antidepressants and clinical efficacy. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven Press, New York, S. 183–217

    Google Scholar 

  28. Möller HJ, Kissling W, Wendt G, Stoll KD (1989) Psychopharmakotherapie. Kohlhammer Verlag, Stuttgart, S. 143–169

    Google Scholar 

  29. Haase HJ (1982) Therapie mit Psychopharmaka und anderen seelisches Befinden beeinflussenden Medikamenten, 5.Aufl., Schattauer Verlag, Stuttgart New York

    Google Scholar 

  30. Baker CE (1985) (Hrsg.) Physicians desk reference, 39. Aufl., Medical Economics Comp., Oradell NJ

    Google Scholar 

  31. Thomann P, Hess R (1980) Toxicology of antidepressants. In: Born GVR, Farah A, Herken H, Welch AD (Hrsg.) Handbook of experimental pharmacology, Vol. 55/I. Hoffmeister F, Stille G (Hrsg.) Psychotropic agents Parti: Antipsychotics and antidepressants. Springer-Verlag, Berlin Heidelberg New York, S. 527–549

    Google Scholar 

  32. Vohra J, Burrows G, Hunt D, Sloman G (1975) Eur J Cardiol Excerpta Medica 3:219–227

    CAS  Google Scholar 

  33. Elonen E (1974) Med Biol 52:415–423

    PubMed  CAS  Google Scholar 

  34. Elonen E, Mattila MJ, Saarnivaara L (1974) Eur J Pharmacol 28:178–188

    PubMed  CAS  Google Scholar 

RM

  1. Vigevani A, Williamson MJ (1980) Doxorubicin In: Florey K (Hrsg.) Ana 9:245–274

    CAS  Google Scholar 

  2. Aleksandrova LG, Rubasheva LM, Zbarskii VB, Salimova EI, Brazhnikova MG (1986) Antibiotiki i Meditsinskaya Biotekhnologiya 31:851– (1987) 106:56004d

    CAS  Google Scholar 

WM

  1. Seeber S (1981) Molekulare, zelluläre und klinische Pharmakologie von Adriamycin. In: Füllenbach D, Nagel GA, Seeber S (Hrsg.) Adriamycin Symposion.Ergebnisse und Aspekte, Beitr Onkol, Karger, Basel 9:1–15

    Google Scholar 

  2. Peterson C, Paul C (1983) Pharmacokinetics of doxorubucin and daunorubicin. In: Hansen HH (Hrsg.) Anthracyclines and cancer therapy. Excerpta Medica, Elsevier Science Publishers BV, Amsterdam, S.7–12

    Google Scholar 

  3. Di Marco A (1894) Epirubicin: mechanism of action at the cellular level. In: Bonadonna G (Hrsg.) Advances in anthracycline chemotherapy: epirubicin, Masson Italia Editori, Milano, S. 41–50

    Google Scholar 

  4. DiMarco A, Acarmone F (1975) Adriamycin and its mechanism of action. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent,Belgium, S. 11–24

    Google Scholar 

  5. Bachur NR (1983) Mechanism of action of doxorubicin. In: Hansen HH (Hrsg.) Anthracyclines and cancer therapy. Excerpta Medica, Elsevier Science Publishers BV, Amsterdam, S. 2–5

    Google Scholar 

  6. Pigram WJ, Fuller W, Hamilton LD (1972) Nature (New Biol) 235:17–19

    CAS  Google Scholar 

  7. Harteel JC, Duarte-Karim MM, Karim OS, Arlandini E (1975) Some physicochemical properties of adriamycin and adriamycin-DNA complex. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin Review, European Press Medikon, Ghent, Belgium, S. 27–36

    Google Scholar 

  8. Ward DC, Reich E, Goldberg IH (1965) Science 149:1.259–1.263

    Google Scholar 

  9. Schwartz HS (1975) Res Commun Chem Pathol Pharmacol 10:51–64

    PubMed  CAS  Google Scholar 

  10. Dasdia T, Di Marco A, Goffredi M, Minghetti A, Necco A (1979) Pharmacol Res Commun 11:19–29

    PubMed  CAS  Google Scholar 

  11. Carafoli E (1983) Effect of anthracyclines on calcium and phosphate transport membrane systems of heart cells. In: Abstr of the Fourth NCI-EORTC Symposion on new drugs in chemotherapy, Brüssel, Abstr. 13

    Google Scholar 

  12. Casazza AM, Isetta AM, Giuliani M, Di Marco A (1975) Immunodepressive activity of daunomcin and adriamycin. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin Review, Eurpean Press Medikon, Ghent, Belgium, S. 121–131

    Google Scholar 

  13. Benjamin RS, Riggs CE, Bachur NR (1977) Cancer Res 37:1.416–1.420

    Google Scholar 

  14. Ehninger RG, Stocker H, Wilms K (1981) Metabolisierung und Ausscheidung von Adriamycin. In: Füllenbach D, Nagel GA, Seeber S (Hrsg.) Adriamycin Symposion. Ergebnisse und Aspekte, Beitr Onkol, Karger, Basel 9:16–25

    Google Scholar 

  15. Dorr RT, Alberts DS (1982) Pharmacology of doxorubicin. In: Jones SE (Hrsg.) Current concepts in the use of doxorubicin chemotherapy, Farmitalia Carlo Erba, Milano, Italy, S. 3–20

    Google Scholar 

  16. Wilkinson PM (1978) Clinical pharmacology of adriamycin. In: Pinedo HM (Hrsg.) Clinical pharmacology of anti-neoplastic drugs, Elsevier North-Holland Biomedical Press, S. 209–223

    Google Scholar 

  17. Bachur NR, Hildebrand RC, Jaenke RS (1974) J Pharmac Exp Ther 191:331–340

    CAS  Google Scholar 

  18. Liss RH, Jesair DW, Schepis JP (1977) Proc Am Ass Cancer Res 18:221

    Google Scholar 

  19. Lee YTN, Chan KK, Harris PA, Cohen JL (1980) Cancer 45:2.231–2.239

    Google Scholar 

  20. Lenaz L, DiFronzo G, Molinari R (1975) Distribution of daunomycin and adriamycin in man. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 89–99

    Google Scholar 

  21. Rosso R, Ravazzoni C, Esposito M, Sala R, Santi L (1972) Europ J Cancer 8:455–459

    CAS  Google Scholar 

  22. Riggs CF, Benjamin RS, Serpik AA, Bachur NR (1977) Clin Pharmacol Ther 22:234–238

    PubMed  Google Scholar 

  23. Takanshi S, Bachur NR (1976) Drug Metab Disp 4:79–87

    Google Scholar 

  24. Dorr RT, Alberts TS (1982) Brit J Cancer 45:35–43

    PubMed  CAS  Google Scholar 

  25. Chan KK, Chlebowski RT, Tong M, Chen HSG, Gross JF, Bateman JR (1980) Cancer Res 40:1.263–1.269

    Google Scholar 

  26. Benjamin RS, Wiernik PH, Bachur NR (1974) Cancer 33:19–27

    PubMed  CAS  Google Scholar 

  27. Goldin A, Johnson RK (1975) Antitumor effect of adriamycin in comparison with related drugs, and in combination chemotherapy. In: Staquet M, Tagnon H, Kenis Y (Hrsg.) Adriamycin and its mechanism of action. Adriamycin Review, European Press Medicon, Ghent, Belgium, S. 7–54

    Google Scholar 

  28. Davis HL, Davis TE (1979) Cancer Treat Rep 63:809–815

    PubMed  CAS  Google Scholar 

  29. Dedrick RL, Myers CE, Bungay PM, De Vita VT Jr (1978) Cancer Treat Rep 62:1–11

    PubMed  CAS  Google Scholar 

  30. Ozols RF, Young RC, Speyer JL, Weltz M, Collins JM, Dedrick RL, Myers CE (1980) Proc AACR/ASCO 21:C-423

    Google Scholar 

  31. Chlebowski RT, Paroly WS, Pugh RP, Hueser J, Jacobs EM, Pajak TF, Bateman JR (1980) Cancer Treat Rep 64:47–51

    PubMed  CAS  Google Scholar 

  32. Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein GR, Freireich E (1982) Ann Intern Med 96:133–139

    PubMed  CAS  Google Scholar 

  33. Creasey WA, Mcintosh LS, Brescian T, Odujinrin O, Aspnes ST, Murray E, Marsh JC (1976) Cancer Res 36:216–221

    PubMed  CAS  Google Scholar 

  34. Bristow M, Thompson PD, Martin RP, Mason J, Billingham M, Harrison DC (1978) Am J Med 68:823–832

    Google Scholar 

  35. Höfling B (1984) Die Anthracyclin Kardiotoxizität, Kehrer, Freiburg

    Google Scholar 

  36. Couch RD, Loh KK, Sugino J (1981) Cancer 48:38–39

    PubMed  CAS  Google Scholar 

  37. Worthman JE, Lucas VS, Schuster E, Thiele D, Logue GL(1979) Cancer 44:1.588–1.591

    Google Scholar 

  38. Toussaint R, Löser H, Stuppenreich E, Bachour G (1979) Herz/Kreisl 11:363

    Google Scholar 

  39. LeFrak EA, Pitha J, Rosenheim S, Gottlieb JA (1973) Cancer 32:302–314

    PubMed  CAS  Google Scholar 

  40. Mikkelsen RB, Lin PS, Wallach DFH (1977) J Molec Med 2:33–40

    CAS  Google Scholar 

  41. Minow R, Benjamin R, Gottlieb J (1975) Cancer Chemother Rep 3:195–201

    Google Scholar 

  42. Minow RA, Benjamin RS, Lee ET, Gottlieb JA (1977) Cancer 39:1.397–1.402

    Google Scholar 

  43. Marzin D, Jasmin C, Maral R, Mathe G (1983) Eur J Cancer Clin Oncol 19:641–647

    PubMed  CAS  Google Scholar 

Mw

  1. Vigevani A, Williamson MJ (1980) In: Florey K (Hrsg) Ana 9:245–274

    CAS  Google Scholar 

  2. Clarke EGC (1974) Isolation and Identification of Drugs, The Pharmaceutical Press, London S. 575

    Google Scholar 

WM

  1. Stephens CR et al. (1963) J Am Chem Soc 85:2643–2652 Gd

    CAS  Google Scholar 

  2. Popov N (1982) Z Ärztl Fortbild 76:624–633

    CAS  Google Scholar 

  3. Witte W, Klare I, Halle E, Spencker FB, Böhme G (1990) Z Klin Med 45:1389–1393

    Google Scholar 

  4. Münnich D (1988) Ther Hung 36:47–50

    PubMed  Google Scholar 

  5. Walther H, Meyer FP (1987) Klinische Pharmakologie antibakterieller Arzneimittel, Urban & Schwarzenberg, München Wien Baltimore, S.245–262

    Google Scholar 

  6. Fabre J, Milek E, Kalfopoulos P, Merier G (1971) Schweiz Med Wochenschr 101:593

    PubMed  CAS  Google Scholar 

  7. Meyer FP, Specht H, Quednow B, Walther H (1988) Zentbl Pharm Pharmakother Lab Diagn 127:2–5

    CAS  Google Scholar 

  8. Keller M, Bezler H, Nieder M (1988) Dtsch Apoth Ztg 128:1565–1571

    Google Scholar 

  9. Campistron G, Coulais Y, Caillard C, Mosser J, Pontagnier H, Houin G (1986) Arzneimittelforschung 36:1705–1707

    PubMed  CAS  Google Scholar 

  10. Weingärtner L, Weigel W, Patsch R, Radzuweit H (1970) Zentbl Pharm Pharmakother Lab Diagn 109:477–482

    Google Scholar 

  11. Bocker R, Mühlberg W, Platt D, Estler CJ (1986) Eur J Clin Pharmacol 30:105–108

    PubMed  CAS  Google Scholar 

  12. Heaney D, Eknoyan G (1978) Clin Pharmacol Ther 24:233–239

    PubMed  CAS  Google Scholar 

  13. Ludwig E, Arr M, Deutsch T, Graber H (1976) Zentbl Pharm Pharmakother Lab Diagn 118:193–196

    Google Scholar 

  14. Meyer FP, Specht H, Quednow B, Walther H (1989) Infection 17:245–246

    PubMed  CAS  Google Scholar 

  15. Rüinzi J, Gikalov I, Durand R (1987) Muench Med Wochenschr 129:163–164

    Google Scholar 

  16. Hoigné R, Keller H, Sonntag R (1988) Penicillins, cephalosporins and tetracyclines. In: Dukes MNG (Hrsg.) Meyler’s side effects of drugs, Elsevier, Amsterdam New York Oxford, S. 501–542

    Google Scholar 

  17. Hummel S, Müller W (1990) Medikamentum 31:59–61

    Google Scholar 

  18. Neuvonen PJ, Penttilä O (1974) Eur J Clin Pharmacol 7:361–363

    PubMed  CAS  Google Scholar 

  19. Venho VMK, Salonen RO, Mattila MJ (1978) Eur J Clin Pharmacol 14:277–280

    PubMed  CAS  Google Scholar 

  20. Pentillä O, Neuvonen PJ, Aho K, Lahtovaara R (1974) Br Med J:470–472

    Google Scholar 

  21. Neuvonen PJ, Penttilä O, Lehtovaara R, Aho K (1975) Eur J Clin Pharmacol 9:147–154

    PubMed  CAS  Google Scholar 

  22. Garaffo R, Dellamonica P, Fournier JP, Lapalus P, Bernard E (1988) Infection 16:297–298

    Google Scholar 

  23. Neuvonen PJ, Penttilä O, Roos M, Tirkkonen J (1976) Int J Clin Pharmacol 14:303–307

    CAS  Google Scholar 

fm/Wh

  1. McCormick JRD et al. (1960) J Am Chem Soc 82:3381–3386

    CAS  Google Scholar 

  2. Stephens CR (1963) J Am Chem Soc 85:2643–2652

    CAS  Google Scholar 

  3. Casy AF, Yasin A (1985) Magn Res Chem 23:767–770

    CAS  Google Scholar 

  4. Asleson GL, Frank CW (1975) J Am Chem Soc 97:6246–6248

    CAS  Google Scholar 

  5. Jäger H et al. (1980) Arzneim-Forsch 30:1932–1943

    Google Scholar 

Gd

  1. McCormick JRD et al. (1960), J Am Chem Soc 82:3381–3386

    CAS  Google Scholar 

Gd

  1. Jap Pat 80 10,576 (TokkyoKoho), zit. nach CA (1980) 93:168021b

    Google Scholar 

Gd

  1. Tilford CH, Shelton RS, Van Campen MG (1948), J Am Chem Soc 70:4001–4009

    PubMed  CAS  Google Scholar 

  2. Sperber N, Papa D, Schwenk E, Sherlock M (1949), J Am Chem Soc 71:887–890

    PubMed  CAS  Google Scholar 

  3. Beil Erg. Werk 3/4, Bd. 21, Teil 2, S. 1434

    Google Scholar 

  4. Fricke FL (1972), J Assoc Off Anal Chem 55:1162–1167

    PubMed  CAS  Google Scholar 

  5. Musumarra C, Scarlata G, Cirma G, Romano G, Palazzo S, Clementi S, Giulietti G (1985), J Chromatogr 350:151–169

    PubMed  CAS  Google Scholar 

  6. Beil Erg. Werk 5, Bd. 21, Teil 3, S.508

    Google Scholar 

MP

  1. Feinberg SM, Bernstein TB (1948) J Lab clin Med 33:319–324

    PubMed  CAS  Google Scholar 

  2. Haas H (1951) Histamin und Antihistamine, Aulendorf i. Württ, Editio Cantor

    Google Scholar 

  3. Brown BB, Werner HW, Peters EL (1948) J Lab clin Med 33:325–331

    PubMed  CAS  Google Scholar 

  4. Marsh DF, Davis AJ jr (1947) J Pharmacol Exp Ther 89:234–246

    PubMed  CAS  Google Scholar 

  5. Sjoqvist F, Lasagna L (1967) Clin Pharmacol Ther 8:48–54

    PubMed  CAS  Google Scholar 

  6. Snyder FH, Klahm GR, Werner HW (1948) J Am Pharm Assoc 37:420–423

    CAS  Google Scholar 

  7. Favis GR (1976) New Engl J Med 294:730

    PubMed  CAS  Google Scholar 

sw

  1. Dibbern HW (1978) UV- und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Edito Cantor, Aulendorf

    Google Scholar 

  2. Eigene Messung

    Google Scholar 

MP

  1. Miescher K, Hoffmann K (1941) Helv Chim Acta 24:458–462

    CAS  Google Scholar 

  2. Mndzhoyan OL, Bagdasaryan ER, Asratyan SN (1968) Arm Khim Zh 21:981–984 CA (1969) 70:106.150j

    CAS  Google Scholar 

Gb

  1. Blicke FF (1944) Ann Rev Biochem 13:549

    CAS  Google Scholar 

  2. Lands AM, Luduena FP (1956) J Pharmacol Exp Ther 117:331–346

    PubMed  CAS  Google Scholar 

  3. Weston AW (1946) J Org Chem 68:345–348

    Google Scholar 

  4. Meier R, Hoffmann K (1940/41) Helv Med Acta 7, Suppl. 6:106–125

    Google Scholar 

  5. Necheles H, Olson HW, Neuwelt F, Spier E (1944) Gastroenterology 2:46–59

    CAS  Google Scholar 

  6. Fleisch A, Formanek K, Habicht E, Weis W (1961) Arzneim Forsch 11:1119–1126

    CAS  Google Scholar 

  7. Gilman A, Goodman L, Thomas JM, Hahn GA, Prutting JM (1942) J Pharm Exper Ther 74:290–298

    CAS  Google Scholar 

  8. Geigy (1990) Fachinfo zu Spasmo-Cibalgin S und Spasmo-Cibalgin compositum S

    Google Scholar 

  9. Wiegand UW, Weder HG, Haller R (1975) Arzneim Forsch 25:839–843

    CAS  Google Scholar 

KC

  1. Dibbern HW, Wirlitzki E (1978) UV-und IR-Spektren wichtiger pharmazeutischer Wirkstoffe, Editio Cantor, Aulendorf

    Google Scholar 

  2. Facchini G, Zaccheo F, Nannetti M (1983) Boll Chim Farm 122:405–411

    PubMed  CAS  Google Scholar 

  3. Longree R, Bosly J (1975) Michrochim Acta 1975:321–336

    Google Scholar 

  4. Cieszynski T (1974) Acta Pol Pharm 31:99–107

    PubMed  CAS  Google Scholar 

Gb

  1. Ruenitz PC, Bagley JR, Mokker CM (1982) J Med Chem 25:1056–1060

    PubMed  CAS  Google Scholar 

AE

  1. Aubry U, Carignan G, Charette D, Lavallee JP (1966) Canad Anaesth Soc J 13:263–271

    PubMed  CAS  Google Scholar 

  2. Corssen G, Chodoff P (1965) Neuroleptanalgesia. In: Orkin L (Hrsg.) Clinical management of the patient in shock, F. A. Davis Comp., Philadelphia, S. 137–154

    Google Scholar 

  3. Cressman WA, Plostnieks J, Johnson PC (1973) Anesthesiology 38:363–369

    PubMed  CAS  Google Scholar 

  4. Etschenberg E (1973) Anaesthesie mit Droperidol und Fentanyl, Editio Cantor, Aulendorf

    Google Scholar 

  5. Heininger K, Siebers S (1992) Pharmakologie. In: Riederer P, Laux G, Pöldinger W (Hrsg.) Neuro-Psychopharmaka, Bd.4, Springer-Verlag, Wien, S. 17–43

    Google Scholar 

  6. Janssen PAJ, Niemegeers CJE, Schellekens KH, Verbruggen FJ, van Neuten JM (1963) Arzneim Forsch 13:205–211

    CAS  Google Scholar 

  7. Janssen PAJ, Allewijn FTN (1969) Arzneim Forsch 19:199–208

    CAS  Google Scholar 

  8. Janssen PAJ, van Bever WFM (1983) Butyrophenone and Diphenylbutylamine. In: Hippius H, Klein HE (Hrsg.) Therapie mit Neuroleptika, perimed Fachbuch-Verlagsgesellschaft mbh, Erlangen, S. 13–53

    Google Scholar 

  9. Hyttel J, Larsen J-J, Christensen AV, Arnt J (1985) Receptor-binding profiles of neuroleptics. In: Casey DE, Chase TN, Christensen AV, Gerlach J (Hrsg.) Dyskinesia-Research and Treatment, Springer-Verlag, Berlin Heidelberg, S. 9–18

    Google Scholar 

  10. Kuemmerle H-P (1989) Klinisch-Pharmakologische Arzneimittelprofile. Droperidol, ecomed

    Google Scholar 

  11. Soudijin W, van Wijngaarden I, Allewijn F (1967) Eur J Pharmacol 1:47–57

    Google Scholar 

OT

  1. Morren HG (1961) Belg. Pat. 601394, zit. nach CA (1962) 56:2460d

    Google Scholar 

  2. Moffat AC, Jackson JV, Moss MS, Widdop B (Hrsg.) (1986) Clarke’s Isolation and Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

  3. Cavazutti G, Gagliardi L, Amato A, Profili M, Zagarese V, Tonelli D, Gattavecchia E (1983) J Chromatogr 268:528–534

    Google Scholar 

  4. Musumarra G, Scarlata G, Cirma G, Romano G, Palazzo S, Clementi S, Giulietti G (1985) J Chromatogr 350:151–168

    PubMed  CAS  Google Scholar 

  5. Bourdais J (1968) Bull Soc Chim France: 3246–3249

    Google Scholar 

KU

  1. Bossi R, Lavezzo A (1988) Preliminary data: levodropropizine prevent fog induced bronchospasm in asthmatic allergic hyperreactive patients, 2nd Int Meeting on Respiratory Allergy, Sorrento, Italy 21–23 April, S. 96

    Google Scholar 

  2. Malandrino S, Melillo G, Bestetti A, Borsa M, Guiliani P, Tonon GC (1988) Arzneim Forsch 38:1141–1143

    CAS  Google Scholar 

  3. Melillo G, Malandrino S, Rossoni G, Caselli G, Bestetti A, Borsa M, Tonon GC, Berti F (1988) Arzneim Forsch 38:1144–1150

    CAS  Google Scholar 

  4. Bastos-Ramos WP, Fortes VA, Ramos AC (1984) Rev Ciènc Bioméd 5:27–32

    CAS  Google Scholar 

  5. Kurz H (1989) Antitussiva und Expektoranzien, Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

SZ

  1. Ringold HJ, Batres E, Halpern O, Necoechea E (1959) J Am Chem Soc 81:427–432

    CAS  Google Scholar 

WM

  1. Ringold HJ, Batres E, Halpern O, Necoechea E (1959) J Am Chem Soc 81:427–432

    CAS  Google Scholar 

WM

  1. Cooperative Breast Cancer Group (1961) Cancer Chemother Rep 11:119

    Google Scholar 

  2. Dorfman RJ, Baba S, Abe O et al. (1968) The influence of drostanolone on a rat mammary fibroadenoma and carcinogen-induced adeno-carcinoma. In: Jarett AS (Hrsg.) The treatment of carcinoma of the breast, Exerpta Medica, Amsterdam, S. 15

    Google Scholar 

  3. Deshpande N, Jensen V, Bulbrook RD (1967) Steroids 10:219

    PubMed  CAS  Google Scholar 

  4. Trams G (1977) Europ J Cancer 13:149

    CAS  Google Scholar 

  5. Thomas AN, Gordan GS, Goldman L et al. (1962) Cancer 15:176

    PubMed  CAS  Google Scholar 

OJ

  1. Seki I, Kitami M (1967/1968) S. African Pat. 03407, zit. nach CA (1969) 71:39247b

    Google Scholar 

KU

  1. Profft F (1952) Chem Tech 4:241–246, zit. nach CA (1953) 47:10531d

    CAS  Google Scholar 

TR

  1. Mar 29, S. 1.215

    Google Scholar 

vB

  1. Jager FC, Michielsms PMLJ, Minter B, Post LC, De Wachter AM, Williams JGC, Zwagenmakers JMA (1988) Summary of the properties of dydrogesterone, Duphar BV, Weesp, The Netherlands

    Google Scholar 

  2. Boris A, Stevenson RH, Trmal T (1966) Steroids 7:7–10

    Google Scholar 

  3. Neumann F (1968) Chemische Konstitution und pharmakologische Wirkung. In: Junkmann K (Hrsg.) Handbuch der experimentellen Pharmakologie, BandXXII/1, Die Gestagene, Teil 1, Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  4. Lauritzen C (1989) Stellungnahme zur klinischen Indikation on Dydrogesteron, 15.12.1989, Duphar BV, Weesp, The Netherlands

    Google Scholar 

  5. Kupfermic MJ, Lessing JB, Amit A, Yoel J, Daid MP, Peyser MR (1990) Human Reproduction 5:271–279

    Google Scholar 

  6. Coutts JR, McNally EM, McEwan HP (1983) Br J Clin Pract 24:27–33

    Google Scholar 

  7. De Cleyn K, Buytaert P, Delbeke L, Gerris J (1986) Eur J Obstet Gynecol Reprod Biol 23:201–209

    PubMed  Google Scholar 

  8. Jesinger DK (1987) The effects of endometrial histology and blood lipids of 10 or 20 mg dydrogesterone for the first 12 days per month to counteract unopposed oestrogen therapy in postmenopausal women, Duphar report No.H. 102.913/M, Duphar Laboratories Ltd., Gaters Hill, Southampton

    Google Scholar 

  9. Lacey RW, Howson GL, Sampson GA (1983) Br J Clin Pract 24:4–10

    Google Scholar 

  10. Lane G, Siddle NC, Ryder TA, Pryse-Davies J, Endacott J, Whitehead MJ (1982) Int Med 2, 1:13

    CAS  Google Scholar 

  11. Lane G, Siddle NC, Ryder TA, Pryse-Davies J, King RJB, Whitehead MJ (1986) Br J Obstet Gynecol 93:55–62

    CAS  Google Scholar 

  12. Lane G, Whitehead MJ, King RJB (1982) Int Med 2:13–18

    Google Scholar 

  13. Serfaty D, Bestaux Y, Brun JP, Malgonyat J, Sally F, Legal M (1986) Contraception-fertilité-sexualité 14:641–648

    Google Scholar 

  14. Soutoul JH, Rozenbaum H, Racinet C, Pauchet H, Netter A (1983) Gynécologique 34:473–470

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Bruchhausen, F. et al. (1993). D. In: von Bruchhausen, F., et al. Hagers Handbuch der Pharmazeutischen Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57995-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57995-0_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63429-1

  • Online ISBN: 978-3-642-57995-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics